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Summary.
There are two distinct biosynthetic pathways to the 
essential amino acid L-lysine (A). The diaminopimelate pathway 
to L-lysine occurs in higher plants and bacteria whereas the a- 
aminoadipate pathway operates in fungi and yeasts. This thesis is 
concerned with the initial step of the diaminopimelate pathway to 
L-lysine, catalysed by the enzyme dihydrodipicolinate synthase 
(DHDPS). The m echan ism  of fo rm a tio n  o f l-2,3- 
dihydrodipicolinate (l-2,3-DHDPA) (B), the product of the reaction 
catalysed by DHDPS, was investigated. The synthesis and testing 
of potential inhibitors of DHDPS was also studied.
CO'2
+
H3N- •H
(CH2)4NH2
(A)
L-Aspartic acid p -sem ialdehyde (l-ASA) (C) is a 
substrate of DHDPS. A former co-worker of ours, Dr. David Tudor, 
had  previously  p repared  and iso la ted  d l -ASA as the 
trifluoroacetate salt. The synthesis of dl-ASA was carried out in 
this work in order to have a supply of DL-ASA for testing of 
compounds with DHDPS. Manipulation of the synthetic route to 
dl-ASA (C) allowed us to prepare several imine derivatives (D). 
These were tested for inhibitory activity with DHDPS. The 
trifluoroacetate salt of the thiosemicarbazone derivative (E) was a 
good inhibitor, showing 46% inhibition at O.lmM with DHDPS.
RN CO - "2 h 2n c n h n co2h
(D) (E)
The synthesis o f  DL-glutamic acid y-semialdehyde (DL- 
GSA) (F) and DL-aminoadipic acid 8 -semialdehyde (dl-AASA) (G) 
was studied. The preparation of the trifluoroacetate salts of DL- 
GSA (F) and dl-AASA (G) was achieved and these compounds 
have been tested as inhibitors and substrates of DHDPS.
A number of heterocyclic analogues of l-2,3-DHDPA (B) 
were prepared and tested for inhibitory effects with DHDPS. 
Dimethyl 4-hydroxy-piperidine-ci's-2,6-dicarboxylate (H) showed 
only 29% inhibition at 5mM with DHDPS. Commercially available
2,2,6,6-tetramethyl-4-piperidinol (I) and 2,2,6,6-tetramethyl-4- 
piperidone (J) were more effective inhibitors, showing 46% and 
22% inhibition at 0.5 mM respectively. The oxime (K) and 
methyloxime (L) derivatives were also reasonable inhibitors at 
0.5 mM. l,3-Thiazole-2,4-dinitrile (M) was an effective inhibitor, 
showing 18% inhibition at 0.1 mM.
?c
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Chapter 1 - L-Lysine : An Essential Amino Acid.
Introduction.
a-Amino acids are found in living organisms in both their 
free forms and joined by amide linkages in peptides and proteins. 
With the development of chromatographic techniques in the last 40 
years, the number of known, naturally occurring amino acids has 
risen to around 1000. As amino acids are finding increasing use in the 
synthesis of pharmaceuticals, agricultural products, the food industry 
and materials science, the synthetic methods used to prepare both 
natural and structurally diversified a-amino acids are becoming 
increasingly important.
There are about 20 different protein a-amino acids, the 
structures of which were determined in the 100 years since Braconnet 
first characterised glycine and leucine in 1820. With the exception of 
glycine, all are optically active and usually have the L-configuration at 
the a-carbon atom. The general structure of the proteinogenic a- 
amino acids is shown in Fig. 1.
An important proteinogenic a-amino acid is L-lysine (1) (R = 
(CH2 )4 NH2 in Fig. 1). Its importance will be discussed in Section 1.2.
H
+NH3 
R = (CH2 )4NH2 (1)
Fig. 1
1
1.1 Amino Acid Biosvnthetic Enzvmes as Targets of 
Herbicide/Antibiotic Action.
Many metabolic differences between the p lan t and animal 
kingdoms exist. Plants, unlike animals, obtain energy from light via 
the process known as photosynthesis. They must also synthesise their 
own plant-specific horm ones and cell walls. Plants and animals 
further differ in their ability to synthesise amino acids and vitamins. 
While plants are able to make all these compounds, animals must 
obtain vitam ins and the essential amino acids from  their diet. 
Scheme 1 shows an overview of amino acid biosynthesis. The 
common metabolic intermediates are written in italics. Amino acids 
essential to the mammalian diet are underlined. The metabolic 
pathways shown below the broken line do not occur in mammals, but 
are found in plants and bacteria, and are therefore potential targets 
for selectively toxic herbicides or antibiotics.
A num ber of herbicides are known to act by inhibiting 
essential amino acid biosynthesis. The biosynthetic pathways which 
each herbicide inhibits are marked by a cross in Scheme 1. 
Glyphosate (GP) (2) is a nonselective herbicide which interferes with 
steps of the common aromatic amino acids pathway.1*2 Aminotriazole 
(AT) (3) was patented as a broad spectrum herbicide in 1954 by the 
American Chemical Paint Company. It was found to antagonize 
histidine biosynthesis in bacteria and yeast by blocking the activity of 
im idazole glycerol phosphate dehydratase .3 The sulfonylurea 
herbicides, chlorosulfuron (CS) (4) and sulfometuron methyl (SM) (5) 
are notable for their high potency and low mammalian toxicity.4 
While sulfom eturon methyl (5) is a broad-spectrum  non-selective
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1
herbicide, chlorosulfuron (4) is selective and can be applied to 
prevent the growth of weeds without detriment to cereal crops. Both 
these compounds inhibit the biosynthetic pathways to branched chain 
amino acids.
One potential target for herbicide/antibiotic action which has 
received relatively little attention is the biosynthetic pathway to 
lysine (1). Our research group at Glasgow has been investigating the 
early stages of the biosynthetic pathway to lysine ( 1 ) as found in 
bacteria and plants. This thesis details the biosynthetic pathway to 
lysine ( 1 ) and describes the synthesis and testing of a range of 
compounds as potential inhibitors of lysine (1 ) biosynthesis.
- O - P - C H 9 - N H T - C H 7 - C O 7 -
NH
N =
(4 ) R1 = C l , R 2 = OCH
(5) Rx = C02CH3 , R2 = CH3
4
1.2 The Importance of L-Lvsine (1).
L-Lysine (1) is economically one of the most im portant amino 
acids. Mammals lack the ability to make L-lysine (1) and so must 
consume it within their diet. In other words, it is an essential amino 
acid for human and animal nutrition. The nutritive value of protein 
depends on the quantity and balance of its constituent essential amino 
acids. Table 1 shows the estimated daily requirements of adults.
Amino Acid Amount (m g/kg)
Isoleucine 10
Leucine 14
Lysine 12
Methionine and cysteine 13
Phenylalanine and tyrosine 14
Threonine 7
Tryptophan 4
Valine 10
Table 1
It is necessary to consume these essential amino acids daily 
and simultaneously. If one essential amino acid is supplied at an 
inadequate rate or at a different time from the other amino acids, the 
level of utilization of all the amino acids is lowered to that of the 
deficient, limiting amino acid. L-Lysine (1) is a limiting amino acid in 
plant protein, especially cereal protein. The nutritional value of plant
5
protein can be improved by adding small amounts of the limiting 
amino acid to food and animal feed. This amino acid fortification is 
im portant both nutritionally and economically as, along with DL- 
methionine, L-lysine (1) is indispensable for the production of animal 
feeds. Commercially, the largest amounts of L-lysine (1) are produced 
by the bacteria Corynebacterium glutamicum , Brevibacterium flavum  
and Brevibacterium lactofermentum.5 The production of L-lysine (1) 
will be discussed in more detail in Section 1.3.
The biosynthesis of L-lysine (1) in bacteria and plants is 
incom pletely understood. This will be discussed in Section 1.4. 
Labelling studies6 have established that m eso-2,6-diam inopim elic 
acid (29) is an intermediate in the biosynthesis of L-lysine (1). meso-
2,6-Diaminopimelic acid (29) is a building block of the peptidoglycan 
of most Gram-negative bacteria as well as Gram-positive bacteria. It 
forms part of the cross-linking moiety between adjacent peptide 
chains of the cell wall peptidoglycans.7 Inhibitors of peptidoglycan 
biosynthesis can have powerful antibiotic properties.8*9 The enzymes 
of peptidoglycan processing are therefore viable targets for the 
rational design of novel antibacterial agents. The absence of the 
peptidoglycan and L-lysine (1) biosynthetic networks in mammals 
suggests that inhibitors may possess antibacterial an d /o r herbicidal 
activity, without mammalian toxicity. The design of inhibitors will be 
discussed in more detail in Section 1.5 and Chapters 3, 4, 5 and 6.
The conversion of L-lysine (1) into alkaloids is an im portant 
biological process which has been studied for many years. Alkaloids 
are a large and diverse group of natural products which contain a 
nitrogen heterocycle, are found mainly in plants, and exhibit a wide
6
range of biological activities. Large numbers of alkaloids have been 
isolated. This has resulted in an increase in the understanding of their 
biological properties and their pharmacological, toxicological and 
ecological significance in nature. The use of isotopically labelled 
precursors in feeding experiments has helped us to understand the 
complex m anner in which alkaloids are biosynthesised. Alkaloids are 
form ed m ostly from  a few a-am ino acids (lysine, ornithine, 
phenylalanine, tryptophan and tyrosine) along with mevalonate and 
acetate. Alkaloids are important in chemistry, industry and medicine. 
In the last category, alkaloids find use in the following types of 
medicinal activity: anticholinergic (scopolamine); antihypertensive 
(rescinnam ine); antim alarial (quinine); antitum our (vinblastine); 
cardiac depressant (quinidine); gout suppressant (colchicine); narcotic 
analgesic (morphine); tranquiliser (reserpine).
There are two main classes of alkaloids which utilise L-lysine
(1) as a precursor, namely the piperidine alkaloids and the 
quinolizidine alkaloids. Scheme 2 outlines the biosynthetic routes 
taken by L-lysine (1) in the production of a piperidine alkaloid, 
anabasine (7), and a quinolizidine alkaloid, sparteine (8a).
Many higher p lants possess the necessary metabolic 
pathways for the synthesis of piperidine alkaloids. Robins et al. 10 
studied the biosynthesis of anabasine (7) in transformed root cultures 
of Nicotiana rustica and N. tabacum using cadaverine (6) precursors 
labelled with deuterium. These labelling studies indicated that the 
pro-R  hydrogen of cadaverine (6) is retained and that the pro-S  
hydrogen is lost at the position which becomes C-2f of anabasine (7).
7
H COoH
L-Lysine(l)
Decarboxylase
(-)-Sparteine (8a)
Cadavenne (6)
Diamine oxidase 
or transaminase
CHO
NH9
N'
(-)-Sparteine (8b)
2' N
‘N*
Anabasine (7)
,co9h
Scheme 2
Quinolizidine alkaloids are important because of their toxicity 
to humans and livestock as constituents of poisonous plants and 
because some of them exhibit potentially useful pharmacological 
activities. These alkaloids are commonly found in species of the genus 
Lupinus from the plant family Fabaceae (formerly Leguminosae). The 
quinolizidine skeleton is built up from two or three C5 units derived 
from L-lysine (1) via its decarboxylation product cadaverine (6 ). A 
common quinolizidine alkaloid is sparteine (8 a). It has been isolated
8
from  m any p lan t species including Spartium scoparium,11 
Sarothamnus scoparius12 and Lupinus lin d en ia n cu sA 3 Careful 
labelling studies by the groups of Robins14 and Spenser15 showed 
that there were equal levels of 13C-enrichment for 6 carbon atoms 
after feeding [13C-15N]-l,5-diaminopentane (cadaverine), and that 
there were two 15C-15N doublets around the signals for C-2 and C-15. 
This confirmed that two moles of cadaverine are incorporated into the 
two outer rings as shown in (8b) (Scheme 2). The biosynthesis of 
quinolizidine alkaloids has recently been reviewed.15a
1.3 Production of L-Lvsine (1).
The amino acid industry has been steadily expanding since 
monosodium glutamate was first marketed as a flavouring material in 
1909. All the amino acids occurring in proteins are now produced 
industrially. Amino acids can be produced by extraction from protein 
hydrolysates, by ferm entation with the aid of microorganisms, by 
enzymatic processes and by chemical synthesis. L-Lysine (1) can be 
produced industrially  by direct ferm entation m ethods (using 
auxotrophic and regulatory mutants) and by a biotransform ation 
process involving both synthetic and enzymic methodology.
With the advancem ent of m odern genetic biochemical 
techniques, it is possible to produce most proteinogenic amino acids 
by fermentation methods. Monosodium glutamate and L-lysine (1) are 
produced in the largest amounts, with annual world production levels 
of 370 000 and 40 000 tons respectively.16 Auxotrophic mutants are 
microorganisms which lack one or more enzymes required for 
biosynthesis of an amino acid. The use of homoserine-less mutants of
9
C. glutamicum  and Escherichia coli leads to the accumulation of L- 
lysine ( l ) . 1 7  The absence of homoserine dehydrogenase in these 
m utants blocks the pathway from aspartic semialdehyde to 
homoserine. This results in the accumulation of L-lysine (1), the end 
product of a branched pathway (Scheme 3).
L-Aspartate aspartate kinase 1,2,3 L-p-Aspartyl phosphate
several
steps
L-Lysine (1)
ASA
dehydrogenase
L-Aspartic acid p-semialdehyde
- X - homoserine 
if dehydrogenase
Homoserine
Methionine
Threonine
Isoleucine
Scheme 3
In regulatory mutants of microorganisms the loss of feedback 
control leads to the accumulation of excess amino acids. L-Lysine (1) is 
produced by the regulatory mutant of B. flavum . 1 8
An enzymatic process for the production of L-lysine (1) 
utilizes DL-a-aminocaprolactam (9), synthesised from cyclohexene . 1 9  
Simultaneous addition of L-aminocaprolactam hydrolase (Cryptococcus 
laurentii) and aminocaprolactam racemase (Achromobacter obae)
10
resu lts  in th e  co m p le te  enzym ic  c o n v e rs io n  in to  L-lysine (1) (Scheme 
4).
L-Lysine 
( 1)
L-Aminocaprolactam
hydrolase
(9)
NH2
D-a-Aminocapro lactam
a-Aminoca prolactam 
raceinase
Scheme 4
1.4 Biosynthesis of L-Lvsine (1).
L-Lysine (1) is biosynthesised via two mutually exclusive 
pathw ays: the a -am inoad ipa te  (AAA) pathw ay and the
diaminopimelate (DAP) pathway. The AAA pathway is characteristic 
of the Euglenids, some Phycomycetes (Chytridiales, Blastocladiales and 
M ucorales), yeasts and  h igher fungi (Ascomycetes and 
Basidiomycetes). It starts with the reaction between a-ketoglutarate
(10) and acetyl-CoA and involves the synthesis of a-aminoadipic acid 
(16) and saccharopine (18) as intermediates in the biosynthesis of L-
11
lysine (1). The DAP pathway occurs in bacteria and higher plants and 
involves the initial condensation of L-aspartic acid p-semialdehyde 
(20) with pyruvate (24). Several unique enzyme catalysed reactions 
result in the production of L-lysine (1). meso-2,6-Diaminopimelic acid 
(29) is an im portant intermediate of the DAP biosynthetic pathway to 
L-lysine (1).
The a-Aminoadipate Pathway to L-Lvsine (1).
Metabolic labelling studies with 14C-acetate have shown that, 
in Saccharomyces cerevisiaey the carbon skeleton of L-lysine (1) is 
derived from acetate.20 The proposed pathway for the formation of 
the carbon chain of L-lysine (1) in yeast (Schem e 5) involves a 
condensation of acetate with a-ketoglutarate (10) to yield homocitrate 
(11) followed by a series of reactions which are analogous to the 
formation of a-ketoglutaric acid via reactions of the citric acid cycle.21 
The resultant a-aminoadipate (16) is converted into L-lysine (1) via 
a-aminoadipate semialdehyde (17) and saccharopine (18).
L-Lysine (1) biosynthesis has been investigated in detail in S. 
cerevisiae .22 The enzymes of a-aminoadipate biosynthesis, namely 
hom ocitrate synthase, hom oaconitate hydratase, hom oisocitrate
12
q  Acetyl-CoA
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dehydrogenase and aminoadipate aminotransferase, are localised in 
the mitochondria. A second aminoadipate aminotransferase and the 
enzymes catalysing the last three steps of L-lysine (1) biosynthesis 
are nonmitochondrial.23 Intracellular free L-lysine (1) is sequestered 
in vacuoles of S. cerevisiae.24
The first intermediate of the AAA pathway is formed by the 
condensation of acetyl-CoA with a-ketoglutarate (10). This reaction is 
catalysed by an ATP and CoA-dependent enzyme, hom ocitrate 
synthase. The second intermediate, homoaconitate (12), is formed 
from the dehydration of homocitrate (11). This is catalysed by 
homocitrate dehydrase. Homoaconitate hydratase then catalyses the 
fo rm ation  of hom oisocitrate  (13). A ction of hom ocitrate  
dehydrogenase results in the reversible oxidation of homoisocitrate
(13) to oxaloglutarate (14). This process has been shown to be both 
NAD and Mg2+ dependent.25
S pontaneous decarboxylation  resu lts in a-ketoadipate (15). 
Aminoadipate aminotransferase catalyses the pyridoxal phosphate- 
dependent transamination of a-ketoadipate (15) to a-aminoadipate
(16).23 The conversion of a-aminoadipate (16) into a-aminoadipic 
semialdehyde (17) is a multistep reaction catalysed by a single ATP, 
Mg2+ and NADPH-dependent enzyme, am inoadipate semialdehyde 
d eh y d ro g en ase .26 The reduction of a-am inoadipate (16) to a- 
aminoadipic semialdehyde (17) in Saccharomyces has been shown to 
be a three step process. The amino acid first reacts with ATP to form 
an adenylyl derivative. This is then reduced in the presence of 
NADPH. The reduced adenylyl derivative is then cleaved to form a- 
aminoadipic semialdehyde (17) (Scheme 6).
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Saccharopine dehydrogenase (glutamate forming) and 
saccharopine dehydrogenase (lysine forming) catalyse the formation 
of saccharopine (18) and L-lysine (1) respectively . 2 7
T he  D iam in o p im e la te  P a thw ay  to L-Lvsine (1).
L-Lysine (1), methionine (21), threonine (22) and isoleucine 
(23) belong to the aspartate family of amino acids. In Escherichia coli, 
they each derive part or all of their carbon atoms from aspartate (19) 
and share a common biosynthetic pathway (Scheme 7).
In plants and bacteria, L-lysine (1) is produced via the 
diaminopimelate pathway2 8  from L-aspartic acid (3-semialdehyde (L- 
ASA) (20). Seven unique enzyme catalysed reactions are required for 
the synthesis of L-lysine (1) (Scheme 8). Most of the enzymes have 
been isolated from E. coli and characterised. However, enzymes 
catalysing only the first and last of these reactions have been isolated 
from plants.
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The first step unique to L-lysine (1) biosynthesis is the 
condensation of l-ASA (20) and pyruvate (24). This is catalysed by 
dihydrodipicolinate synthase and presum ably proceeds in several 
stages. Nucleophilic attack by the methyl carbon of pyruvate (24) 
upon the aldehyde carbon of l-ASA (20) would result in carbon- 
carbon bond formation. Loss of water followed by spontaneous ring 
closure and the loss of a second molecule of water results in the 
product, dihydrodipicolinate (25). An NADPH-dependent reduction of 
d ih y d ro d ip ic o lin a te  (25) re su lts  in  the  fo rm a tio n  of 
tetrahydrodipicolinate (26). Succinylation serves to protect the 2- 
amino group during the synthesis of the diam ino interm ediate. 
Desuccinylation results in L,L-diaminopimelate (28). This is followed 
by epim erisation at one of the L-centres to give m e s o -2 ,6 - 
diaminopimelate (29). Decarboxylation at the D-centre of meso-2,6- 
diaminopimelate (29) gives L-lysine (1).
An alternative biosynthetic route, which bypasses several 
stages of the proposed DAP pathway has been found to operate in 
some bacteria and maize. The enzyme, m eso -d iam in o p im ela te  
dehydrogenase, directly converts L-2,3,4,5-tetrahydrodipicolinic acid 
(26) into meso-2,6-diaminopimelate (29).
The diam inopim elate pathway to L-lysine (1) will be 
discussed in more detail in Chapter 2.
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1.5 Design of Inhibitors of the PAP Pathway to I-Lvsine.
m eso-2,6-Diam inopim elate (29) has been found to be an 
im portant building block of the peptidoglycan in bacterial cell walls.7 
As mentioned earlier, inhibitors of peptidoglycan biosynthesis should 
provide selective antibacterial action, without mammalian toxicity.
ll-2 ,6-DAP (28), meso-DAP (29) and  L-lysine (1) are 
biosynthetically closely related in the DAP biosynthetic pathway 
(Scheme 8). Epimerisation of ll-2 ,6-DAP (28) results in meso-DAP
(29) and subsequent decarboxylation gives L-lysine (1). It follows that 
inh ib itors of the DAP pathway to L-lysine (1) may possess 
antibacterial properties with no mammalian toxicity. It is believed 
that the DAP pathway to L-lysine (1) in plants is analogous to that 
found in bacteria. Therefore, inhibitors may have additional herbicidal 
activity.
The synthesis of L-aspartic acid (3-semialdehyde (20) was 
achieved within our group by Dr. D. Tudor. This will be discussed in 
Chapter 3. A num ber of derivatives of L-aspartic acid (3-semialdehyde 
(20) were prepared in this work. The synthesis and testing of these 
com pounds will be discussed in Chapter 3. L-Glutamic acid y- 
semialdehyde (122) and L-aminoadipic acid 8-semialdehyde (17) are 
homologues of L-aspartic acid p-semialdehyde (20). Chapter 4 of this 
thesis deals with their synthesis and testing.
The first synthesis of the proposed interm ediate of the DAP 
pathway, L-2,3,4,5-tetrahydrodipicolinic acid (26), was achieved by 
Dr. L. Couper, a former co-worker. This will be discussed in Chapter 2. 
Analogues of L-2,3,4,5-tetrahydrodipicolinic acid (26) and l-2,3- 
dihydrodipicolinic acid (25) have been prepared. The synthesis and
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test results of these heterocyclic analogues will be discussed in 
Chapters 5 and 6.
Chapter 2 - The Diaminopimelate Pathway to L-Lysine.
Introduction.
Bacteria and some plants have been shown to biosynthesise 
L-lysine (1) via the diaminopimelate (DAP) pathway (Scheme 8). 
Whereas all seven of the enzymes of the DAP pathway have been 
identified in Escherichia coli, only four have been isolated and 
characterised from plants. The initial step on the pathway involves 
the condensation of L-aspartic acid p-semialdehyde (20) and pyruvate 
(24). The enzyme involved in this reaction is dihydrodipicolinate 
synthase (DHDPS). A further six, unique enzyme catalysed reactions 
result in L-lysine (1). In this Chapter, reported studies on each of the 
enzymes of the DAP pathway in bacteria and higher plants will be 
reviewed. This will include discussions of enzyme isolation and 
purification and mechanistic and inhibitor studies.
2.1 Dihydrodipicolinate Synthase.
L-Lysine (1) biosynthesis via the DAP pathway in bacteria 
and higher plants starts with aspartate (19) and shares the first two 
reactions with the synthesis of L-methionine (21), L-threonine (22) 
and L-isoleucine (23) (Scheme 7).29 The first step unique to L-lysine 
(1) biosynthesis is the condensation of pyruvate (24) and L-aspartic 
acid p-semialdehyde (l-ASA) (20). This is catalysed by the enzyme 
dihydrodipicolinate synthase (DHDPS).
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DHDPS has been characterised from bacteria and a wide 
range of higher plants including spinach (Spinacia oleracea), wheat 
germ (Triticum aestivum  L.), maize seedlings (Zea mays L.) and has 
been highly purified from wheat cell suspension cultures and tobacco 
leaves (Nicotiana sylvestris). The complete amino acid sequences of 
DHDPS from E. coli Cornynebacterium glutamicum , wheat and maize 
have been reported.30*31 These enzymes have been shown to exist as 
homotetramers, composed of four identical subunits.
Shedlarski and Gilvarg purified DHDPS 5000-fold from crude 
extracts of E. coli W.32 The protein was shown to be homogeneous by 
polyacrylamide gel electrophoresis and to bear a net negative charge 
in the pH range 6.0 to 9.2. Amino acid analyses indicate the complete 
absence of methionine. The purified protein showed a single band 
upon a denaturing gel (SDS-PAGE) corresponding to a molecular mass 
of 33,000.33 This is in good agreement with the molecular weight of 
31,372 predicted from the nucleotide sequence of the dapA gene.30 
Since the molecular mass of the native protein has been estimated at
134,000 by gel permeation chromatography, DHDPS is most likely to 
be a tetram er composed of four subunits with identical molecular 
masses.32*33*34 In bacteria, DHDPS is subject to two different types of 
control. In E. coli 35 and Bacillus sphaericus 36 the DAP pathway is 
characterised by a lysine feedback inhibition of DHDPS. In C. 
glutamicum  37 and some Bacillus 38,39 species there exists a lysine- 
insensitive form of DHDPS.
In 1975, Cheshire and Miflin first repo rted  a partial 
purification of DHDPS from maize (Z. mays L.).40 Mazelis and co­
workers detected DHDPS activity in a range of both dicotyledonous 
and monocotyledonous species including corn, bean shoot, cabbage 
leaf, spinach leaf, potato tuber and squash fruit and succeeded in
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partially purifying DHDPS from wheat germ.41 Wallsgrove and 
Mazelis obtained partially purified DHDPS from spinach leaves (S. 
oleracea L.) by chromatography and gel filtration.42 They found the 
molecular weight of the enzyme to be 11.5,000. The DHDPS of spinach 
leaves was found to be localised in the chloroplast where the pH 
optimum is pH 8.2, close to the stromal pH of chloroplasts in the 
light.43 DHDPS was purified 5100-fold from suspension cultured cells 
of wheat (Triticum aestivum  var. Chinese Spring) by Kumpaisal and 
co-workers in 1987.44 An average molecular weight of 123,000 was 
obtained from gel filtration with a subunit m olecular weight of 
between 32,000 to 35,000. The enzyme exhibited maximum activity 
at pH 8.0.
Ghislain and co-workers45 isolated and characterised DHDPS 
from N. sylvestris. The synthase was localised in the chloroplasts and 
iden tified  as a soluble strom a enzyme by enzym atic and 
immunological methods. The molecular weight of the enzyme was 
determ ined to be 164,000. By carrying out isotopic labelling 
experim ents with 14C-pyruvate, the enzyme was shown to be 
composed of four identical subunits of 38,500.
A more recent isolation of the enzyme was from maize leaves 
(Z. mays L.) by Frisch and co-workers.46 They obtained a 30,000-fold 
purification and a molecular weight of 130,000 for the native enzyme. 
The subunit molecular weight of maize DHDPS was estimated to be 
38,000 on SDS-PAGE.
2.2 Mechanism of Dihydrodipicolinate Svnthase.
The sequence of steps in the mechanism of formation of L-
2,3-dihydrodipicolinic acid (l-2,3-DHDPA) (25) from L-aspartic acid (3- 
semialdehyde (l-ASA) (20) and pyruvate (24) has not yet been fully 
elucidated. It is believed that pyruvate (24) binds to the enzyme via 
an amino group of a lysine residue.32’44 One possible mechanism is C- 
C bond formation between the aldehyde group of (20) and the methyl 
carbon of the activated pyruvate (30) to give the enzyme bound 
intermediate (31). Ring closure would result in 4-hydroxy-L-2,3,4,5- 
THDPA (32). Loss of a mole of the elements of water gives the 
enzymic product (25) (Scheme 9).
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OH OH
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An alternative mechanism could involve the initial formation 
of the intermediate (33). This would be followed by a ring closing step 
to give 4-hydroxy-L-2,3,4,5-THDPA (32). Again, the loss of a mole of 
the elements of water would give the enzyme product (25) (Scheme 
10 ).
Previous studies with various aldolases have shown that 
imine formation between a keto substrate and an e-amino group of a 
lysine residue on the enzyme is an obligatory step in enzyme- 
catalysed condensation reactions.47
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Shedlarski and G i l v a r g 3  2 have shown that there is 
irreversible loss of enzyme activity upon the addition of sodium
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borohydride only in the presence of pyruvate (24) with DHDPS 
isolated from E. coli. This suggests that the formation of a Schiff s base 
interm ediate between DHDPS and pyruvate (24) takes place in the 
enzymatic reaction. They also established, by chromatographic and 
electrophoretic methods, that the Schiff’s base is between the 
carbonyl group of pyruvate (24) and an e-amino group of a lysine 
residue attached to the protein. More recently, in an X-ray study of 
DHDPS, Laber et al. have identified Lys-161 as the active site lysine 
residue of DHDPS.34 Sequence alignment and comparison revealed 
tha t Lys-161 is the only lysine residue conserved in the five 
characterised DHDPS isoenzymes.
From kinetic studies carried out on DHDPS isolated from 
wheat suspension cultures, Kumpaisal et al. 44 have proposed that the 
reaction proceeds via a 'ping-pong1 mechanism. Pyruvate (24) first 
binds to the enzyme to form a Schiff s base (Km 11.76 mM). Km is the 
Michaelis constant, the dissociation constant of the enzyme-substrate 
complex. Water is then released, followed by the binding of l-ASA 
(20) (Km 0.88 mM). Nucleophilic attack of the pyruvyl enamine on the 
l-ASA aldehyde group could then take place to give interm ediate
(31).
Kinetic studies carried out by Laber e t al. 34 with E. coli 
DHDPS have also given results consistent w ith a ping-pong 
mechanism. Km values of 0.57 mM and 0.55 mM for pyruvate (24) 
and dl-ASA (20) respectively were achieved.
The product of the enzymic reaction catalysed by DHDPS was 
found to be extremely labile, severely limiting efforts for its thorough 
characterisation. It has been suggested that the proposed product, L-
2,3-DHDPA (25), would be expected to be in equilibrium with L-2,5- 
dihydrodipicolinic acid (34) and 4-hydroxy-L-2,3,4,5-THDPA (32)
26
(Scheme l l ) . 32 It is not clear which of these compounds is the 
immediate product of the enzymatic reaction.
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2.3 Inhibition of Dihydrodipicolinate Svnthase.
In general, L-lysine (1) acts as an allosteric inhibitor, tightly 
controlling its own biosynthesis by shutting down the lvsine-specific 
branch of the biosynthetic pathway when levels are high.
The DHDPS enzyme from spinach leaves (Spinacia oleracea 
L.), isolated by Wallsgrove and Mazelis42 is strongly inhibited by L- 
lysine (1) with an IC5 0  of 20 gM. The IC5 0  value denotes the 
concentration of inhibitor required to produce 50% inhibition. S-{2- 
Aminoethyl)-L-cysteine (SAC), a lysine analogue, was less effective 
with an IC5 0  of 0.4 mM.
Frisch et al. 46 found, that in enzyme isolated from maize, 
several lysine analogues inhibited DHDPS activity (Table 2). 
However, none was as effective as L-lysine (1) itself. Analogues 
missing the a-amino group (e-aminocaproic acid) or the e-amino 
group (norleucine) were not inhibitory, indicating the importance of 
both amino groups.
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DHDPS isolated from E. coli by Laber et aL34 was 50% 
inhibited by 1.0 mM L-lysine (1), by 1.2 mM sodium dipicolinate and 
by 4.6 mM S-(2-aminoethyl)-L-cysteine. No significant inhibition of 
DHDPS activity was observed in the presence of analogues of pyruvate 
(24) such as 3-fluoropyruvate, a-oxobutyrate, phenylpyruvate and 
oxaloacetate. However, 3-bromopyruvate competitively inhibited the 
condensation reaction with respect to pyruvate with a K* value of 1.6 
mM.
Concentration (jM)
25 100 1000
% Inhibition
L-Lysine (1) 51 97 100
Lysine ethyl ester 14 89 95
threo hydroxylysine 4 83 100
SAC 0 18 93
Arginine 6 8 55
5-Hydroxylysine 0 2 45
D-Lysine 0 0 27
DAP (28) 0 0 0
e-Aminocaproic acid 0 0 0
Norleucine 0 0 0
Table 2 (Ref. 46)
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Within our group at Glasgow, a number of analogues of L -2,3- 
DHDPA (25) and l-2,3,4,5-THDPA (26) have been tested on DHDPS 
isolated and purified from E. coli. 48 These compounds, which have a 
common structural feature of a 5- or 6-membered heterocyclic 
system containing nitrogen substituted with acid mimics at the a- or 
a, a ’-positions, were prepared by Dr. L. Couper and Dr. D.W. Tudor.
Dipicolinic acid (35) showed significant inhibition of DHDPS at 
0.5 mM, as did some of its derivatives. An IC5 0  value of 0.2 mM was 
observed for both the diimidate (36) and the N-oxide derivatives of 
dipicolinic acid (35). Compounds with only one carboxyl group such as 
pipecolinic acid, proline and picolinic acid and their derivatives 
showed less inhibition of DHDPS. Poor inhibition was observed with 
the fully saturated piperidine-2,6-dicarboxylic acid (37) analogues.48
/ \
R N R
R = C02H (35)
R = C=NH? cr (36)
l +
OMe
Chelidamic acid (38) and its N-substituted derivatives 
showed good inhibition of DHDPS at low concentrations. N- 
Methylchelidamic acid (39) gave the best inhibition of 63% at 0.1 mM. 
The diesters of chelidamic acid and their iV-substituted derivatives 
also showed good inhibition. Interestingly, piperid-4-one-2,6- 
dicarboxylic acid (40) and its N-methyl derivative (41) also showed 
good inhibition, with values of 30% and 54% respectively at 0.1 mM.
(37)
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R = II (38) R = II (40)
R = Me (39) R = Me (41)
Sulfur analogues of L-2,3DHDPA (25) and 1-2,3,4,5-THDPA 
(26) showed good inhibition of DHDPS. Diethyl (/0-3,4-dihydro-2//-
l,4-thiazine-3,5-dicarboxylate (42) gave 13% inhibition at 0.1 mM. 
Diethyl l,3-thiazole-2,4-dicarboxylate (43) showed 15% inhibition at 
0.1 mM.
,S
EtQ2C NH
(42)
XCQ2Et
c
El02C " 'x I/ '  'C 0 2Et 
(43)
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2.4 Dihydrodipicolinate Reductase.
The enzyme dihydrodipicolinate reductase (DHDPR) catalyses 
the pyridine nucleotide-linked reduction of l - 2 , 3 - D H D P A  (25) to L-
2,3,4,5-THDPA (26) (Scheme 12).
The reductase was first described in E. coli by Farkas and 
Gilvarg.49 Tamir and Gilvarg50 succeeded in purifying the protein to 
homogeneity. A molecular weight of 110,000 was calculated and the 
Km value obtained for L-2,3-DHDPA (25) was 9.0 jaM. The pH optimum 
was 7.0 with either NADPH or NAPH as the cocatalyst.
DHDPR was purified 100-fold from crude extracts of both 
Bacillus cereus and B. megaterium .51 The molecular weights of the 
proteins were 155,000 and 150,000 respectively. The reductases 
were inhibited noncompetitively by dipicolinic acid (44) with respectrt
to l-2,3-DHDPA (25) and the Ki values were 85 jiM and 140 jiM 
respectively.
DHDPR has also been isolated and partially purified by Tyagi 
etal. from maize kernels.52 The crude maize extract and the partially 
purified enzyme were assayed for DHDPR by their ability to restore 
the capability of crude extracts of a m utant E. coli (defective in 
DHDPR) to synthesise meso-2,6-diaminopimelate (29) from L-ASA 
(20) and pyruvate (24). The Km value obtained for l-2,3-DHDPA (25) 
was 0.43 mM and for NADPH the Km was 46 jiM. The enzyme had a 
pH optimum close to 7.0 and was much more tem perature labile than 
the bacterial enzyme. Its molecular weight was 80,000.
+
o
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2.5 Mechanism of Dihydrodipicolinate Reductase.
2.5.1 L-2.3-Dihvdrodipicolinic Acid (L-2.3-DHDPA).
l-2,3-DHDPA (2 5 ) is extremely unstable and its isolation has 
not yet been achieved. Shedlarski and Gilvarg32 suggested that l-2 ,5- 
dihydrodipicolinic acid (34) might be the reaction product of the 
pyruvate-ASA condensing enzyme and that this isomer may be in 
equ ilib rium  with L-2,3-DHDPA (25) and  4-hydroxy-3 ,4,5,6- 
tetrahydrodipicolinic acid (32) (Scheme 12). It is not clear which of 
these three compounds is the immediate product of the enzymatic 
condensation.
Tyagi e ta /.52 described the synthesis of l-2,3-DHDPA (25) by 
the condensation of l-ASA (20) with oxaloacetic acid in alkali, l-2,3- 
DHDPA (25) was precipitated as its barium salt. The compound was 
stored in water at -80 °C and was found to be unstable at room 
tem perature at neutral pH. Only freshly prepared material was used 
in enzyme assays.
2.5.2 Mechanism of Formation of L-2.3.4.5-Tetrahvdrodipicolinic Acid
(L-2,3,4,5-THDPA).
The reduction of l-2,3-DHDPA (25) to l-2,3,4,5-THDPA (26) 
by dihydrodipicolinate reductase requires the use of NADPH as a co­
enzym e. NADPH, the reduced form of n icotinam ide adenine 
dinucleotide phosphate, is the major electron donor in reductive 
biosynthesis. When a substrate is reduced, the hydride anion is
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transferred from the nicotinamide ring of NADPII to produce NADP+. 
The reduced co-enzyme has a prochiral centre and the process is 
stereospecific. The reduction may involve a 1,4-addition of the 
hydride anion to the conjugated system to form L-1,2,3,4- 
tetrahydrodipicolinic acid (45) which could tautomerise to L-2,3,4,5- 
THDPA (26) (Scheme 13). It has not yet been established whether 
the enzyme donates the pro-S or the pro-R hydrogen of its co-factor, 
NADPH.
NADPII NADP+
II+
o 2c C02II -o 2c n" k n^i C02h
L-2,3,4,5-THDPA
(26)
H H
(45)
Scheme 13
2.5.3 l-2.3 A5-Tetrahvdrodipicolinic Acid.
Shapshak53 claimed the formation of the D -isom er of THDPA 
by treatment of DL-2,6-diaminopimelic acid (28) with the L-amino
acid oxidase from Neurospora crassa, but no chemical or spectroscopic 
evidence for the product was provided.
Kimura and Sasakawa54 reported the formation of DPA (44) 
and L-2,3,4,5-THDPA (26) on cyclisation of aa'-dioxopimelic acid (46) 
with ammonia. Since the reaction rate was not affected by the 
presence or absence of oxygen, they assumed that the initial product,
1,4-dihydrodipicolinic acid (47), disproportionated to DPA (44) and L-
2,3,4,5-THDPA (26) (Scheme 14). Evidence for the formation of the 
products was provided by UV absorption (for DPA) and by colour 
reactions with ninhydrin and o-aminobenzaldehyde (for l- 2 , 3 , 4 , 5 -  
THDPA).
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The potassium salt of l-2,3,4,5-THDPA (26) has been 
prepared by the elimination of p-toluenesulfinic acid from the N- 
toluenesulfonvl (tosyl) derivative (50) of dimethyl cis-piperidine-2,6- 
dicarboxylate (49) at Glasgow by Couper et al. (Scheme 15).55
Dimethyl dipicolinate (48) was made from DPA (44) by 
heating at reflux in methanol and conc. sulfuric acid. Hydrogenation of
(48) gave dimethyl c/s-piperidine-2,6-dicarboxylate (49) in good 
yield. Dimethyl N-tosyl-cis-piperidine-2,6-dicarboxylate (50) was 
synthesised from (49) by stirring overnight in pyridine with 
toluenesulfonyl chloride.
o 7c j j  C02H MeO ' N '  Vx),Me MeOiC'"' "N "  V/C02Me
(44) (48)
2 II
(49)
K+ Q ,( f  'h'  C02- K+
(26)
K+ 0 2C"' N’ 'COz-KII
(51)
c o c o 2- K
K '0 2C 2
(52)
Me02Cs'' //C02Me 
(50)
Scheme 15
The elimination was carried out using potassium f-butoxide 
in dichloromethane at room temperature. The ester groups were 
simultaneously cleaved during the reaction. Purification was achieved 
by stirring the reaction product in distilled water with the weak anion 
exchanger Amberlite 1R-45 (hydroxide form) for 24 hours. 1 IT and 
NMR data indicated that the potassium salt of L-2,3,4,5-TIIDPA (2b)
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exists in solution in equilibrium with the corresponding enamine (51) 
and an open chain form (52). The potassium salt of L-2,3,4,5-THDPA 
(26) was shown to be a substrate for meso-DAP dehydrogenase by 
incubation with the enzyme and observation of the disappearance of 
NADPH. This dehydrogenase is used by some bacteria in the 
biosynthesis of L-lysine ( l ) ,56 and L-2,3,4,5-THDPA (26) is converted 
directly into mesoDAP (29) using NADPH. meso-DAP Dehydrogenase 
will be discussed in more detail in Section 2.12.
2.6 Inhibition of Dihydrodipicolinate Reductase.
Theoretically, L-2,3-DHDPA (25) could exist in the open chain 
form with an amino group and a keto group at the a and e positions or 
as a cyclic compound (Scheme 12). The DHDPR enzyme isolated from 
£  coli by Tamir and Gilvarg50 was inhibited by dipicolinic acid (DPA)
M
(44). It was found to be a competitive inhibitor with a Ki value of 1.0 
mM. a-Picolinic acid (53) and isophthalic acid (54) were also found to 
be inhibitors of the enzyme. The high affinity and competitive nature 
of the inhibition shown by DPA (44) and to a lesser extent, isophthalic 
acid (54), strongly suggests that a cyclic form of the substrate binds to 
the active site on the enzyme.
0?C N H
(53)
(55)
c o 2h
‘c o 2h
(54)
/A
CO?H
'CbC NH
(56)
Tyagi et al. 52 found that the DHDPR isolated from maize was 
also inhibited by DPA (44), with a Ki value of 0.9 mM, indicating that, 
as in £  coli, the substrate of the enzyme is the cyclic form of l-2,3- 
DHDPA (25) rather than its open chain counterpart. A number of 
other compounds with similar structures to L-2,3-DHDPA (25) also 
inhibited the reductase (Table 3).
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Inhibitor % Inhibition
20 mM 10 mM 5mM 1.5 mM
a-Picolinic acid (53) 24 4 8 0
L-Pipecolic acid (55) 23 30 0 0
Isophthalic acid (54) 44 20 0 0
Isocinchomeronic acid (56) - - 50 0
Dipicolinic acid (44) - - - 100
Table 3
2.7 Tetrahvdrodipicolinate Succinvlase.
Tetrahydrodipicolinate (THDP) succinylase catalyses the N- 
succinylation of L-2,3,4,5-THDPA (26) by succinyl-coenzyme A to 
form succinyl-e-keto-a-aminopimelate (27) (Scheme 16).
+ Succ-CoA
(27)
Scheme 16
The purification of THDP succinylase was not fully 
investigated until recently, largely due to the unavailability of its 
substrate, l-2,3,4,5-THDPA (26), required for the enzyme assay. 
Simms et al. 57 purified THDP succinylase 1900-fold from crude
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extracts of E. coli. The L-2,3,4,5-THDPA (26) required for the enzyme 
assay was enzymatically prepared by the oxidative deamination of 
m eso-D A P (29) in the presence of NADPH and  meso-DAP 
dehydrogenase. The protein  was found to be homogeneous by 
polyacrylamide gel electrophoresis and consists of two subunits each 
with a mass of 31,000. The pH optimum of the enzyme is 8.2. The 
equilibrium of the reaction lies predominantly in favour of product 
formation but the reverse reaction has been demonstrated in vitro.
THDP Succinylase is a sulfhydryl enzyme. In the absence of 
mercaptoethanol the enzyme lost 80% of its activity if kept at 4 °C for 
4 days. No loss of enzymatic activity was observed when the same 
enzyme solution was stored in 0.001 M mercaptoethanol under the 
same conditions. Furtherm ore, known inhibitors of sulfhydryl 
enzymes were found to be effective in inhibiting THDP succinylase.
The acyl donor for the reaction is succinyl-CoA in E. coli. In 
Brevibacterium lactofermentum, both succinyl-CoA and acetyl-CoA 
can serve as the acy 1-donor.58
2.8 Mechanism of THDP Succinylase.
Berges e ta / .59 have proposed a stereochemical model for the 
succinylation of L-2,3,4,5-THDPA (26) from studies on the active site 
of THDP succinylase of E. coli (Scheme 17).
They tested cyclic and acyclic analogues of l-2,3,4,5-THDPA 
(26) for their ability to act as substrates or inhibitors of the 
succinylase. From these experiments, they were able to draw some 
conclusions regarding the catalytic mechanism of the enzyme and the 
structural requirem ents of the active site. The proposed model
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involves the initial binding of L-2,3,4,5-THDPA (26) to the active site 
of the enzyme. Water adds to the double bond, cis to the 6-carboxyl 
group, producing a trans-piperidine-2,6-dicarboxylate (57). The 
hydrated product is then succinylated (58) and ring opening results in 
succinyl-e-keto-a -aminopimelate (27).
■07C
N = C -^
XC02-
L-2,3,4,5-THDPA
(26)
O7C
■O7C
"02C-(CH2)2—
NHO
0
(27)
H?0
(57)
^■Succ-CoA 
>CoASH
C02'
-O7C
•02C-(CH2)2—
N
O '"
0  
A '" H
(58)
Scheme 17
An important piece of evidence for this model is the strong 
inhibition of the enzyme observed with 2-hydroxytetrahydropyran-
2,6-dicarboxylic acid (59). With regard to the proposed mechanism,
(59) would be expected to be a transition state analogue because of its 
similarity to the proposed hydrated intermediate (57). Its very low Ki 
value of 58 nM is consistent with this expectation.
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2.9 Inhibition of THDP Succinylase.
2.9.1 Acvclic Analogues of L-2.3.4.5-THDPA (26).
Gilvarg e ta l.59 found D-2-aminopimelate (D-2-AP) (60) to be 
a reasonable acyclic inhibitor of the enzyme, with a Ki value of 0.41 
mM. The presence of two carboxylate groups was shown to be 
im portant for binding to the enzyme. Furthermore, the spatial 
separation of the carboxyl groups was important for binding and 
substrate activity. D- and L-2-aminoadipic acid (one methylene group 
less than D-2-AP) and DL-2-aminosuberic acid (one methylene group 
more than D-2-AP) were very poor inhibitors of the enzyme. 
Substituting a sulfur for a methylene group had little effect as dl-2- 
amino-5-thiapimelic acid was a reasonable inhibitor, with a Ki value 
of 1.1 mM.
(60)
Introducing a hydroxyl group a to a carboxylate group was 
effective in increasing inhibition of the enzyme. Both enantiomers of
2-hydroxypimelic acid had high affinity for the enzyme with Ki
values of 0.33 mM and 0.19 mM respectively. The hydroxyl group 
may be involved in hydrogen-bonding with the enzyme. DL- 
Dihydroxypimelic acid was also a relatively good inhibitor with a Ki 
value of 0.14 mM.
2.9.2 Cvclic Analogues of L-2.3.4.5-THDPA.
The only cyclic compound other than l-2,3,4,5-THDPA (26) 
found to be a substrate for the succinylase was 3,4-dihydro-2//-l,4- 
thiazine-3,5-dicarboxylic acid (DHT) (61 ).5 9 Only the enamine 
tautomeric form of DHT (61) was observed in the lH NMR spectrum of 
the disodium salt in aqueous solution (Scheme 18). The higher Km 
value of DHT (61) may be explained by the fact that the imine form, 
which is used by the enzyme as a substrate, makes up only a small 
fraction of the total DHT (61).
-02C jfO C02H -02C -tN 5 c o 2HH H2
(61)
Scheme 18
Other cyclic compounds were found to be inhibitors and are 
listed in Table 4. The best inhibitor was 2-hydroxytetrahydropyran-
2,6-dicarboxylic acid (59). This was a competitive inhibitor with 
respect to L-2,3,4,5-THDPA (26) with a Ki value of 0.06 jiM.
Compound X Name Ki(pM)
H02cX P " co2h
N
CH
D ipicolinic acid  
B enzene-2,6-dicarboxylic ac id
12,800
8,500
jO lH02Ca o co2h Pyran-2,6-dicarboxylic acid 1,800
0
h o 2c ^ x ^ " co2h
NH
0
Chelidam ic acid  
Chelidonic acid
2,600
3,100
ho2cv^ C^ ^ c o 2h
NH
0
trans-P iperid ine-2 ,6- 
d icarboxylic ac id  
trans- T e tra h y d ro p y  ra n -2,6- 
d icarboxvlic acid
2,000
680
ho2c*C<^ ^ c o 2h
NH
0
cis-P iperid ine-2 ,6-dicarboxylic
acid
c is-T e trahydropyran-2 ,6 - 
dicarboxylic acid
63,000
3,900
H 0 2C ^ VX ,^co2h
OH
Y=H
Y=OH
2-H ydroxy te trah y d ro p y ran - 2,6- 
dicarboxylic acid  
2 ,6-D ihydroxy te tra h y d ro p y ra n - 
2 ,6-dicarboxylic acid
0.06
0.20
ho2c— 1(C02h
OH
trans-2-H ydroxycyclohexane- 
2,6-dicarboxylic acid  
cis-2-H ydroxycyclohexane-2,6- 
dicarboxvlic acid
5,600
12,000
Table 4 (Ref. 59)
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2.10 N-Succinvl Diaminopimelate Am inotransferase.
N-Succinyl diaminopimelate aminotransferase catalyses the 
interconversion of N-succinyl-a-amino-e-ketopimelate (27) and N- 
succinyl-L-diaminopimelate (62) (Scheme 19). The succinylated 
intermediate is aminated at the e-position with glutamate as the 
amino group donor.
H 0 2C(CH 2)2CONH
h o 2c
.“'U J2
(2 7 )
N -Succinvl
C 0 2'
H 0 2C(CH 2) 2CONH — H
(CH2)3
diaminopimelate
aminotransferase
H- -NH
CO
(62)
Scheme 19
The enzyme has been isolated and partially purified from E. 
coli by Peterofsky and G i l v a r g . 6 0  The aminotransferase is pyridoxal 
phosphate dependent and is inhibited by hydroxylamine. Treatment 
of the enzyme at 0 °C with 0.05 M hydroxylamine causes 95% 
inhibition of enzyme activity.
2.11 N-Succinvl Diaminopimelate Desuccinvlase.
N-Succinyl diaminopimelate desuccinylase catalyses the 
hydrolysis of N -succ iny l-L -d iam inop im ela te  (62) to L,L* 
diaminopimelate (28) and succinate (Scheme 20). The enzyme has 
been partially purified from E. coli by Kindler and Gilvarg.6 l It has a 
pH optimum of 8  and has been shown to require Co2+ for activity.
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ccv
H02C(CH2 )2C 0 N H ^ H  n -Succinvl
(CH2 ) 3 ^ ^ — r*rY^_\ ^  diaminopimelate
I + 3 desuccinylaseco2-
(62)
Scheme 20
+ C02'
h 3 n-4 - h
(ch 2 ) 3
H— NH
C02-
(28)
2.12 meso-Diaminopimelate Dehvdrogenase.
Certain bacteria possess an alternative pathway for meso-
2,6 -DAP (29) production and can transform the early precursor, L-
2,3,4,5-THDPA (26) directly into m eso-2,6-DAP (29) using m eso- 
diaminopimelate (DAP) dehydrogenase (Scheme 21).
H 02c  N' 
H
meso-DAP 
dehydrogenase 
+ NH3
rco
L-2,3,4,5-THDPA
(26)
H,N
CO'
(28)
,s\
co2
NH:
HN
DAP 
epimerase H3N
,nNH3 
c o 2h  C 02- 
^NADPH
N ^nadp+
* n h 3
C 07- C 02-
(29)
L-Lysine (1)
Scheme 21
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Like o ther amino acid dehydrogenases, this NADPH- 
dependent enzyme reduces a primary imine functionality, formed 
from the cleavage of the l-2,3,4,5-THDPA (26) ring by transamination 
with ammonia.
At neutral or slightly basic conditions, the dehydrogenase 
normally catalyses the reductive amination of l-2,3,4,5-THDPA (26) 
to meso-2,6-DAP (29) with concommitant conversion of NADPH into 
NADP+, which allows continuous spec tropho tome trie assay at 340 nm. 
In contrast, pH 10.5 is the optimum for the reverse reaction, oxidative 
deamination of meso-2,6 -DAP (29).
Misono and Soda62 purified the protein to homogeneity from 
extracts of Bacillus sphaericus. The molecular weight of the enzyme 
was determ ined to be approximately 80,000. Optimum activity was 
observed at pH 10.5 when the enzyme was found to deaminate 
exclusively the meso form of 2,6-DAP (29), but did not act upon the 
D- and L-isomers. This process was shown to require NADP+ as a 
cofactor. The Km values were 2.5 mM for meso-2,6-DAP (29) and 0.83 
\lM for NADP+.
Misono et al. 63 also purified meso-DAP dehydrogenase 400- 
fold from C. glutamicum. The enzyme had a molecular weight of 
70,000 and consisted of two identical subunits. The pH optima for 
deamination and amination were about 9.8 and 7.9 respectively. The 
Michaelis constants were 3.1 mM for meso-2,6 -DAP (29), 0.12 mM for 
NADP+, 0.28 mM for L-2-amino-6-ketopimelate, 36 mM for ammonia 
and 0.13 mM for NADPH. The enzyme was detected in a wider range 
of bacterial species than previously reported, suggesting that the 
a lterna tive  lysine b iosynthetic  pathw ay (u tilising meso-DAP 
dehydrogenase) is more widespread than realised. Both the DAP and
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m eso -DAP dehydrogenase pathways were found to operate in C 
glutamicum.
In plant systems, Wenko et ah 64 have isolated and purified 
meso-DAP dehydrogenase from Glycine m ax  em bryos. Maximum 
enzyme activity was observed at pH 8.0. From preliminary molecular 
weight determ inations, the enzyme was found to have no subunit 
structure and had an apparent molecular weight of 67,000.
2.13 Mechanism of meso-DAP Dehydrogenase.
The mechanism of meso-DAP dehydrogenase has not yet 
been fully established. Studies by Misono and Soda56 on the enzyme 
from B. sphaericus showed that it donates the 4-pro-S hydrogen of 
its co-factor NADPH to the substrate in the reductive reaction and is 
highly specific for the meso-isomer of DAP. In the active site of the 
dehydrogenase there is a non-essential th iol g roup 65 and a 
tryptophan residue .56 Product inhibition studies indicated that the 
sequence of addition of substrates in the oxidative deamination is 
NADP+ followed by meso-2,6-DAP (29) and that the order of release 
of products is ammonia, then l-2,3,4,5-THDPA (26) and finally 
NADPH.
2.14 Inhibition of meso-DAP Dehydrogenase.
Lam e t a l .6 6  examined the in te rac tio n  of several 
diaminopimelate analogues with meso-DAP dehydrogenase from B. 
sphaericus. Of the diaminopimelate analogues tested, only l l -
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lanthionine (63) was found to be a weak competitive inhibitor with 
respect to meso-2,6-DAP (29) with a Ki of 38 mM.
-o2c £ ^ 2  (63) L L -lanth ionine (25, 65)
Nfh NH3 (64) m e so -la n th io n in e  (2R, 65)+ +
Some other analogues tested acted as substrates for the 
enzyme. The enzyme was shown to exhibit strict specificity for meso- 
isomers and barely accommodates substitutions in the main carbon 
chain. meso-Lanthionine (64) acted as a substrate for the enzyme, 
with a Km of 5.8 mM compared with 1.1 mM for meso-2,6-DAP (29).
In a more recent report, Abbot et a / . 6 7  described the 
synthesis and testing of heterocyclic analogues of meso-2,6-DAP (29) 
as inhibitors of meso-DAP dehydrogenase. They found (25, 55')-2- 
amino-3-(3-carboxy-2-isoxazolin-5-yl)propanoic acid (65) to be a 
potent and specific inhibitor of the dehydrogenase. At pH 7.5 or 7.8 
(65) shows competitive inhibition (Ki 4.2 gM) with L-2,3,4,5-THDPA 
(26) for the forward reaction and noncompetitive inhibition (Ki 23 
|iM) with meso- 2,6-DAP (29) for the reverse process.
N—0 NH3
4-
(65)
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2.15 LL-Piaminopimelate Epimerase.
Some bacteria can synthesise m eso-2,6-DAP (29) directly 
from l-2,3,4,5-THDPA (26). This reaction is catalysed by meso-DAP 
dehydrogenase and is discussed in detail in Section 2.12. However, in 
most bacteria and higher plants, the enzyme LL-diaminopimelate (LL- 
DAP) epimerase catalyses the interconversion of LL- (28) and 
meso-2,6-DAP (29) (Scheme 22).
+ c o 2- + C02-
H3 N— H . HSN—h H
(CH2 ) 3 ll-DAP e + (CH7 ) 3
H—j—NH3 ~'r H3 N -|-H
C02- C02'
(28) (29)
Scheme 22
ll-DAP epimerase was first detected over 30 years ago in E. 
colfeS but was only recently purified and characterised. Wiseman and 
Nicols6 9  achieved the first purification of ll-DAP epimerase from E. 
coli. In order to facilitate the purification of LL-DAP epimerase, they 
took advantage of the fact that the alternative pathway for meso-2 ,6 - 
DAP (29) synthesis is utilised by some bacteria6 2  to develop a rapid, 
convenient assay for ll-DAP epimerase. In the alternative pathway, 
L-2,3,4,5-THDPA (26) is transformed directly into meso-2,6-DAP (29) 
by reductive amination using ammonia and NADPH, catalysed by 
meso-DAP dehydrogenase. This reaction is reversible and allowed the 
coupling of the epimerisation of LL-2,6 -DAP (28) to meso-2,6-DAP
(29) with the meso-DAP dehydrogenase catalysed oxidation of
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meso-2,6-DAP (29) by NADP+. The production of NADPH can be 
continually monitored at 340 nm.
The epimerase was found to have a m olecular weight of 
45,000. It irreversibly loses activity at pH 6 and below. Activity is 
lost in a few hours at pH 8 in the absence of reducing thiols such as 
d ith io threito l. Enzyme inactivated in this m anner is partially  
reactiva ted  by thiols. The enzym e is also inac tiva ted  by 
iodoacetamide. This all suggests that the enzyme has a free thiol, 
necessary for activity.
Richaud e ta l .70 recently determined the location of the dapF 
gene, encoding for LL-DAP epimerase. They were able to isolate the 
gene from a high-copy-number plasmid, thereby producing large 
amounts of the enzyme.
2.16 Mechanism of ll-DAP Epimerase.
LL-DAP Epim erase is m echanistically  in teresting . It 
interconverts LL-2,6 -DAP (28) and meso-2,6-DAP (29) without the aid 
of cofactors, metal ions or reducible imine or keto functionalities. This 
unusual transform ation, which is analogous to tha t catalysed by 
proline and glutam ate racemases, appears to proceed via an 
interm ediate having anionic character at the a-carbon .71 The two- 
base in-line mechanism proposed for the action of ll-DAP epimerase 
on l l-2 ,6 -DAP (28) is shown in Scheme 23. Bi and B2 designate 
enzymic acid/bases of unspecified structure. At least one of these 
groups is thought to be a cysteine sulfhydryl moiety .69
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Scheme 23
2.17 Inhibition of ll-DAP Epimerase.
Lam et al.6 6  synthesised and tested a number of analogues of 
m eso-2,6-DAP (29) for inhibition of LL-DAP epimerase of E. coli. 
m eso -Lanthionine (64) and the LL-isomer (63) were competitive 
inhibitors with Ki values of 0.18 mM and 0.42 mM respectively. 
Oxidation of the sulfur atom to a sulfoxide or sulfone drastically 
lowered the affinity for the enzyme's active site. N-Hydroxv DAP (6 6 ) 
was the most potent competitive inhibitor with a Ki of 0.0056 mM. N- 
Amino DAP (67) is weaker with a Kj of 2.9 mM. 4-Methylene-DAP 
(6 8 ) is a noncompetitive inhibitor with Ki 0.95 mM.
A proposed mechanism for the interaction of the epimerase 
with N-hydroxy DAP (6 6 ) is shown in Scheme 24.
Higgins e t a / . 7 2  found that ll-DAP epimerase is irreversibly 
inhibited by 2-(4-amino-4-carboxybutyl)-2-aziridine carboxylic acid 
(AZIDAP) (69). This irreversible inactivation results in the active site 
modification of a cysteine residue. Sequence determination of the 
protein shows this active site cysteine to be Cys 73 in the overall 
sequence. The proposed concerted mechanism with AZIDAP (69) as 
inhibitor involves the formation of an AZIDAP-cysteine adduct (70) 
(Scheme 25).
B
I
H H
H
Scheme 24
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NH
f----SH
(69)
NH
y ^ ' i N H
Scheme 25
Gelb et al.7 1  synthesised several fluorinated analogues of 
meso-2,6-DAP (29) in stereochemically pure form. The compounds 
were shown to be potent inhibitors of LL-DAP epimerase. Compounds 
(71), (72), (73) and (74) gave IC5 0  values of 4, 1 0 , 25 and 8  gM 
respectively.
n h 3
(71) (72)
-CbC CO
n h 3 n h 3
+ 0 +
(73)
'CbC
NH
.C02- 
NH3
(74)
More recently, Abbot et a l 6 7  synthesised and tested a 
number of heterocyclic analogues of meso-2,6-DAP (29). However, 
none showed any inhibition of LL-DAP epimerase.
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2.18 meso-Diaminopimelate Decarboxylase.
The enzyme meso-diaminopimelate decarboxylase catalyses 
the pyridoxal 5’-phosphate decarboxylation of the D-centre of meso-
2,6-diaminopimelate (29) to give L-lysine (1) (Scheme 2 6 ) . 73>74
■CbC
meso- 2,6-DAP 
(29)
meso-DAP 
decarboxylase
L-Lysine
( 1 )
Scheme 26
Dewey and Work7 5  first detected the enzyme in E. coli. Asada 
e ta i . 7 6  purified the enzyme to homogeneity from Bacillus sphaericus. 
The molecular weight of the decarboxylase was determined to be 
approximately 80,000. The enzyme shows maximum activity in the 
pH range from 6 . 8  to 7.8 and decarboxylates exclusively the meso- 
form of 2,6-diaminopimelate (29). The DD- and LL-isomers of 2,6- 
diaminopimelate are neither substrates nor inhibitors of the enzyme. 
m eso-Diaminopimelate decarboxylase has also been isolated from 
higher p l a n t s , 7 7 >7 8,79 where it is localised solely in the chloroplasts. 
The molecular weight in higher plants varies between 75,000 for 
wheat germ7 9  and 85,000 for maize endosperm. Estimates of the Km 
range from 0.1 to 0.3 mM.
2.19 Mechanism of meso-Diaminopimelate Decarboxylase.
m eso-2,6-D iam inopim elate decarboxylase is the only 
pyridoxal 5 '-phosphate-dependent a-decarboxylase known to act on a 
D-amino acid. Soda et alfi® found the enzyme from B. sphaericus to 
operate with inversion of configuration, in direct contrast to other 
pyridoxal 5 '-phosphate-dependent a-decarboxylases for which the 
stereochemistry of the reaction has been determ ined. In all other 
cases examined, the reaction proceeds with retention of configuration 
- that is, the incoming proton occupies the same stereochemical 
position as did the departing carboxyl group .81*82*88
Kelland and co-workers84 carried out a detailed mechanistic 
analysis of the decarboxylases from wheat germ and B. sphaericus 
using two-dimensional !H-13C heteronuclear NMR shift correlation 
spectroscopy with 2H decoupling. Both enzymes were found to operate 
with inversion of configuration.
In pyridoxal 5 '-phosphate-dependent enzyme catalysed 
reactions, the bond to be broken in the substrate is expected to be 
perpendicular to the plane of the conjugated k system  of the 
substrate-pyridoxal 5'-phosphate complex.85 In decarboxylases, it is 
the bond between the a-carbon and the carboxyl carbon that must be 
aligned in this way. Where retention of configuration occurs, 
protonation m ust take place on the same face as of the planar 
carbanionic intermediate as did decarboxylation. However, in the case 
of either B. sphaericus or wheat germ meso-DAP decarboxylase, the 
pro ton  m ust attach  to the opposite face of the carbanionic 
intermediate to that from which the carboxyl group left.
The first step in the mechanism is the form ation of the 
Schiffs base (75) between the cofactor and the enzyme (Schem e
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27). Addition of m eso-2,6-DAP (29) gives the imine (76). Carbon 
dioxide is then lost to give the intermediate (77). The cofactor 
essentially 'stores' the electrons of the cleaved bond until protonation 
can occur to give (78). The resulting imine (78) is then hydrolysed to 
give L-lysine (1).
R
(75)
+ h 3n -
~~V ro-N ENZ C 02
O' H
H
© 0 .
HN, R
N« a.
H
CO7'
O verall reac tion
-C02
H3N-
H
R
H
+ PLP-ENZ
0 0 .
HN.
-C02
©O.
HN.
(77)
a / R
^ N = < * h
Scheme 27
Asada et a l 8 0  have proposed two possible explanations for 
the inversion of configuration at the a-carbon. First, the catalytic 
group which donates a proton to the a-carbon atom of the anionic 
intermediate exists on the opposite side of the plane to that of
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decarboxylation. Secondly, a drastic conformational change occurs 
leading to the ro tation  of the Schiff base plane and thereby to 
protonation from the same direction as the initial decarboxylation 
step. Conformational changes that occur upon substrate binding have 
been suggested for aspartate  am inotransferase86  and tyrosine 
d ecarboxy lase . 87 However, a rotation of alm ost 180° after the 
formation of the anionic intermediate seems improbable because of 
the necessity of an extremely large structural rearrangement.
2.20 Inhibition of mesoDAP Decarboxylase.
Vederas et at.88 synthesised a number of analogues of 2,6- 
diaminopimelic acid (29) and tested them for inhibition of meso-DAP 
decarboxylases from B. sphaericus and wheat germ. Lanthionine 
sulfoxides (79) (all stereochem istries) were found to be good 
inhibitors of both enzymes, giving 50% inhibition at ImM. The N- 
modified analogues of 2,6-DAP, (6 6 ) and (67), were the most potent 
competitive inhibitors. The Ki values for B. sphaericus and wheat 
germ carboxylases with N-hydroxydiaminopimelate (6 6 ) (mixture of 
isom ers) w ere 0.91 and  0.71 mM respec tive ly . For N- 
aminodiaminopimelate (67) (mixture of isomers) the Ki values were
0.10 and 0.084 mM.
Girodeau e t ai.89 synthesised unsaturated analogues of 2,6- 
DAP (29) and tested them with meso-DAP decarboxylase of E. coli. 
trans-3,4-Didehydro-DAP (80) was found to be the most potent 
inhibitor of meso-DAP decarboxylase.
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Schem e 2 8  shows the proposed mechanism for the 
irreversible inhibition of a pyridoxal 5 '-phosphate-dependent 
decarboxylase by a vinylic amino acid.
h 3n
R
PLP-ENZ PLP:
H
CO-
PLP
H
R
Nu-ENZ
R
✓  +
H C02‘
-CO
PLP
Nu-ENZ
Nu-ENZ
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Chapter 3 - Synthesis of L-Aspartic Acid-p- 
Semialdehyde and Derivatives.
Introduction.
L-Aspartic acid p-sem ialdehyde (L-ASA) (20a) is an 
im portan t in term ediate in the biosynthesis of L-lysine (1), L- 
threonine (22) and L-methionine (21) (Scheme 7). L-ASA (20a), 
along w ith py ruvate  (24), is a su b stra te  of the enzyme 
dihydrodipicolinate synthase. This enzyme catalyses the first unique 
step in the biosynthesis of L-lysine (1) in bacteria and higher plants.
L-ASA (20a) has also become an im portan t synthetic 
interm ediate. A range of poly functional non-protein and unnatural 
amino acids can be accessed by m anipulation of the aldehyde 
functionality .9 0 *91*92
In this Chapter there will be a brief description of the use of 
protecting groups in amino acid synthesis followed by a review of the 
Black and Wright synthesis of L-ASA (20a), first reported in 1955. Dr.
D. Tudor, a former coworker of ours at Glasgow, carried out an 
im proved synthesis of L-ASA (20a ) .94  This procedure has been 
followed in order to prepare dl-ASA (20) for enzyme assays and 
testing of compounds and for use in the preparation of derivatives of 
dl-ASA (20). The preparation and test results of these derivatives 
will also be detailed in this Chapter.
3.1 Protecting Groups in oeAmino Acid Chemistry.
The selective use of protecting groups is of param ount 
im portance in a-amino acid chemistry. The protection of both the 
carboxyl and amino functionalities of a-am ino acids masks their 
zw itterionic character and allows for easier handling  of the 
com pounds in organic solvents. A protective group m ust fulfill a 
num ber of requirements. It must react selectively in good yield to 
give a protected substrate that is stable when subjected to further 
reaction conditions. The protective group should have a minimum of 
additional functionality to avoid further sites of reaction. Finally, the 
protective group must be selectively removed by reagents which do 
not destroy any new functionality within the molecule.
q-Amino Protection.
The nucleophilic reactivity of an a-am ino group can be 
supressed by draining its electron density into an appropriate 
substituent or by concealing it with a sterically hindered substituent.
Amino groups are easily converted into alkoxycarbonylamino 
derivatives (81), also known as urethanes or carbamates. These can 
be considered to be a com bination of bo th  am ide and ester 
functionalities. As amides, the nucleophilic reactivity of the nitrogen 
of (81) is greatly reduced. As esters, they can be degraded by alkyl- 
oxygen fission to the corresponding carbamic acids (82) which 
undergo spontaneous decarboxylation to regenerate the amine (83) 
(Scheme 29). [In a number of the mechanisms drawn, it should be
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noted that the carbonyl group is involved in the mechanism, but 
arrows have been omitted for clarity.]
Many carbamates have been used as protective groups. The 
carbamates which have been used in our amino acid work include the 
t-butoxycarbonyl (Boc) group and the benzyloxycarbonyl (Cbz) group 
The Boc group is not hydrolysed under basic conditions and 
is inert to hydrogenolvsis. There are many reagents available for the 
formation and removal of the Boc group . 9 4  The two most common 
reagents for introducing the Boc group are di-t-butyl dicarbonate9 5
(84) and  2 -( t-butyloxycarbonyloxyimino)-2 -phenylacetonitrile9 6  
(Boc-ON) (85). The mechanisms of formation of Boc-protected amines 
are shown in Schemes 30 and 31.
O
(81)
-  H2N -R 2
(83)
Scheme 29
“OH
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Removal of the Boc group is conveniently carried out by 
dissolution in trifluoroacetic acid at room temperature for one hour 
(Scheme 32).97
R \
/
R: O’
Rl\  + 
n h 2
CF3C02-
c f 3c o 2h
H'
-  CO
/
R: O-
- isobutylene
1
Scheme 32
The Cbz group was first described as an amino protecting 
group by Bergmann and Zervas in 1932.98 It is normally introduced 
using benzyl chloroformate (8 6 ) under basic conditions (Scheme 33).
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The Cbz group is stable under mild acidic conditions. It can 
be removed by catalytic hydrogenolysis with a variety of catalysts 
and conditions, by hydrogen bromide in acetic acid or by use of a 
Lewis acid such as trimethylsilyl iodide (Scheme 3 4 ) ."
Me3Si-M
R 1 o  /  R1 OSiMe3 R
\  II IMS! s . ,  I MeOII xN /'•,-Lf'I I,1>H Mpf'N ,-I N >  /lnon/'li  /  “/  O CJI2Ph eC  /  quench T1/
I
S ( \  M U C U L l l
R2 A R2 °  2
Scheme 34
A number of imine derivatives has been prepared as amine 
protective groups. The N-diphenylmethyleneamine derivative of 
glycine (89) can be prepared from an exchange reaction with 
benzophenoneimine (87) and glycine ethyl ester hydrochloride (8 8 ) 
(Scheme 3 5 ) . 1 0 0 >101 The protective imine group can be cleaved 
under mild acidic conditions to yield the free amine.
94
> = N H  +
Ph
(87) C02Et
( 88)
NH3 CP
+
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Scheme 35
g-Carboxvl Protection.
The usual means of carboxyl protection is esterification. 
Methyl esters provide good carboxyl protection and are not affected 
at am bient tem pera tu re  by trifluoroacetic  acid, catalytic 
hydrogenolysis or hydrogen bromide in acetic acid, so the selective 
removal of amino-protecting groups presents no difficulty.
a-Amino acid methyl esters are often isolated as salts, or 
must be stored at low temperatures, as the methyl ester free bases 
can dimerise to form the corresponding diketopiperazines (90) 
(Scheme 36).
t-Butyl esters are relatively hindered esters and are stable 
under mild basic conditions. There are several reagents used to form
0 0
0
Scheme 36
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t-butyl esters. The most common procedure involves the use of 
isobutylene and concentrated sulfuric acid at room temperature for 
one day (Scheme 37 ) .102
0
0
+
Scheme 37
t-Butyl esters are cleaved by moderately acidic conditions, 
similar to those required for the removal of the Boc group (Scheme 
32). Thus the Boc and the t-butyl ester protecting groups are often 
used together in amino acid chemistry as they can both be removed 
in one step.
p-Methoxybenzyl esters can be prepared from the carboxylic 
acid and p-methoxybenzyl chloride (91) (Scheme 3 8 ).1 0 3  They can 
be removed under the same conditions as t-butyl esters and Boc 
groups.
(91)
0
Scheme 38
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3.2 Black and Wright Synthesis of I -Aspartic Acid ft -Semialdehvde.
Black and Wright reported the first synthesis of the separate 
isomers of aspartic acid-p-semialdehyde (20) from DL-allylglycine 
(92) (Schem e 3 9 ) . 104  DL-Allylglycine (92) was resolved into its D- 
(92b) and L-isomers (92a) by asymmetric enzymatic hydrolysis of the 
N-acetyl derivative (93). N-Acetyl-DL-allylglycine (93) was prepared 
from  DL-allylglycine (92) using 2M sodium hydroxide and acetic 
anhydride. Hydrolysis of N-acetyl-DL-allylglycine (93) using hog 
kidney acylase gave L-allylglycine (92a) and unchanged N-acetyl-D- 
allylglycine (93b). L-Allylglycine (92a) crystallised on cooling. N- 
Acetyl-D-allylglycine (93b) was hydrolysed in 2M hydrochloric acid to 
give D-allylglycine (92b). Upon ozonolysis of D- (92b) and L- 
allylglycine (92a), D- (20b) and L-aspartic acid-p-semialdehyde (20a) 
were formed. Only the L-isomer was found to be a substrate of DHDP 
synthase. Black and W right found tha t the aspartic  acid 13- 
semialdehyde was reasonably stable in acid solution at 0 °C. They 
were unable to isolate the product as the solid salt. Identification of 
the product of ozonolysis relied on the fact that it could be converted 
into homoserine by homoserine dehydrogenase.
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When our group repeated the Black and Wright procedure, 
the product obtained by ozonolysis was analysed by : H NMR 
spectroscopy. This indicated that dl-ASA (20) was present along with 
formaldehyde (94) and DL-aspartic acid (19) (Schem e 40). No 
aldehyde signal was observed in the *H NMR spectrum, therefore the
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aldehyde presumably exists as the hydrate. Attempts to purify the 
mixture using ion-exchange chromatography were unsuccessful.
^  O3 , 1M HC1 « ™ 3 C1- NH3 CV
♦ BO jC  iV (C02■ 0°C HO X /  Cq 2h ‘ ^  C02H
(92) (20) (19)
+ H2C = 0  (94)
Scheme 40
3.3 Modified Synthesis o f  L-Aspartic Acid ft-Semialdehvde.
Our group at Glasgow required a readily available, pure form 
of DL- (20) or L-ASA (20a) for inhibitor and kinetic studies with the 
enzyme DHDP synthase. dl-ASA (20) prepared by the method of Black 
and Wright1 0 4  could be used for the enzyme assay. However, this 
material was impure and available only as an acidic solution of 
variable concentration which meant that careful buffering of the 
assay was necessary. Other methods for the formation of DL- (20) or 
L-ASA (20a) were therefore investigated.
Several reports of the synthesis of L-ASA (20a) doubly 
protected on the amino and carboxyl groups had appeared in the 
literature. Keith et ai .9 1  used N-benzyloxycarbonyl-L-aspartic acid 
semialdehyde benzyl ester (95) in their total synthesis of the amino 
acid rhizobitoxine (96). Fushiya e ta l . 1 0 5  used protected L-ASA in the 
synthesis of avenic acid (97) and 2'-deoxymugineic acid (98), amino 
acids with an iron-chelating activity. Baldwin and Flinn9 0  prepared L- 
ASA (20a) doubly protected on the amino and carboxyl groups from 
L-methionine (21) via homoserine in their route to more complex
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amino acids. However, no deprotection step to prepare free L-ASA 
(2 0 a) was described by any of these authors.
C02-CH2Ph NH2
0HC 1  HO. A A
NH-C02CH?Ph 
(95) (96) +NH3
c o 2- CO/ C02H c o2- c o 2- co2h
HO' v  N OH < N N v  OH
H2 h 2 \ / H  h 2
(9 7 ) (98)
Our group reported the synthesis of the trifluoroacetate salts 
of D- (20b), L- (20a) and DL-ASA (2 0 ).93 These were prepared from 
the ozonolysis of doubly protected allylglycine followed by careful 
deprotection with trifluoroacetic acid. The synthetic procedure was 
followed in this work in order to provide a supply of DL-ASA (20) for 
use in the preparation and testing of potential inhibitors of DHDP 
synthase. DL-Allylglycine (92) was converted into its t-butyl ester 
derivative using 2 -methylpropene and a catalytic amount of conc. 
sulfuric acid (Scheme 41).95 The product was precipitated as the 
hydrochloride salt (99). The N-t-butoxycarbonyl (Boc) derivative
(100) was prepared by treatment of (99) with di-t-butyl dicarbonate 
under basic conditions . ! 0 6  Ozonolysis of (100) at -78°C in 
dichloromethane and subsequent reductive decomposition of the 
ozonide gave the protected aspartic acid p-semialdehyde derivative
(101). The mechanism of formation and decomposition of the ozonide
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(103) is shown in Scheme 42. The l H and 13C NMR spectra of (101) 
confirmed the presence of the aldehyde, i.e. there was a singlet at §h 
9.74 and a signal at 3c 199.4.
NH
(92)
3
C 02'
1. 2-Methylpropene, 
c. H2SQ4, c h 2c i2_
-78°C
2 . Ether/HCl (g)
NH3 Cl'
C 0 2t-Bu
(99) 35%
O NHC02 t-Bu
H
1. 0 3, -78°C
C02t-Bu 2 . Et3N (2 eq), V ' S  cCbt-Bu
(Bo c ) 20 ,  
NaHC03, NaCl, 
CH2C12, H20, A
NHC02 t-Bu
71% (101) -78°C — r.t. (100) 98%
TFA, CH2C12 
lh, r.t.
OH NH3 CF3C02'
Overall yield 19%
HO v  C02H 
79 % ( 102 )
Scheme 41
Removal of the Boc group and the t-butyl ester was carried 
out in one step by stirring ( 1 0 1 ) in triHuoroacetic acid and 
dichloromethane for one hour at room tem perature under an 
atmosphere of nitrogen. Removal of the solvent in vacuo gave an oily 
residue which solidified to a pale yellow solid upon addition of ether.
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and 13C NMR data indicated that the product exists as a hydrate
(1 0 2 ), i.e. no signal for an aldehyde proton was observed and there 
was a double doublet at 5h 5.1 for the 4-H and a signal at 5c 89.4 for 
C-4. The trifluoroacetate salts of L- (102a) and dl-ASA (102) were 
shown to act as substrates for DHDP synthase. The D-isomer (102b) 
was not a substrate of the enzyme.
■ o '
^ 3 0  NHC02 t-Bu ( Q o  NHC02 t-Bu
*  v  C02 t-Bu v  v  C02 t-Bu
(100) Primary ozonide
Et,N
0-^-0 NHC02 t-Bu
C02 t-Bu
Secondary ozonide
(103)
Et,N
O 0 \  NHC02 t-Bu
o C02 t-Bu
LT +' °  °n NHCO?t-Bu h 2l .  j
C02 t-BuOv
0  NHC02 t-Bu
H v  C02 t-Bu 
( 1 0 1 )
+ Et3N-0 + H2C=0
Scheme 42
This modified synthesis can provide our group at Glasgow 
with a stable, pure and easily handled form of dl-ASA (102) for use 
in the study of DHDP synthase.
One drawback of the synthesis of DL-ASA (102) as shown in 
Scheme 41 is the low-yielding first step, namely the formation of 
the t-butyl ester of allylglycine (99) using 2-methylpropene and conc. 
sulfuric acid. The highest yield obtained for this reaction was only 
35%.
Replacing the t-butyl ester with the p-methoxybenzyl ester 
(Scheme 43) improves the overall yield of the TFA salt of dl-ASA 
(102).93 This synthesis was originally carried out by Dr. David Tudor 
in our group and was followed in this work. The potassium salt of N-1- 
butoxycarbonyl-D L-allylglycine (104) was p repared  from DL- 
allylglycine (92) using di-t-butyl d icarbonate and  potassium  
bicarbonate in water and dioxan . 107  The p-m ethoxybenzyl ester 
(105) was made from (104) using p-methoxybenzyl chloride in DMF. 
Ozonolysis of (105) gave the aldehyde (106). Removal of the p- 
methoxybenzyl ester and the Boc group was carried out in one step 
by stirring (106) in trifluoroacetic acid for two hours. The product 
was isolated as a pale yellow solid which had identical spectral data to 
the TFA salt of DL-ASA (102) prepared by the m ethod shown in 
Schem e 41. This material was shown to act as a substrate of DHDP 
synthase.
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(Boc)20 ,  KHCO: 
H2 0, dioxan
0  NHC02 t-Bu
NHCO?t-Bu
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H v  C02R 
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1 . 0 3, -78°C
2 . Et3N (2 eq), XC02R
-78°C-*-r.t.
TFA, CH2C12 
2 h, r.t.
OH NH3 CF3C02'
(105) 95%
R = CH2-C6 H4-OMe
Overall yield 40%
HO v  C02H 
( 1 0 2 ) 55%
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3.4  Studies with DHDP Synthase.
Isolation and Purification of DHDP Svnthase.
The enzyme dihydrodipicolinate synthase catalyses the 
condensation of aspartic acid p-semialdehyde (20) and pyruvate (24) 
to form dihydrodipicolinate (25).35 The gene encoding this enzyme in
E. coli {dap A) has been cloned and sequenced3 0  and the over­
expressed enzyme has been purified and crystallised . 3 4
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The DHDP synthase required for use in our biochemical 
experiments can be routinely obtained from an over-expressing strain 
of E. coli. This work was initially carried out by Emma Borthwick 
(Biochemistry Department, University of Glasgow).108 Plasmid pDA2 
carrying the dap A gene of E. coli was obtained as a gift from Dr. P. 
Stragier, Institu t Pasteur, Paris. It was transform ed into E. coli 
MV1190 (Rec A~) to p roduce the over-expressing  stra in  
MV1190/pDA2, the source of our enzyme. The specific activity of 
DHDP synthase from the over-expressed strain was 52 units/mg. [One 
unit of enzyme activity is defined as the am ount of enzyme that 
catalyses the formation of 1 pinole of product per minute.]
Standard Assay System for DHDP Synthase.
The enzyme was assayed at 25 °C by m onitoring the 
formation of dipicolinic acid at 270 nm using a Gilford model 2600 
spectrophotometer. The initial product of the reaction, l-2,3-DHDPA 
(25), is unstable and is spontaneously oxidised in vitro to DPA (44) 
which absorbs with a ^max value at 270 nm (Scheme 12). The assay 
product was isolated by HPLC and its UV and XH NMR spectra were 
shown to be indistinguishable from those obtained from an authentic 
sample of dipicolinic acid (44).l ° 8
This assay has enabled us to test analogues and derivatives 
of L-aspartic acid p-semialdehyde (20a), pyruvate (24), l-2,3-DHDPA 
(25) and L-2,3,4,5-THDPA (26) for substrate or inhibitor activity of 
DHDP synthase.
The -standard 1 ml assay consisted of 100 pM imidazole 
buffer, 1 mM aspartic acid p-semialdehyde (102), 1 mM pyruvate
75
(24) and 16 absorbance units of DHDP synthase. Various 
concentrations of compounds were studied, usually 5 mM, 1 mM, 0.5 
mM and 0.1 mM. Each result is an average over three assay runs. The 
level of inhibition was measured as a percentage of the standard rate 
as shown by the equation and graph in Fig. 2.
Significant inhibition was taken to be about 10% inhibition at
0.5 mM of the compound being tested. All test data obtained are 
detailed in Chapters 3, 4, 5, 6  and in the experimental section of 
Chapter 7.
a = rate of standard  assay
speed
x = rate of assay plus 
com pound
time
  x 100 = Inhibition (%)
a
Fig. 2
Electrosprav Mass Spectrometry of DHDP Svnthase.
Electrospray mass spectrometry (ESMS) is a relatively gentle 
technique used to examine samples with high molecular weights. 
Ionisation takes place at atmospheric pressure and moderate
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temperatures, thus no fragmentation of the molecules occurs. ESMS 
can be used to determine or confirm the molecular weight of some 
proteins and to establish the presence of any post-translational 
modifications.
A homogeneous sample of our DHDP synthase was analysed 
by ESMS by Andrea Shneier and Dr. C. Abell (University of 
Cambridge) on a VG BioQ_mass spectrometer. The observed molecular 
weight was 31 272 (average of eleven determinations). The ESMS 
spectrum of DHDP synthase is shown in Fig. 3 .109
Results: Mass calculated from several ESMS 31 273.2  .
Smoothed spectrum of DHDPA synthase
1 1 5 1 . 41945.4
129).3
1394.9
1439
1544.3
1444.4
1 9 7 1 . 5  I 1 1 7 - 5\
:^ /I799  Baa 199 1899 1199 1299_____1389 1499____ 1599 1499 1799
Component analysis
unmodified DHDPA synthase
3 1 8 8 9  3 1 2 8 9  3 1 4 9 9  3 1 6 6 9
Fig. 3
77
Richaud e t al.30 had previously calculated the mass of DHDP 
synthase as 31 372 (100 greater than that observed by ESMS), based 
on the DNA-derived amino acid sequence. Unpublished amino acid 
sequence data by Laber indicate that one glutamic acid residue is in 
fact a glycine residue. This reduces the calculated mass to 31 300, still 
28 larger than the observed mass. The difference of two methylene 
groups between the predicted and observed values is well within the 
resolution of the mass spectrom eter. The spectrum  shows no 
significant tailing, indicating that the mass observed is real and not a 
consequence of poor resolution. Furthermore, this result has been 
repeated by ourselves with the assistance of Dr. A. Pitt (University of 
Strathclyde). The discrepancy between the experimentally observed 
weight and the molecular weight calculated from the derived amino 
acid sequence indicates that the amino acid sequence must contain at 
least one more error.
Mechanistic Studies of DHDP Svnthase.
The mechanism of DHDP synthase is believed to involve 
initial binding of pyruvate (24) as an imine to an active site lysine 
re s id u e .32,34 w e have shown that there is irreversible loss of 
enzymatic activity of DHDP synthase upon addition of sodium 
borohydride only in the presence of pyruvate (24). This suggests that 
the formation of an imine intermediate (30) between DHDP synthase 
and pyruvate (24) occurs. Reduction of the imine (30) by borohydride 
results in the irreversible formation of (107) (Scheme 44).
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Imine formation between pyruvate (24) and DHDP synthase 
has been detected directly using ESMS, without borohydride 
treatment (Fig. 4).3 3  When DHDP synthase was mixed with pyruvate 
(24) immediately prior to injection into the mass spectrometer two 
peaks were observed, corresponding to native protein (A) and the 
imine adduct (B) (observed MW 31 346, calculated MW 31 343).
DHDP Synthase was incubated with pyruvate (24) and 
inactivated by the addition of sodium borohydride. The ESMS of this 
sample showed a single protein species, indicating that all the active 
sites had been modified. The observed MW was 31 347 (4 
determinations) compared to a calculated MW of 31 345 for the 
reduced imine. In a control experiment with borohydride, in the 
absence of pyruvate (24), no loss of enzyme activity was observed 
and analysis by ESMS showed only unmodified enzyme.
As the proposed mechanism requires initial imine formation 
between the enzyme and pyruvate (24), it was not expected that any 
adduct between DHDP synthase and DL-aspartic acid p-semialdehyde 
(102) would be observed. There was no loss of enzyme activity upon 
addition of sodium borohydride in the presence of dl-ASA (102) and
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the ESMS of the sample showed only unmodified enzyme. This 
confirmed that there is no imine formation between DHDP synthase 
and dl-ASA (102) in the enzyme reaction.
Observation of imine between DHDPS and pyruvate
M/'
3 1 3 0 0  3 1 2 0 0  3 1 4 0 0  3 1 6 0 0  3 1 8 0 0
u J \V, j T  Y
V
B
co,-
DHDPS plus pyruvate (1 mM)
3 1 0 0 9  3 1 2 0 0  3 1 4 0 9  3 1 6 0 0  3 1 3 0 9
Fig. 4
Further mechanistic studies of DHDP synthase, using ESMS 
and NMR spectroscopy, are being undertaken by our co-workers John 
McKendrick and Dr. Philip Mallon.
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3.5 Synthesis and Test Results o f  Derivatives o f  L-Aspartic Acid p -
Semialdehvde.
Primary amines can add to aldehydes and ketones to give 
im in e s 1 1 0  which are stable enough for isolation. Imines are 
sometimes referred to as Schiff s bases.
The general mechanism of formation of imines formed from 
the reaction between a carbonyl compound and a primary amine is 
shown in Scheme 45. The initial N-substituted hemiaminal (108) is 
unstable and loses water to form the stable imine (109).
(108) (109)
Scheme 45
A number of imine derivatives of dl-ASA (20) were 
synthesised in this work and tested as inhibitors of DHDP synthase. 
The oxime (110), methyloxime (111), semicarbazone (112), 
thiosem icarbazone (113) and ethyl hydrazinoaceta te  (114) 
derivatives of protected dl-ASA (101) were all prepared under 
similar reaction conditions in 59%, 84%, 90%, 8 6 % and 65% yields 
respectively (Scheme 46). A solution of diprotected dl-ASA (101) in 
dichloromethane was added to a solution of the respective amine 
hydrochloride in water and the two-phase mixture was rapidly 
stirred for 24 hours. Extraction of the resultant mixture with 
dichloromethane, concentration and purification by chromatography, 
if necessary, gave the desired products. Alternatively, these imine
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derivatives could be prepared by treatment of diprotected dl-ASA 
(1 0 1 ) with the appropriate amine hydrochloride and triethylamine in 
dichloromethane under an atmosphere of nitrogen. Concentration in 
vacuo and purification by column chromatography gave the desired 
products.
NH
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3
C02-
o  NHC02 t-Bu
H v  CCAt-Bu 
( 101 )
A. RNH2 .HC1,
c h 2c i2, h 2o
or
B. RNH2 .HC1, 
CH2C12, Et3N
/  
RN 3
n h 3 CF3C02-
c o2h
TFA,
1 h, r.t.
R = OH (115) 65%
R = OMe (116) 48%
R = NHCONH? (117) 65% 
R = NHCSNH2 (118) 79%
NHCO?t-Bu
RN/ N f 2 C02 t-Bu
R = OH (110) 59%
R = OMe (111) 84%
R = NHCONH2 (112) 90%
R = NHCSNH2 (113) 8 6 %
R = NHCH2C02Et (114) 65%
Scheme 46
Analysis by *H NMR spectroscopy showed the presence of a 
mixture of the cis-{Z-) and trans-{E~) isomers of the oxime (110), 
methyloxime (111) and the semicarbazone (112). For example, the XH 
NMR spectrum of the semicarbazone derivative (112) showed two 
triplets in 2:1 ratio, one at 8 r  7.11 (J  3.8 Hz) for the 4-H of the E- 
isomer and another at ^  6.53 {J 5.6 Hz) for the 4-H of the Z-isomer.
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Deprotection of compounds (110), (111), (112) and (113) was 
achieved by stirring in dichloromethane and trifluoroacetic acid for 
one ho u r a t room  tem peratu re  to give the  corresponding  
trifluoroacetate salts (115), (116), (117) and (118) in reasonable 
yields (Schem e 46). A ttem pted d ep ro tec tion  of the ethyl 
hydrazinoacetate derivative (114) gave an oily residue. There were 
no signals in the 1H NMR spectrum corresponding to the ethyl ester, 
indicating that com pound (114) was degraded under the acidic 
conditions.
The pro tected  methyloxime derivative (111) and the 
protected semicarbazone derivative (112) showed no significant 
inhibition of DHDP synthase at ImM. However, the protected 
thiosemicarbazone derivative (113) gave some inhibition, showing 
33% at 0.25 mM. The protected ethyl hydrazinoacetate derivative 
(114) gave 17% inhibition at 0.5 mM. The oxime derivative (110) has 
not yet been tested.
Of the deprotected derivatives, only the trifluoroacetate salt 
of the thiosem icarbazone, compound (118), gave any significant 
inhibition below 1.0 mM. This was a very good inhibitor showing 46% 
inhibition at 0.1 mM.
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3.6 Attempted Synthesis of Difluoro Analogues of dl-ASA (20).
1,1-Difluoroalkenes are a class of fluoroorganic molecules 
with interesting chemical and biological properties . 1 1 1 »1 1 2  They are 
potential mechanism-based enzyme inhibitors1 1 3  and can be used as 
isosteric replacements for a carbonyl group . 1 1 4  Edwards et al . 1 1 5  
reported a new reagent for the conversion of carbonyl compounds 
into 1 ,1 -difluoroalkenes - difluoromethyldiphenylphosphine oxide 
(119). We decided to synthesise (119) in order to react it with 
d ip ro tected  dl-ASA (101) in an a ttem pt to prepare the 1,1- 
difluoroalkene derivative (1 2 0 ).
Difluoromethyldiphenylphosphine oxide (119) was prepared 
by ad d ition  of ch lo rod ifluo rom ethane  to a so lution of 
diphenylphosphine oxide and n-butyllithium in THF at -50°C 
(Scheme 47). Concentration in vacuo and purification on a silica gel 
column gave compound (119) as a white solid in 48% yield.
O n -BuLi, 9
CHC1F2 + (Ph)2PH THF, -50 °c" (Ph)2PCHF2
(119) 48%
Scheme 47
The l U NMR spectrum of (119) (Fig. 5) shows a double 
triplet at 8 h 6.35 ( 2J h f  50.0 Hz and 27ph 22.4 Hz) for the methine 
proton.
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(PVi>2PCHPz
9-0 |.5  %.0 r s  7.0 45 &•« S.5 5*9 4*5
Fig. 5
A solution of diprotected DL-ASA (101) in THF was added 
dropwise at -50°C to a solution of (119) and lithium diisopropylamide 
in THF (Scheme 48) according to the procedure of Edwards e t a l . n 5 
However, only starting materials were recovered from the reaction 
mixture - the 1,1-difluoroalkene (120) was not formed. Time 
constraints prevented further investigation of this reaction. It may be
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that fresh reagents, longer reaction times or higher temperatures are 
required.
n  NHCO?t-Bu
V l.LDA, THF, -50 °C p a  1
(Ph)2PCHF2 ......................................*- y V ' m t . j u
2 . Protected dl-ASA (101) I - “
(119) F (i?0)
Scheme 48
The gem-difluoro analogue (121) would be an interesting 
compound to test as a potential inhibitor of DHDP synthase. However, 
attempts to synthesise (121) from diprotected dl-ASA (95) and 
die thy lam inosulfur trifluoride (DAST)H6  have so far proved 
unsuccessful (Scheme 49).
0  NHRl Et2NSF3, CH2C12 F NHR
H v  C 0 2R2 F v  C 0 2R2
(95) (121)
Rp = C 02CH2C6H5 Rj = c o 2c h 2c 6h 5
R2 = CH2c 6H5 r 2 = c h 2c 6h 5
Scheme 49
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Chapter 4 - Synthesis of Homologues of L-Aspartic Acid p-
Semialdehyde.
Introduction.
L-Aspartic acid p-semialdehyde (20a) is a substrate of 
dihydrodipicolinate synthase, the first enzyme unique to L-lysine (1) 
biosynthesis in plants and bacteria. The homologues of l-ASA (20a) 
are glutamic acid y-semialdehyde (GSA) (122) and a-aminoadipic acid
5-semialdehyde (AASA) (17). While synthesising and testing potential 
inhibitors of DHDP synthase, we decided that GSA (122) and AASA 
(17) would be interesting compounds to test as inhibitors and /or 
substrates of the enzyme.
Both GSA (122) and AASA (17) are biologically important. 
GSA (122) is a common in term ed ia te  in the enzymatic 
interconversions of glutamic acid, proline and ornithine . 1 1 7  AASA 
(17) has been identified as a precursor of saccharopine (18), a key 
intermediate in lysine ( 1 ) biosynthesis by yeast . 1 1 8
There are several reports in the literature detailing the 
synthesis of protected forms of GSA (122). Bold e ta l . 9 2  prepared GSA
( 1 2 2 ) doubly protected on the amine and the carboxyl functionalities 
via the Rosenmund reduction reaction. The doubly protected 
semialdehyde was used directly in further transformations. Lee and
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Miller1 1 9  made the protected semialdehyde by reduction of the 
corresponding acid chloride (1.23) with a hydride agent such as 
tr ib u ty lt in  hydride  or lithium  tri-tert-butoxyaluminohydride 
(Schem e 50). The protected semialdehyde ( i 24) was used for 
further transformations.
/ ?(CH2)2-Cx
c b z -n ^ Y ° C 1  -
\ — 0  Li(OtBu)3AlH
(123)
Scheme 50
A Japanese patent in 1980 described a process for preparing 
optically active N-acetylglutamic acid ^semialdehyde from oxidation 
of optically active N-acetylornithine with persulfate. The product was 
formed as an aqueous solution and was not isolated.
Rodwell1 2 0  described the synthesis of an aqueous solution of 
an equilibrium mixture of a-aminoadipic acid 5-semialdehyde (AASA) 
( 1 7) and A'-piperidine-6 -carboxylate (1.25) (Scheme 51).
O
(CH2 )2-Cn
Cbz-N
( 12 4 )
O
H
The synthetic procedure was analogous to that used by Black 
and Wright1 0 4  in the preparation of L-aspartic acid p-semialdehyde 
(2 0 a) in that the product existed as an acidic aqueous solution, formed 
by ozonolysis of the corresponding unsaturated amino acid.
In the same article Rodwell reported the biosynthesis of and 
isolation of L-a-aminoadipic acid 6-semialdehyde (l-AASA) (17) from 
DL-pipecolate using pipecolate dehydrogenase (Pseudomonas putida) 
as a catalyst. The equilibrium mixture of (17) and (125) was isolated 
as the hydrochloride salt - a pale yellow, hygroscopic amorphous 
solid, mp 75-79°C. No spectral data were provided although the 
material was optically active and was converted into L-ot-amino- 
adipate by a-aminoadipate 8-semialdehyde NAD oxidoreductase . 1 2 1
We wanted to synthesise and isolate GSA (122) and AASA 
(17) as their trifluoroacetate salts by using synthetic routes similar to 
the one we had developed for the production of DL-aspartic acid p- 
semialdehyde (102 ) , 9 3  as detailed in Chapter 3. This would entail 
protection of the appropriate amino acid, followed by ozonolysis to 
afford the aldehyde and subsequent deprotection to give the 
trifluoroacetate salt of the semialdehyde. The starting amino acids 
that we required were 2-amino-5-hexenoic acid (126) and 2-amino-
6 -heptenoic acid (127) (Scheme 52). These are not commercially 
available.
+
n = 2 GSA (122) 
n = 3 AASA (17)
n = 2  (126) 
n = 3 (127)
Scheme 52
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This Chapter will contain a brief overview of general a-amino 
acid synthetic methodology followed by a detailed description of the 
routes we used to synthesise the amino acids (126) and (127) and the 
corresponding semialdehydes (122) and (17). The use of chiral 
bis-lactim ethers in the synthesis of optically active amino acids will 
also be discussed.
4.1 General a-Amino Acid Synthesis.
The increasing demand for a-amino acids for use in food 
products, drugs and as starting materials in organic synthesis has led 
to an enormous increase in methods available for their production. 
New and general synthetic routes to a-amino acids are of interest for 
both the large-scale production of known amino acids as well as the 
preparation of rare an d /o r unknown amino acids. A review by 
O'Donnelll22 details some recent synthetic methods developed for use 
in a-amino acid chemistry. More traditional m ethods include the 
Strecker synthesis, am ination of a-halogen acids, rearrangem ent 
reactions and alkylation of m alonate/glycine derivatives. Each of 
these synthetic strategies will be briefly discussed in this section.
The Strecker Synthesis.
a-Aminonitriles can be p repared  in one step by the 
treatm ent of an aldehyde or ketone with sodium  cyanide and 
ammonium chloride. This is known as the Strecker synthesis. A 
possible mechanism is shown in Schem e 53. Initial addition of
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ammonia to the aldehyde followed by loss of water would give the 
imine (128). Sodium cyanide could then attack the imine to form the 
aminonitrile (129). As nitriles are readily hydrolysed to carboxylic 
acids, this is often a convenient method for the preparation of a- 
amino acids, although it can be limited by the accessibility of some 
aldehydes.
n h 3 A Hz -h 9o
R-CHO  R-CH — '-  R-CH=NH
(128)
NaCN
\ OH
n h 3 n h ?
R-CH   R-CH
XC02- ncn
2 (129)
Scheme 53
Amination of a-Halogen Acids.
The ammoniolysis of a-halogen acids (130) is, in general, high 
yielding and convenient and remains a useful method for the 
synthesis of a-amino acids (Scheme 54).
H H
I NH3 I
R -C —C02H -------- — ► R—C —CO?'
I i
X n h 3
(130)
Scheme 54
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If the requisite a-halo acid reactants are not available, these 
may be synthesised by either bromination of the appropriate malonic 
ester derivative or by the Hell-Volhard-Zelinsky procedure.
Rearrangement Reactions Leading to arAmino Acids.
The Curtius, Hofmann and Schmidt rearrangements1 2 3  have 
all been used for the synthesis of a-amino acids via the corresponding 
isocyanate (131) (Scheme 55).
Schmidt
O
Curtius
O
OH NHNH2
h n 3
NaN02,
HC1
Hofmann
O 0
Br2
O 0
R—N=C=0
(131)NHBr
V
amino acid
Scheme 55
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Alkvlation of Malonate/Glvcine Derivatives.
Compounds that contain strong electron-withdrawing groups 
(Z) on a carbon atom with an attached hydrogen, can easily be 
converted into the corresponding enolate anions (132) (Scheme 56). 
These enolate anions can attack alkyl halides, resulting in alkylation.
Z Y
(132)
aR^X R
Scheme 56
The Sorenson method of amino acid synthesis applies this 
reaction to diethyl acetamidomalonate (133). Hydrolysis and 
decarboxylation of the alkylated product (134) results in the amino 
acid (Scheme 57).
NHCOCH3
CO?Et
C02Et
(133)
Na, EtOH
X-R
NHCOCH
^-*C02Et
C02Et
R- <
NH hydrolvsis
CO-
RX
NHCOCH3 
R—( - C 0 2Et
C02Et
(134)
Scheme 57
Phase-transfer reactions provide a potentially attractive 
synthetic route for the preparation of higher amino acids from
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derivatives of the simplest, glycine. The Schiff base (89) is an active 
methylene compound in which both the amino acid and carboxylate 
groups of glycine have been protected towards proton abstraction by 
groups which will stabilise an adjacent carbanion. The use of phase- 
transfer reagents in a two-phase system can bring about alkylation of 
(89). The alkylated Schiff base (135) can then be hydrolysed to the 
corresponding amino acid (Scheme 58).
Ph Ph NH,
/ N _ < ph M , . .» R_ / N^ Ph hydrolysis R /
\  2 -phase \  \
C0 2 Et system C02Et CO:
(89) ' (135)
Scheme 58
The classic phase-transfer experiment involves an aqueous- 
organic two-phase system and a phase-transfer catalyst, usually an 
ammonium salt (Q_+X“). Scheme 59 shows the stages in the phase- 
transfer catalysed alkylation of a weak C-H acid (H-Sub).
H20  Aqueous
Phase
Interface
NaOOH" Na+ Na+ Na+ X" 
H-Sub Sub Sub-
x [Q.+ x
R-X
_i Sub-R 0- Organic
R-X R-X ^  x Phase
Scheme 59
The catalyst ion pair (CL+X~) acts partly by facilitating 
deprotonation but mainly by detaching the substrate anions attached
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at the phase boundary, with the release of the original anion of the 
catalyst into the w ater and fast subsequent reaction with the 
alkylating agent. This assumption is supported by the finding that a 
number of phase-transfer reactions proceed without a catalyst but are 
accelerated by one.124
4.2 Synthesis of Required Amino Acids.
Alkylation of Malonate Derivatives.
Our initial attem pt at the synthesis of 2-amino-5-hexenoic 
acid (126) and 2-amino-6-heptenoic acid (127) was based on a 
method previously described by Rodwell.l20 The appropriate alkyl 
halide was added dropwise to a refluxing solution of sodium and 
diethyl acetamidomalonate (133) in ethanol to give the alkylated 
product (Scheme 60). The alkyl halides used were 4-brom obut-l- 
ene and 5-brom opent-l-ene which gave the crystalline derivatives 
(136) and (137) respectively in no more than 44% yield after 
purification by column chromatography. Sequential ester hydrolysis, 
decarboxylation and amide hydrolysis of compounds (136) and (137) 
gave the amino acids (126) and (127) which were isolated as their 
hydrochloride salts.
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n h c o c h 3 1. Na, EtOH, 
RBr, A
2 . Column
R -^ - C 0 2Et
CO?Et
NHCOCH3
R= CH2=CH(CH2)2- (136) 37% 
R= CH2=CH(CH2)3- (137) 44%
1 . 10% NaOH
2 . c.HCl
3. 25% NaOH
+
R= CH2=CH(CH2)2- (126) 90% 
R= CH2=CH(CH2)3- (127) 80%
R
Scheme 60
Sodium chloride, formed as a side product in the final stages 
of Scheme 60, was not removed but the amount was estimated and 
carried on through the next stage of the synthesis.
Both amino acids (126) and (127) were water soluble white 
solids. The l H NMR spectra of both (126) and (127) had distinctive 
multiplets at around 5h 4.98 and 5.72 for the olefinic protons and a 
triplet at around 5h 3-85 for the hydrogen of the a-carbon. The 13C 
NMR spectra both showed signals at around §c 174 for the acid 
carbons.
Although this procedure was straightforward and used 
readily available, inexpensive starting materials the overall yields 
were low and purification by column chromatography was necessary 
after the first stage.
The reaction was repeated using a different malonate 
derivative, ethyl acetamidocyanoacetate (138) (Scheme 61). The 
alkylated derivatives (139) and (140) were recrystallised from 
ethanol and water to give white crystalline solids, mp 98-101 °C and
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43-45 °C respectively. The 13C NMR spectra showed signals at around 
5c 116.4 for the carbons of the nitriles. As before, sequential 
hydrolysis and decarboxylation gave the amino acids (126) and (127), 
as the hydrochloride salts.
NHCOCH3
<^CN
C02Et
(138)
Na, EtOH,
RBr, A R-
NHCOCH3 
■ -^CN
CO?Et
R= CH2=CH(CH2)2- (139) 36% 
R= CH2=CH(CH2)3- (140) 20%
1 . 10% NaOH, A
2 . c. HC1
NH
R= CH2=CH(CH2)2- (126) >95% R /
R= CH2=CH(CH?)3- (127) >95% 'CQ
Scheme 61
The hydrochloride salts of the amino acids, (126) and (127), 
showed no inhibition of DHDP synthase at 1 mM. The alkylated 
malonate derivatives, compounds (136), (137), (139) and (140), 
showed only slight inhibition of DHDP synthase at 5 mM
As both the synthetic routes detailed in Schemes 60 and 61 
are low-yielding and as we required several grams of the amino acids, 
other methods of oeamino acid synthesis were investigated.
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Alkylation of Schiff s Base Derivatives of Glycine.
The protected glycine derivative, JV-(diphenylmethylene)- 
glycine ethyl ester (89), was alkylated under anhydrous reaction 
conditions (S chem e 62). The base  u sed  was lith iu m  
diisopropylamide (LDA), formed in situ from the dropwise addition of 
n-butyl lithium  to diisopropylamine in dry THF a t -70 °C. Slow 
addition of the appropriate bromoalkene with subsequent warming to 
50 °C resu lted  in good yields of the m onoalkylated products. 
Compounds (141) and (142) were isolated as dark red oils which each 
showed one spot by TLC analysis. The lH NMR, i3C NMR and mass 
spectra all confirmed the formation of (141) and (142).
The benzylidene protective groups of (141) and (142) were 
removed under mild acidic two-phase conditions. Basification and 
extraction of the aqueous layers yielded the free amino acid esters, 
(143) and (144). Compounds (143) and (144) were subjected to mild 
basic hydrolysis followed by acidification and freeze-drying of the 
aqueous portions to yield the amino acids (126) and (127) as their 
hydrochloride salts.
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Ph
N = <
Ph
COjEt
(89)
1 '  H >
2 . nBuLi
3. RBr, -70°C-
THF, -70°C
R
50°C
N = <
Ph
Ph
‘C02Et
R= CH2=CH(CH2)2- (141) 81% 
R= CH2=CH(CH2)3- (142) 72%
2M HC1, 
Et20
R“ <
n h 3 cr
C021I
1. MeOH, NaOH
2 . 2M HC1 R
n h 2
C02Et
R= CH2=CH(CH2)2- (126) 95% R= CH2=CH(CH2)2- (143) 67% 
R= CH?=CH(CH2)3- (127) 95% R= CH2=CH(CH2)3- (144) 63%
Scheme 62
Although the overall yields and purity of compounds were 
improved upon with this route, the need for strong, expensive bases, 
low temperatures and anhydrous reaction conditions dissuaded us 
from applying this route to larger scale preparations of the amino 
acids. This reasoning led us to investigate the use of phase-transfer 
methods in the synthesis of our amino acids. Phase-transfer 
techniques are noteworthy because of their simplicity and use of 
inexpensive reagents and solvents. This can favour their application in 
larger scale preparations.
An attempt to alkylate N-(diphenylmethylene)glycine ethyl 
ester (89) under phase-transfer conditions was made. A two-phase 
mixture of (89), tetrabutylammonium hydrogen sulfate (TBAH), 4- 
b ro m o b u t- l -e n e ,  1 0 % aqueous sodium  hyd rox id e  and  
dichlorom ethane was stirred at room tem perature  overnight 
(Scheme 63 ).125 G.C. analysis of the organic portion of the reaction
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mixture indicated that no alkylated material was present. The main 
peak of the GC spectrum may have been due to the free acid of (89). 
This would be formed from hydrolysis of the ester under the basic 
reaction conditions.
<
Scheme 63
The use of a different Schiff base, N-(diphenylmethylene)- 
aminoacetonitrile (145), allows stronger basic conditions to be 
employed without affecting the starting materials . 1 2 6  The catalytic 
phase-transfer alkylation of (145) was carried out with benzyltriethyl 
ammonium chloride (BTEAC) as the phase-transfer catalyst and 50% 
aqueous sodium hydroxide as the base (Scheme 64).
Ph Ph
N = < ph  -T-BAH, ^  / V ^ N= < p h
rn  10% NaOH, CH2C12, I rn
C02Et 4-bromobut-l-ene C02Et
(89) (141)
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Ph Ph
N =< BTEAC, N=<
/  Ph  ► r  —/  Ph
V XT 50% NaOH, toluene, \ rxrCN CN
(145) RBr> °°c - *" D°°c r =  CH2=CH(CH2)2- (146) 91%
R= CH2=CH(CH2)3- (147) 96%
R= CH?=CH(CH2)4- (148) 99%
2M HC1,
Et20
p NH3 C1 10% NaOH / NH2
Rn  x Rn
C02H CN
R= CH2=CH(CH2)2- (126) 95% R= CH7=CH(CH7)2- (149) 69%
R= CH2=CH(CH2)3- (127) 95% R= CH2=CH(CH2)3- (150) 67%
R= CH2=CH(CH2)4- (152) 95% R= CH2=CH(CH2)4- (151) 69%
Scheme 64
The alkylated products, (146), (147) and (148), were 
synthesised in high yield and without the need for further 
purification. Only monoalkylated compounds were observed. Removal 
of the benzylidene groups under mildly acidic conditions gave the 
aminonitriles (149), (150) and (151). Alkaline hydrolysis of the nitrile 
groups yielded the amino acids (126), (127) and (152) which were 
isolated as the hydrochloride salts. This route was suitable for the 
multi-gram preparation of the required amino acids.
None of the compounds detailed in Schem es 62 and 6 4 
showed significant inhibition of DHDP synthase. The alkylated Schiff s 
base derivatives, compounds (141), (142), (146), (147) and (148), 
interfered with the enzyme assay due to their insolubility. The amino 
acid esters, (143) and (144), were poor inhibitors. They both showed 
around 15% inhibition at 1 mM. The aminonitriles, (149) and (150), 
did not show anv levels of inhibition below 1 mM.
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An approximation of the overall yields of amino acids 
obtained by the different synthetic methods described in this Chapter 
is shown in Table 5.
Anhydrous reaction 
conditions
Phase-
transfer
N a/EtOII EDA 50% NaOH
/ S / y ^ c r  
(126) C02II
33% 52% 60%
(127) NH3Cr 
^ / ^ C 0 2H
35% 43% 61%
(152) C02H
* - 61%
Table 5
4.3 Optically Active (x-Amino Acids.
The possibility of synthesising optically active 2-amino-5- 
hexenoic acid (126) and 2-amino-6-heptenoic acid (127) was 
investigated.
There are several well documented methods used in the 
asymmetric synthesis of a-amino acids. 1 2 7  Schollkopf el al. developed 
the enantioselective synthesis of a-amino acids from the reaction of 
l i th ia ted  b is -lactim e thers  of 2 ,5 -d iketop iperaz ines  with 
electrophiles. 1 2 8  This asymmetric approach is based upon heterocyclic 
chemistry with the following requirements. The heterocycle is 
composed of a lower amino acid (e.g. glycine or racemic alanine) and a
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a chiral auxiliary. The most studied and widespread bis-lactim ether 
is (153), tha t made from L-valine and glycine (Fig. 6). The 
heterocycle has an acidic hydrogen next to the potential amino group 
and has two sites susceptible to hydrolysis (—).
Bis-lactim ethers react readily with n-butyl lithium to give 
the lithiated heterocycles (154) which possess a prochiral carbon atom 
(Scheme 65). Electrophiles can be in troduced both  regio- and 
diastereo- selectively to the anion (154) to give the alkylated product 
(155). The high diastereoselectively of this reaction, often > 95%, can 
be explained if we consider the lithium  com pound as a planar 
dihydropyrazine anion (154a), one diastereotopic side of which is 
strongly shielded by the comparatively large isopropyl group of the 
chiral auxiliary.
Subsequent mild hydrolysis of the alkylated heterocycle 
(155) liberates the chiral auxiliary (156) and the new amino acid 
methyl ester (157). If (156) and (157) differ sufficiently in boiling 
points, the esters can be separated by bulb-to-bulb or fractional 
distillation.l29 Chromatographic techniques may also be used, after 
further hydrolysis to the amino acids.
(153)
Fig. 6
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J.
0.25M HC1
MeO N R
(155)
Scheme 65
Several alkylated bis-lactim ethers were prepared (Table 
6 ). The starting bis-lactim ethers were commercially available. 
Alkylation of the lithiated anions with 4-bromobut-l-ene resulted in 
good yields of the alkylated heterocycles, compounds (158), (160),
(162) and (164) as clear oils. Diastereomeric excess (de) values were 
estimated to be around 84-95% from Ml and 13c NMR spectra or by 
gas chromatography. The NMR spectrum of (158) is shown in Fig. 
6 .
Hydrolysis of each of the alkylated bis-lactim ethers was 
readily achieved by stirring with 0.25-1.0 M aqueous 1IC1 solution at 
room temperature for several hours. This yielded a 1:1 mixture of the 
chiral auxiliary (either L-valine methyl ester or D-valine methyl ester) 
and the desired amino acid methyl ester, compounds (159), (161),
(163) or (165), in quantitative yields. Under these conditions 
practically no 2,5-diketopiperazines (90) were formed. However, after 
several weeks storage under a sealed atmosphere of nitrogen at 4 °C, 
insoluble solid material was observed in some of the samples. This 
was evidence that formation of 2,5-diketopiperazines was eventually 
occurring.
Alkylated bis- 
lactim ether
% Yield % de Products of 
hydrolysis
A
MeO
(158)
OMe
78 84
L-Val-OMe + 
C02Me
h2n - W
(159)
A
MeO
(160)
/ OMe
79 85
D-Val-OMe + 
CO?Me
A
MeO/
r N^
(162
OMe 
[ Mew 95 >95
L-Val-OMe + 
CO?MeMe,^ W
HzN ,163)
A
MeO
N OMe
T Me
(164)
99 >95
D-Val-OMe + 
C02Me
H?N *
Me (16^)
Table 6
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The separation of the valine auxiliaries from the required 
amino acid esters proved extremely difficult. This is not very 
suprising considering the similarities in molecular weight and 
functionality of the compounds being investigated. No suitable solvent 
system was found for separation using chromatography. The best
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separation was attained by careful fractional distillation. For example, 
m icrodistillation of the mixture of D-valine m ethyl ester and 
compound (165) gave a sample of the amino acid methyl ester (165). 
Analysis of the XH NMR spectrum showed this to be approximately 
75% pure.
Better separation of the products of hydrolysis is necessary 
before this synthetic procedure can be considered a viable route to 
optically active 2-amino-5-hexenoic acid (126) and 2-amino-6- 
heptenoic acid (127).
4.4 Attempted Synthesis of Glutamic Acid y-Semialdehvde and a- 
Aminoadipic Acid 5-Semialdehvde.
Our first attem pts at synthesising glutam ic acid y- 
sem ialdehyde (122) involved a synthetic route sim ilar to that 
previously used in our synthesis of DL-aspartic acid p-semialdehyde 
(102). The amino acid, 2-amino-5-hexenoic acid (126) was doubly 
protected on the amino and carboxyl functionalities as the t- 
butoxycarbonyl derivative and the t-butyl ester respectively 
(Scheme 66).
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NH3 Cr 1. =< , H+ ^  ^NHC02t-Bu
( 1 2 6 ) C02H 2. (Bo c )20  (167) C02t-Bu 61%
1. 0 3> -78°C
2. Et3N
H 0 ^ 3 - C 0 2t-Bu .SP °n,tane0US * o d ~ \ - C 0 2X.-Ku 
^  N cyclisation V  NHC02t-Bu
73% C02t-Bu (168)
Scheme 6 6
This doubly protected material (167) was then subjected to 
ozonolysis at -78 °C followed by reductive work-up with 
triethylamine to yield around 73% of a pale yellow oil. However, 
analysis by iH and i3C NMR showed that the aldehyde (168) had not 
been isolated. Instead, spontaneous intramolecular cyclisation took 
place between the carbamate nitrogen and the aldehyde group to give 
the 5-hydroxyproline derivative (169). The mass spectrum showed a 
peak at m / z  270, corresponding to the parent ion of (169), less a 
hydroxyl group, and the iH and i3 C NMR spectra were more 
complicated than expected due to the presence of diastereoisomers of 
(169).
A literature search revealed that o ther workers had 
en co u n te red  this same cyclisation problem  with similar 
compounds.92^ 30 A solution to this problem lies within the work of 
Grehn and Ragnarsson.13!*132 They described the synthesis of N- 
(Boc)2 compounds by the exhaustive t-butoxycarbonylation of amide 
nitrogens using di-t-butylcarbonate and a catalytic amount of 4-
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dimethylaminopyridine. Bold e t a l 92 used this method to synthesise 
an N-(Boc)2 derivative of glutamic acid, (170), in order to prevent 
cyclisation to the 5-hydroxyproline compound (169) (Scheme 67).
We applied the method of Grehn and Ragnarsson to our 
synthetic routes of GSA (122) and AASA (17) in order to avoid 
intramolecular cyclisation at the oxidation stage. We also decided to 
use the p-methoxybenzyl ester as the carboxyl protecting group as 
opposed to the t-butyl ester. This resulted in higher overall yields and 
gave aromatic signals in the !H NMR spectra, making them easier to 
interpret.
NHCO?t-Bu
PhCH?0?C
(Boc) 20 ,  
DMAP, Et3N, 
CH2C12
C02t-Bu
(169)
N(C02t-Bu)2
PhCH20 2c ' ^ / C 02t:-Bu
(170)
Scheme 67
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n = 2 (180) 43%
Scheme 68
The doubly protected amino acids (173) and (174) were 
prepared in good overall yields (Scheme 68) as similarly described 
in the synthesis of dl-ASA (102) in Chapter 3. The N-(Boc ) 2  
derivatives (175) and (176) were prepared using (Boc^O and a 
catalytic amount of 4-dimethylaminopyridine (DMAP). (175) and 
(176) were isolated as yellow oils in 82 and 94% yields respectively. 
Analysis of each of (175) and (176) by lH NMR showed a broad 
singlet at around §h 1.45 in each spectrum, integral 18H,
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corresponding to the two Boc groups. The 13C NMR spectra each had 
signals at around 8c 155 and 152 for the amide carbonyl carbons.
Ozonolysis of compounds (175) and (176) followed by 
reductive work-up and purification by silica gel chromatography gave 
compounds (177) and (178) as pale orange oils in around 75% yield. 
The lH NMR spectra of (177) and (178) had singlets at 8h 9.76 and 
9.75 respectively for the aldehyde proton and the 13C NMR spectra 
had signals at 8c 201.0 and 201.8 for the aldehyde carbons. The mass 
spectra also supported the formation of the aldehydes.
A solution of (177) in dichlorom ethane was stirred with 
trifluoroacetic acid under an atm osphere of n itrogen at room 
tem perature for 2-3 hours. The reaction mixture was concentrated in 
vacuo, taken up in distilled water and washed with ethyl acetate. The 
aqueous layer was freeze-dried to yield a cream -coloured, 
hygroscopic solid, mp 57-58 °C. Analysis of the solid by lH NMR and 
13c NMR spectroscopy indicated the presence of the trifluoroacetate 
salt of DL-glutamic acid y-semialdehyde hydrate (179). The !H NMR 
spectrum showed broad multiplets at 8h 1.84-2.30 (3- and 4 -H2), 4.16 
(2-H) and 5.40 (5-H). The sample also contained impurities (possibly 
isobutylene polymer derivatives). No attem pts have been made to 
purify the impure material.
Removal of the protecting groups of compound (178) was 
achieved under similar conditions as for compound (177). Freeze- 
drying of the aqueous layer yielded a yellow, hygroscopic solid, mp 
59-61 °C. The lH NMR and i3C NMR spectra indicated an impure 
sample of the trifluoroacetate salt of DL-a-aminoadipic acid 8- 
semialdehyde hydrate (180). The !H NMR spectrum had broad signals 
at 1.35-2.32 (3-, 4- and 5 -H2) and 3.80 (2-H). The expected signal 
corresponding to the methine proton of C-6 appears to be hidden by
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the broad water peak. No attem pts to purify this m aterial were 
undertaken.
The potassium salts of the N-Boc amino acids, compounds
(171) and (172), showed no inhibition of DHDP synthase at 1 mM. The 
remaining intermediates of the synthetic pathway shown in Schem e 
68, compounds (173)-(178), were found to be insoluble in the enzyme 
assay mixture. The impure sample of DL-glutamic acid y-semialdehyde 
hydrate (179) showed no inhibition of DHDP synthase. DL-a- 
aminoadipic acid 8-semialdehyde hydrate (180) was a poor inhibitor 
of DHDP synthase, showing only 27% inhibition at 1.0 mM.
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Chapter 5 - Synthesis of Sulfur Analogues of l - 2 , 3 - D H D P A
and l-2,3,4,5-THDPA.
Introduction.
In recent years an ever-increasing number of organosulfur 
compounds have been introduced into medicine and agriculture. 
These compounds contain sulfur in a variety of forms and oxidation 
states such as thioethers, sulfoxides, sulfones, thiols and thiones. The 
sulfur atom may form part of a heterocyclic ring system, often in 
combination with other heteroatoms such as nitrogen. Around 30% of 
the chemicals currently used as insecticides, herbicides, plant growth 
regulators and fungicides contain sulfur.
Sulfur heterocycles commonly encountered in medicinal and 
agricultural applications include phenothiazine (181), thiophene 
(182), thiazole (183) and thiazolidine (184).
Phenothiazine drugs are used in the treatment of psychiatric 
illness and as sedatives, anti-histamines and tranquilisers.1 3 3  Two 
im portant phenothiazine drugs are chlorpromazine (185) and 
triflupromazine (186).
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R = CF3 (186)
The 1,3-thiazole ring system is often found in natural 
products as it can be produced by the cyclisation of cysteine residues 
in peptides. An important natural product is vitamin Bi (187) which 
contains both a pyrimidine and a 1,3-thiazole ring system.
NH
Me
2 cr
Me
(187)
The most general synthetic route to 1,3-thiazoles is based on 
the cyclisation of intermediates formed from the reaction of a- 
halocarbonyl compounds and thioamides. This is known as the 
‘Hantzsch thiazole synthesis’ after A. Hantzsch who first introduced 
the synthesis in 1888.134 An example of the Hantzsch thiazole 
synthesis is shown in Scheme 69. Nucleophilic attack by sulfur on 
the carbon atom bearing the halogen atom results in the acyclic 
intermediate (188). Cyclisation and dehydration occur to give the 
product, 2 ,4-diphenyl-1,3-thiazole (189).
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A number of sulfur analogues of L-2,3-DHDPA (25) and L- 
2,3,4,5-THDPA (26) had been previously synthesised within our 
group and tested with DHDP s y n th a se . 135 Among the best inhibitors 
tested were diethyl (R ) - 3 ,4 - d i h y d r o - 2 H - 1 ,4 - t h i a z i n e - 3 ,5- 
dicarboxylate (42) and diethyl l,3-thiazole-2,4-dicarboxylate (43). 
Compound (42) gave 10% inhibition at 0.1 mM with DHDP synthase 
and (43) showed 15% inhibition at 0.1 mM.
In this work compounds (42) and (43) were synthesised and 
kinetic studies were carried out to determine whether they showed 
competitive or non-competitive inhibition with DHDP synthase. A 
number of other sulfur heterocycles were also prepared and tested 
with DHDP synthase.
(42) (43)
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5.1 Synthesis and Test Results of 1.4-Thiazines.
Berges and Taggart136 first reported the preparation and 
isolation of diethyl (i?)-3,4-dihydro-2//-l,4-thiazine-3,5-dicarboxylate 
(42) as an orange syrup. We followed their procedure by treating L- 
cysteine ethyl ester hydrochloride with ethyl brom opyruvate in 
dichlorom ethane in the presence of triethylam ine (Schem e 70). 
Purification by column chromatography yielded compound (42) as a 
golden orange syrup in 95% yield.
There are two possible mechanisms for the formation of (42) 
from L-cysteine ethyl ester hydrochloride and ethyl bromopyruvate.
Nucleophilic attack by sulfur on the carbon atom bearing the 
bromine would result in the acyclic intermediate (190). This could be 
followed by cyclodehydration and tautomerisation to give the more 
stable enamine form (42). Alternatively, attack of the amino group on 
the keto functionality of ethyl bromopyruvate could occur first to 
give the imine interm ediate (191). Subsequent cyclisation via 
nucleophilic attack by sulfur on the carbon atom bearing the bromine 
would give the ketimine (192). Tautomerisation would give the more 
stable enamine (42).
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The iH NMR spectrum of (42) (Fig. 7) indicated that only 
the enamine form was present. There is a singlet at 8 h 6.17 for the 
olefinic proton at C-6 . A well defined ABX splitting pattern is 
observed between the C-2 methylene protons and the adjacent C-3 
proton. The 2a-H at C-2 gives a signal at 5h 2.99 and a coupling 
constant of 6.7 Hz with the 3-H. The 2b-H at C-2 gives a signal at 5h 
3.25 and a coupling constant of 2.9 Hz with the 3-H. The geminal 
coupling constant between 2a-H and 2b-H is 12.1 Hz.
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3,4-Dihydro-2//-l,4-thiazine-3,5-dicarboxamide (193), the 
diamide derivative of (42), was prepared in 30% yield by stirring the 
diester (42) in methanolic ammonia solution (Scheme 71). The 
diamide (193) precipitated out of solution as an orange solid.
Diethyl 2//-l,4-thiazine-3,5-carboxylate (194) was prepared 
by treating a solution of the diester (42) in dichloromethane with the 
hydride abstractor, 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) 
(Scheme 71). DDQ, is a reactive quinone which is reduced to the 
corresponding h y d r o q u in o n e .l37 The 1,4-thiazine (194) was isolated 
as a yellow oil in 65% yield. The methylene protons of C-2 gave a
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doublet at 8 h 3.32 (7 1.2 Hz) in the lH NMR spectrum. The proton of C- 
6  gave a triplet at 5r 7.60 (J  1.2 Hz).
Et02C N
H
(42)
C02Et
DDa
CH2C12
MeOH, NH: 
r.t., 2  d H2NO(T ^ c o n h 7
H
(193) 30%
y  POCl3,
^  110°C
Et0 2C ^ N  c ° 2Et 
(194) 65%
NC N
H
(195)
rCN
Scheme 71
Nitriles can be prepared by the dehydration of amides. 
Dehydrating reagents commonly used include phosphorus pentoxide, 
phosphorus pentachloride and phosphorus oxychloride. The general 
reaction mechanism for the dehydration of amides by inorganic acid 
halides is shown in Scheme 72. Initial complexation of the acid 
halide with the amide results in polarisation of the C-0 bond. 
Nucleophilic attack by a chloride anion results in elimination of XO ( 
X= PCI3 , or POC1) to form the imidoyl chloride (196). Loss of hydrogen 
chloride gives the nitrile.
119
R0
> -N H ;
R—C = N
+ HC1
XCh
K
r *
, x - c i
o ' 
+ c - n h 2
c r
r - c = nh 
ci
(196)
+ X = o
Scheme 72
Attempts to synthesise the dinitrile (195) by treating the 
diam ide (193) with phosphorus oxychloride in 1,1,2,2- 
tetrachloroethane were unsuccessful (Scheme 71). The diamide
(193) decomposed under the harsh reaction conditions.
S-Benzyl-L-cysteinol (197) is commercially available. It was 
expected that treatment of (197) with an equimolar amount of ethyl 
bromopyruvate would give the half ethyl ester/a lcohol (198) 
(Scheme 73). However, nucleophilic attack by nitrogen upon benzyl 
bromide formed in situ resulted in formation of the N-benzyl 
derivative (199) as an orange oil in 73% yield. Analysis by TLC 
showed only one spot and the mass spectrum recorded the parent ion 
at m / z  293. In the lH NMR spectrum the methine proton of C- 6  gave 
a singlet at 5h 6 . 8 8  and the aromatic protons gave a multiplet at 5h 
7.38.
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Test Results.
In this work, diethyl (i?)-3,4-dihydro-2i7-l,4-thiazine-3,5- 
dicarboxylate (42) showed 15% inhibition at 0.1 mM with DHDP 
synthase and further kinetic studies (Lineweaver Burk plots) showed 
it to be a competitive inhibitor against dl-ASA (102), with Ki= 0.06 
mM, and a noncompetitive inhibitor against pyruvate (24), with K[=
0.05 mM.
The high insolubility of the diamide derivative (193) in both 
organic and aqueous solvent systems prevented us from obtaining 
accurate test results of (193) with DHDP synthase. Solubility' problems 
were also encountered with the testing of compounds (199) and
(194).
121
5.2 Synthesis and Test Results of 1.3-Thiazoles.
Diethyl l,3-thiazole-2,4-dicarboxylate (43) was prepared by 
treating ethyl thioxamate with ethyl bromopyruvate in ethanol 
(Scheme 74). Purification on a neutral alumina column eluting with 
20% ethyl acetate in hexane gave a cream solid in 48% yield. The !H 
NMR spectrum showed a singlet at 5h 8.45 for the proton at C-5 and 
the 13C NMR spectrum showed a signal at 5c 132.3 for C-5. The 
mechanism of formation of (43) is similar to that of 2,4-diphenyl-1,3- 
thiazole (189) (Scheme 69).
Br EtOH
E tO ^C ^ O + H2N ^ C 0 2Et A
N C '  ''jvj "CN 
(201) 44%
POC1
C2 H2C14) A H->NOC
Et02C ^  N C02Et 
(43) 48%
MeOH,
NH3
N‘ CONH
(200) 85%
Scheme 74
1.3-Thiazole-2,4-dicarboxamide (200) was prepared in 85% 
yield by treating diethyl 1,3-thiazole-2,4-dicarboxylate (43) with a 
solution of methanolic ammonia at room temperature (Scheme 74). 
The 13C NMR spectrum showed two signals at 5c 161.8 and 163.0 for 
the two amide carbonyls.
1.3-Thiazole-2,4-dinitrile (201) was prepared  from the 
diamide (2 0 0 ) by treatment with phosphorus oxychloride in 1 ,1 ,2 ,2 -
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tetrachloroethane (Scheme 74).138 Recrystallisation from ethanol 
gave (201) as white needles in 44% yield. The !H NMR spectrum 
showed only one signal at 5h 8.35 for the 5-H. The 13C NMR spectrum 
had signals at 6c 111.0 and 112.0 for the two nitrile carbons.
Test Results.
Diethyl l,3-thiazole-2,4-dicarboxylate (43) showed 15% 
inhibition at 0.1 mM with DHDP synthase and further kinetic studies 
(Lineweaver Burk plots) showed it to be a competitive inhibitor 
against dl-ASA (102), with Ki= 0.16 mM, and a noncompetitive 
inhibitor against pyruvate (24), with Ki= 0.06 mM.
The diamide derivative (200) was highly insoluble under the 
assay conditions, thus no accurate test results were obtained for this 
compound. However, the dinitrile derivative (201) was a good 
inhibitor of DHDP synthase, showing 18% inhibition at 0.1 mM.
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Chapter 6 - Synthesis of cis-2,6- and cis-2,4,6-Substituted
Piperidines.
Introduction.
Alkaloids containing a cis-2,6-disubstituted piperidine ring 
(Fig. 8) occur frequently in nature and have been shown to exhibit 
significant biological activity . 1 3 9  Several cis-2,6-dialkylpiperidines 
found in venomous myrmicine ants have fungicidal, insecticidal and 
repellant properties . 1 4 0
cis-2,6-Piperidinedicarboxylic acid (37) has some structural 
similarity to the intermediates of the first two enzymic steps of the 
d iam inopim elate  pathway to L-lysine (1), nam ely l- 2 , 3-  
dihydrodipicolinic acid (25) and L-2,3,4,5-tetrahydrodipicolinic acid
4
H
Fig. 8
(26).
4
H2
(37)
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Preparation of cis-2,6-piperidinedicarboxylic acid (37) can be 
readily carried out by a number of methods. 1 4 1 ,1 4 2  Th|s Chapter 
describes the synthesis and testing of derivatives of cis-2 ,6 - and cis-
2,4,6 -piperidines as potential inhibitors of DHDP synthase.
6.1 Synthesis and Testing of Substituted Piperidine Derivatives.
Chelidamic acid (40) is commercially available. The structure 
of chelidamic acid may be drawn as an equilibrium mixture of the y- 
pyridone (40) and the hydroxypyridine (202) (Scheme 75).
0 OH
h o2c N co2- h o 2c co2-h 2 H2
(40) (202)
Scheme 75
We subjected chelidamic acid (40) to catalytic hydrogenation 
with 5% rhodium-alumina catalyst in water under 10 Bar hydrogen 
for 8  hours at 80 °C. 1 4 3  The resultant light brown solid was found to 
be a mixture of 4-hydroxy-piperidine-cis-2,6-dicarboxylic acid (203) 
and piperidine-cis-2,6-dicarboxylic acid (204) (Schem e 76). 
Subsequent esterification with methanol gave an approximately 1:1 
mixture of the dimethyl esters, (205) and (206), which were readily 
separated by column chromatography.
125
0 R
H2, h 2o , A
5% Rh-alumina,
H0 2C h 7 c ° 2 10 Bar, 8  h, 80 °C H° 2C
(40)
+  ^ 
N
h 2
R = OH (203) 
[R = H (204)
rCO
100%
OH
A
l. MeOH, c. H2S04
2 . Chromatography
+
(205) 25%
MeO?C 2 N 6 C02Me MeCbC 2 N 6 C02Me 
2 H H
(206) 24%
Scheme 76
Compound (205) was isolated as a white solid, mp 134-136 
°C. The XH NMR spectrum of (205) showed a singlet at 5h  3.76 for the 
six hydrogens of the two methyl esters and a multiplet at 5h  3.74 for 
the hydrogen at C-4. The 13C NMR spectrum had a signal at 5c 68.0 for 
C-4. Compound (206) was also a white solid, mp 92-94 °C. Both the 
NMR and 13C NMR spectra of (206) differed from that of compound
(205). The i-H NMR spectrum of (206) lacked a signal around 5h 3.74 
for the methine hydrogen at C-4 and the 13C NMR spectrum had a 
signal at 5c 24.1 for C-4. The 13C NMR spectra of compounds (205) and
(206) are shown in Fig. 9.
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Attempts were made to oxidise the 4-hydroxy group of (205) 
to the corresponding ketone, (207) (Scheme 77).
O
oxidation  ►
MeO?C< ^  N ^ C 0 2Me 
z H
(207)
Scheme 77
The various oxidation methods tried for the conversion of 
(205) into (207) are listed in Table 7. Attempted oxidation of (205) 
with dimethylsulfoxide and N,N-diisopropylcarbodiimide1 4 3  failed to 
afford the ketone (207). The use of chromate-based oxidative 
reagents allows for relatively mild and selective reaction 
conditions . 1 4 4  Chromic acid on a polymer support is commercially 
available. A solution of (205) in dichloromethane was stirred with 
polymer-supported chromic acid under an atmosphere of nitrogen for 
several hours. Analysis by TLC indicated that no reaction had 
occurred and only starting material was recovered.
Pyridinium chlorochromate (PCC) adsorbed onto alumina was 
prepared by adding alumina to a solution of PCC and evaporating to 
d ryn ess . 1 4 5  A solution of (205) in dichloromethane was stirred 
vigorously with PCC on alumina. Analysis of the reaction mixture by 
TLC indicated that no starting material remained. However, 
subsequent workup failed to afford a product.
The use of pyridinium dichromate (PDC) with freshly 
activated molecular sieve powder and a small amount of anhydrous 
acetic acid has been reported to effect the oxidation of alcohols . 1 4 6  A
OH
MeO?C 2 N 6 C02Me 
1 H
(205)
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solution of (205) in dichloromethane was treated with the above 
reagents at room temperature. Purification of the reaction mixture by 
column chromatography yielded a pale coloured solid. This solid 
showed only one spot on TLC but analysis by GCMS showed it to be a 
1:1 mixture of the ketone (207) (M H+, 216) and the over-oxidised 
enone (208) (MH+, 214). The !H NMR spectrum showed three singlets 
at 8h 3.80, 3.82 and 3.91 corresponding to the three different methyl 
esters present. There was a singlet at Sh 5.78 for the methine proton 
at C-3 of (208).
Reagents Result
DMSO, N.N-diisopropylcarbo- 
diimide, TFA, pyridine, toluene
No product
Chromic acid-polymer, CH2 CI2 Starting material
PCC-alumina, CfbCb No product
PDC, activated 3A sieves, glac. 
AcOH, CH2Cb
1:1 Mixture of (207) and (208)
Table 7
O
MeCbC 2 N "6*C 02Me 
H
(208)
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The ring n itro g en  can firs t be p ro tec te d  as the 
benzyloxycarbonyl (Cbz) derivative before derivatisation of the 4- 
hydroxy group is attem pted. Benzyl chloroform ate was added 
dropwise at 0 °C to a solution of a mixture of compounds (203) and 
(204) in 2M aqueous sodium hydroxide solution (Scheme 78). This 
produced a mixture of the N-protected compounds (209) and (210). 
Subsequent esterification of the mixture of (209) and (210) with 
methanol in the presence of acid gave a clear oil which showed two 
distinct spots by TLC. Separation was achieved on a silica gel column 
eluting w ith ethyl acetate  to give d im ethy l 4-hydroxy-N- 
benzyloxycarbonyl-piperidine-cis-2,6-dicarboxylate (211) as a clear 
oil in 49% yield and dimethyl N-benzyloxycarbonyl-piperidine-cis-
2,6-dicarboxylate (212) in 39% yield.
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Scheme 78
The IR spectrum of compound (211) had a signal at around 
3470 cm-1 for the free hydroxyl group. The NMR spectrum of 
(211) showed a broad doublet at 5h 3.59 {J 3.6 Hz) which was absent 
after a D2 O exchange experiment. This signal was due to the free 
hydroxyl group. The 13C NMR spectrum of compound (212) had a 
signal at oc 16.5 for C-4.
Oxidation of compound (211) to the ketone was best achieved 
using N-iodosuccinimide and tetra-N-butylammonium iodide in 
dichloromethane at room temperature (Scheme 79).1 4 7  Purification 
of the reaction mixture was achieved on a silica gel column eluting 
with 50% ethyl acetate in hexane to give (213) as a pale solid, mp 74-
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76 °C. The 13C NMR spectrum had a signal at 5c 202.7 for the 
quaternary carbon at C-4.
OH
A.
o
N-iodosuccinimide,
(Bu)4N+T, CH2C12
MeO?C N C02Me 
Cbz 
( 2 1 1 )
MeO?C N CO?Me
Cbz 
(213) 32%
Scheme 79
The Cbz-protecting group could possibly be removed via 
treatment with trimethylsilvl iodide. This reagent has been reported 
to convert benzyl carbamates into the free amines in the presence of 
methyl e s te r s ."  The deprotection was attem pted in this work, 
however time limits did not allow for the satisfactory completion of 
this synthesis.
Test Results.
Dimethyl 4-hydroxy-piperidine-cis-2,6-dicarboxylate (205) and 
dimethyl piperidine-cis-2,6-dicarboxylate (206) were both poor 
inhibitors of DHDP synthase, showing only 29% and 6% inhibition 
respectively at 5mM. The mixture of dimethyl 4-piperidone-cis-2,6- 
dicarboxylate (207) and the enone (208) showed 22% inhibition at 2.5 
mM. Neither of the Cbz-derivatives, compounds (211) and (212), 
showed any inhibition at 5 mM. Compound (213) was also a poor 
inhibitor, giving only 12% inhibition at 5 mM.
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6.2 Diammonium Piperidin-4-one-2.6-dicarboxvlate.
l,4-Pentadien-3-one-l,5-dicarboxylic acid (215) was prepared 
by stirring a suspension of 2-furanacrylic acid (214) in hydrogen 
peroxide and conc. hydrochloric acid (Scheme 80).148 The product 
precipitated out of solution as an orange solid. The IR spectrum of 
(215) had peaks at 1700 and 1665 cm-1 for the acid and the ap- 
unsaturated ketone respectively. The mass spectrum showed a parent 
ion at m /z  170. Further signals due to the loss of the carboxylic acid 
groups were observed.
As (215) was insoluble in all deuteriated solvents available for 
NMR spectroscopy, thus making characterisation difficult, the 
dimethyl ester (216) was prepared by heating (215) with methanol 
and acid (Scheme 80). Recrystallisation from ethyl acetate yielded 
an orange solid, mp 169-171 °C. The l U NMR spectrum of (216) had a 
singlet at 5h 3.84 for the two methyl esters and an AB system at 5h 
6.82 and 7.34 (J15.9 Hz) due to the olefinic protons (Fig. 10).
O
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The ap-unsaturated carbonyl system of l,4-pentadien-3-one-
1,5-dicarboxylic acid (215) can undergo Michael additions with 
nucleophiles such as ammonia. We carried out this reaction according 
to the procedure of Hermann and Dreiding143 by heating at reflux a 
mixture of (215) and conc. ammonia solution (Schem e 81). A 
mixture of diammonium cis- (218) and trans-piperidin-4-one-2,6- 
dicarboxvlate (217) was obtained as a brown solid.
co2h
+
NH4' 0 2C"" N c o 2‘ n h 4 ^ h 4-o 2c ^ n ^ c o 2- n h 4 
(217) (218)
Scheme 81
The l H NMR spectrum showed a broad multiplet at 5h 2.28-2.33 
for the methylene protons of C-3 and 5 of both the cis- (218) and 
trans-isomers (217). The multiplet at 5h 4.05 was assigned to the C-2 
and 6 protons of the major isomer. This could be the cis-isomer (218) 
as both carboxyls are likely to be equatorial, thus keeping 
destabilising 1,3-diaxial interactions to a minimum. The multiplet at 
5r 4.20 was assigned to the C-2 and 6 protons of the minor isomer, 
possibly the trans-isomer (217). Purification and separation of the 
mixture of (217) and (218) proved impossible as no suitable TLC 
solvent system was found and attempted recrystallisation from water 
or methanol failed to yield any solid material.
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Test Results.
The mixture of the diammonium salts of cis- (218) and trans- 
piperidin-4-one-2,6-dicarboxylate (217) showed good inhibition of 
DHDP synthase, giving around 30% inhibition at 0.1 mM.
6.3 2,2,6,6-Tetramethylpiperidine Derivatives.
2 ,2 ,6 ,6 -T e tram ethy l-4 -p iperid ino l (219) and  2,2,6,6- 
tetramethyl-4-piperidinone (220) are both commercially available. As 
they have some structural similarity to the first two intermediates of 
the DAP biosynthetic pathway, L-2,3-DHDPA (25) and l-2,3,4,5- 
THDPA (26), we decided to test them for inhibitory effects on DHDP 
synthase.
(219) (220)
The oxime (221) and methyloxime (222) derivatives of 2,2,6,6- 
tetramethyl-4-piperidinone (220) were prepared by stirring (220) in 
a two-phase system of dichloromethane and water with the 
appropriate amine at room temperature (Scheme 82). The products 
were isolated as the hydrochloride salts after trituration with 
ether/HCl.
h 2 C1-
R = OH (221) 67%
R = OMe (222) 11%
Scheme 82
The l U NMR spectrum of the oxime (221) had a singlet at Sh 
1.28 for the twelve hydrogens of the four methyl groups. There were 
a further two singlets at 5h  2.30 and 2.58 for the methine hydrogens 
at C-3 and C-5. The IR spectrum of (221) had a strong peak at 3280 
cm-1 for the hydroxyl group of the oxime.
The 1H NMR spectrum of the methyloxime (222) had an 
additional singlet at 8h 3.87 for the methyl hydrogens of the methoxy 
group.
Test Results.
2 ,2 ,6 ,6 -T e tram ethy l-4 -p iperid ino l (219) and  2,2,6,6- 
tetramethyl-4-piperidinone (220) were reasonable inhibitors of DHDP 
synthase at 0.5 mM, showing 46% and 22% inhibition respectively. 
Derivatisation of the carbonyl functionality of (220) had no significant 
effect upon inhibitory activity, the oxime (221) and methyloxime 
(222) derivatives showing 8% and 23% inhibition at 0.5 mM.
H
( 220 )
Chapter 7 - Experimental
7.1 General Notes.
All melting points were measured with a Gallenkamp Melting 
Point A pparatus and are uncorrected. Infra-red spectra were 
obtained on a Philips analytical PU9800 FTIR spectrometer. Nuclear 
magnetic resonance spectra were recorded with a Perkin Elmer R32 
spectrometer operating at 90 MHz (§h) or with a Bruker WP-200 SY 
spectrom eter operating at 200 MHz (5h ) or 50 MHz (5c). Low 
resolution mass spectra were determined with a VG updated A.E.I. MS 
spectrometer and high resolution mass spectra were determined with 
a VG updated MS 902 spectrometer.
Analytical TLC was carried out on Kieselgel 60 F254  plastic 
sheets of 0.25 mm thickness. Spots were viewed under a UV lamp and 
were developed by iodine vapour. Column chrom atography was 
carried out using 70-230 mesh silica gel.
All solvents and reagents were of analytical grade unless 
otherwise stated. Aqueous solutions were freeze-dried on a Christ 
Alpha 1-4 freeze drier. Organic solvents were dried with magnesium 
sulfate and evaporated on a Buchi rotary evaporator under water- 
pump vacuum with slight heating. Dichloromethane was distilled from 
calcium hydride; ethanol was distilled from magnesium turnings and 
iodine; triethylam ine was distilled from potassium  hydroxide; 
tetrahydrofuran was distilled from sodium pieces and benzophenone; 
dimethylformamide was distilled from silica gel; and acetonitrile was 
dried with calcium hydride.
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7.2 Experimental to Chapter 3.
General Procedure Til - Ozonolvsis of Protected Allvlglvcine.
A solution of d ipro tected  allylglycine (1.0 mmol) in 
dichloromethane (15 ml) was flushed with ozone at -78 °C until a pale 
blue colour persisted for 10 min. Excess ozone was removed by 
flushing the reaction  flask with n itrogen. The ozonide was 
decomposed with triethylamine (2.0 mmol) at -78 °C with stirring and 
allowed to warm to room tem perature overnight. Dichloromethane 
was rem oved in vacuo  and  e ther was added to precip itate 
triethylam ine N-oxide. The mixture was filtered and ether was 
removed in vacuo to give a gluey oil. Purification was achieved on a 
silica gel column eluting with ether to give the aldehyde.
General Procedure \2  ^ - Deprotection of Aspartic Acid gSemialdehvde 
Analogues using Trifluoroacetic Acid.
Trifluoroacetic acid (2 ml) was added to a solution of the 
aspartic acid (3-semialdehyde analogue (1.0 mmol) in dichloromethane 
(2 ml) under nitrogen atmosphere. The mixture was stirred for 1 h 
and rem oval of the solvents in vacuo  gave a yellow residue. 
Trituration with ether precipitated a light yellow solid. The solid was 
filtered and dried under vacuum to give the desired product.
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General Procedure R1 - Imine Derivatisation of Protected
Aspartic Acid fl-Semialdehvde.
To a solution of the hydrochloride salt of the amine (1 equiv.) 
and triethylam ine (1 equiv.) in dichlorom ethane (8 ml) under a 
nitrogen atmosphere was added dropwise a solution of (101) (1.0 
mmol). The mixture was stirred a t room tem perature for 12 h. 
Removal of the solvent in vacuo left an oily residue. Ether (10 ml) was 
added with stirring to precipitate triethylamine hydrochloride. The 
m ixture was filtered and the solvent was rem oved in vacuo. 
Purification was achieved where necessary on a neutral alumina 
column eluting with the appropriate solvent system.
2-Methylpropene (100 ml) was added to a stirred suspension 
of DL-allylglycine (4.77 g, 41.5 mmol) in dichloromethane (100 ml) at 
-78 °C. Cone, sulfuric acid (5 ml) was added dropwise over 10 min. 
The mixture was stirred at -78 °C for 15 min then allowed to warm to 
room tem perature and stirred for 18 h with a dry ice condenser 
fitted. The resulting clear solution was carefully basified to pH 8 with 
sodium bicarbonate solution. The organic layer was separated, washed 
with brine solution (2 x 50 ml), d ried  (Na2S0 4 ), filtered and 
concentrated in vacuo to give a yellow oil. A white precipitate
DL-Allylglvcine t-Butvl Ester Hydrochloride (OOIAQ2
+
NH3 Cl
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resulted on addition of a solution of dry HC1 gas in ether (20 ml). The 
white solid was filtered and dried under vacuum, 2.72 g (32% yield), 
mp 115-118 °C; vmax (KBr disc) 2980, 2880, 1735, 1570 and 1500 
cm*1; 8H (200 MHz) (D20) 1.32 (9H, s, 7-, 8 - and 9-H3), 2.54 (2H, dd, 3- 
H2), 3.94 (1H, dd, 2-H), 5.15 (2H, m, 5-H2) and 5.60 (1H, m, 4-H); 8c 
(50 MHz) 28.3 (C-7, 8 and 9), 35.4 (C-3), 53.8 (C-2), 86.9 (C-6 ), 122.7 
(C-5), 131.2 (C-4) and 169.6 (C-l); m /z  130, 70 (100%), 57, 43 and 41 
(Found: M+, 172.1332; C, 52.08; H, 8.78; N, 6.73. C9Hi8N02 requires M, 
172.1338; C, 52.05; H, 8.67; N, 6.75%).
DL-lV-t-Butoxvcarhonvlallvlglvcine f-Butvl Fster (1001.106
14
NH-CO
To a stirred  suspension of (99) (3.00 g, 14.4 mmol) in 
dichlorom ethane (40 ml) was added sodium bicarbonate (1.21 g, 1 
equiv.) in w ater (15 ml), sodium chloride (2.5 g) and di-t- 
butyldicarbonate (3.32 ml, 1 equiv.). The mixture was heated at 
reflux for 1.5 h then cooled to room tem perature and the organic 
layer was separated . The aqueous layer was ex tracted  with 
dichloromethane (2 x 60 ml) and the combined organic extracts were 
dried (MgS0 4 ), filtered and concentrated in vacuo to give a yellow oil, 
3.84 g (98% yield), RF 0.53 (25% EtOAc/hexane); vmax (CHCI3 ) 3425, 
2980, 1710 and 1495 c n r l; 5H (200 MHz) (CDCI3 ) 1.41 (18H, br s, 7-, 
8 -, 9-, 12-, 13- and 14-H3), 2.45 (2H, m, 3-H2), 4.20 (1H, m, 2-H), 5.06 
(3H, m, 5-H2 and NH) and 5.67 (1H, m, 4-H); 5C (50 MHz) 27.9 (C-7, 8
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and 9), 28.3 (C-1 2 , 13 and 14), 36.8 (C-3), 5 3 .2  (C-2), 79.5 and 81.7 
(C-6 and 1 1 ), 118.7 (C-5), 132.5 (C-4), 155.1 (C-10) and 171.1 (C-l); 
m /z  230, 170, 130, 114, 70, 57 (100%) and 41 (Found: C, 61.95; H, 
9.01; N, 5.25. C14H25NO4 requires C, 61.91; H, 9.21; N, 5.16%).
DL-N-t-Butoxvcarbonvlasnartic Acid B-Semialdehvde f-Rutvl Ester
( 101).
|13
NH-CO2 1  129 ^ |
OHC. - 11
4 Y 'c o rs f - 7
A solution of (100) (2.30g, 8.48 mmol) in dichloromethane 
(80 ml) was saturated with ozone according to general procedure [1]. 
Purification was achieved on a silica gel column eluting with ether to 
give a light yellow oil, 1.65 g (71% yield), Rp 0.63 (ether); Vmax (CHCI3) 
3425, 2980, 1710 and 1495 cu rl; 5h ( 2 0 0  MHz) (CDCI3) 1.44 (18H, br 
s, 6 -, 7-, 8 -, 11-, 12- and 13-H3), 2.98 (2H, m, 3-H2), 4.48 (1H, m, 2-H), 
5.40 (1H, br d, NH) and 9.74 (1H, s, 4-H); 5c (50 MHz) 27.9 (C-6 , 7 and 
8 ), 28.3 (C -ll, 12 and 13), 36.8 (C-3), 46.3 (C-2), 80.0 and 82.6 (C-5 
and 10), 155.3 (C-9), 169.9 (C-l) and 199.4 (C-4); m /z  172, 118, 72, 
57 ( 1 0 0 %) and 41 (Found: C, 56.95; H, 8.32; N, 5.20. C13H23NO5 
requires C, 57.07; H, 8.41; N, 5.12%).
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Potassium Salt of DL-A/'-t-Butoxvcarbonvlallvlglvcine (1041.107
To a solution of DL-allylglycine (5.00 g, 43.4 mmol) in water 
(10 ml) was added dioxan (10 ml), potassium bicarbonate (4.78 g, 1.1 
equiv.) and di-t-butyl dicarbonate (9.98 ml, 1.0 equiv.) with 
continuous stirring at room temperature for 18 h. The solvents were 
removed in vacuo to give a white solid, 9.11 g (83% yield); vmax (KBr 
disc) 3360, 2985, 1675, 1590 and 1530 c n r l;  5H (200 MHz) (D2 O)
1.27 (9H, s, 8 -, 9- and IO-H3), 2.25 (2H, m, 3-H2), 2.77 (1H, m, 2-H), 
4.98 (2H, m, 5-H2) and 5.61 (1H, m, 4-H); 8C (50 MHz) 28.6 (C-8 , 9- 
and 10), 37.3 (C-3), 56.6 (C-2), 81.9 (C-7), 118.9 (C-5), 134.8 (C-4),
166.5 (C-6 ) and 180.2 (C-l); m /z  214 (M+, 0.3%), 112, 59 (100%) and  
41.
DL-JV-t-Butoxvcarbonvlallvlglvcine p-Methoxvbenzvl Ester (105).107
8 9
To a solution of (104) (8.10 g, 31.9 mmol) in DMF (20 ml) 
was added 4-methoxybenzyl chloride (4.64 ml, 1.0 equiv.) with 
continuous stirring for 48 h. DMF was removed with xylene in vacuo
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and the resultant residue was partitioned between dichloromethane 
(50 ml) and aqueous sodium bicarbonate solution (60 ml). The organic 
portion was washed with water (4 x 80 ml), dried (MgS0 4 ) and the 
solvent was removed in vacuo to give a yellow oil. Purification was 
achieved on a silica gel column eluting with 60% ether in hexane to 
give a clear oil, 10.2 g (95% yield), Rf 0.57 (50% Et2 0 /hexane); vmax 
(CHC13) 3440, 3020, 2985, 1720, 1710, 1620, 1515 and 1500 cm“l; 8H 
(200 MHz) (CDCI3) 1.43 (9H, s, 16-, 17- and I 8 -H3), 2.50 (2H, dd, 3- 
H2), 3.79 (3H, s, I 3 -H3), 4.39 (1H, m, 2-H), 5.10 (5H, m, 5-H2, 6-H2 and 
NH), 5.67 (1H, m, 4-H), 6.89 (2H, d, J S  Hz, 9- and 11-H) and 7.30 (2H, 
d, J  8 Hz, 8 - and 12-H); SC (50 MHz) 28.3 (C-16, 17 and 18), 36.7 (C-3), 
53.0 (C-2), 55.2 (C-13), 66.9 (C-6 ), 79.7 (C-15), 113.7 (C-7), 113.9 (C-8 
and 12), 119.1 (C-5), 127.4 (C -ll), 130.2 (C-9 and 11), 132.2 (C-4),
159.9 (C-14) and 171.9 (C-l); m /z  335 (M+, 1.0%), 279, 170, 121 
(100%), 70 and 57 (Found: M +, 335.1720. Ci8H25N05 requires M, 
335.1730).
DL-N-t-Butoxvcarbonvlaspartic Acid p-Semialdehvde p- 
Methoxvbenzvl Ester (106).
A solution of (105) (9.98 g, 29.75 mmol) in dichloromethane 
(60 ml) was saturated with ozone according to general procedure [1]. 
Purification was achieved on a silica gel column eluting with ether to
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give a light orange oil, 9.24 g (92% yield), Rp 0.80 (Et2 0 ); vmax (CHCI3) 
3430, 3030, 2980, 1735, 1690, 1620 and 1500 cm 'l; 5H (200 MHz) 
(CDCI3 ) 1.42 (9H, s, 15-, 16- and 17-H3), 3.04 (2 H, t, 74 .8  Hz, 3-H2), 
3.81 (3H, s, I 2 -H3), 4.60 (1H, br m, 2-H), 5.11 (2H, s, 5-H2), 5.42 (1H, 
br d, NH), 6.89 (2H, d, J S  Hz, 8 - and 10-H), 7.27 (2H, d, J S  Hz, 7- and
11-H) and 9.70 (1H, s, 4-H); 8C (50 MHz) 28.2 (C-15, 16 and 17), 46.0 
(C-3), 48.8 (C-2), 55.2 (C-12), 67.4 (C-5), 80.2 (C-14), 113.9 (C-7 and 
11), 115.1 (C-6 ), 128.7 (C-9), 130.2 (C-8  and 10), 160.0 (C-13), 171.2 
(C-l) and 199.5 (C-4); m /z  337 (M* 0.5%), 281, 202, 137, 121 (100%), 
72 and 57.
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Trifluoroacetate Salt of DL-Aspartic Acid ft-Semialdehvde Hvdrate
(102) 93
Method 1
Compound (101) (400 mg, 1.83 mmol) was deprotected with 
trifluoroacetic acid (3 ml) according to general procedure [2] to give a 
pale yellow solid, 336 mg (79% yield), mp 63:65 °C (lit.93, 63-65 °C); 
vmax (KBr disc) 3420 (broad), 2925, 1675 and 1645 cm 'l; 8h (200 
MHz) (D20) 1.98 (2H, m, 3-H2), 3.82 (1H, dd, 2-H) and 5.10 (1H, t, 4- 
H); 5c (50 MHz) 37.8 (C-3), 51.9 (C-2), 89.2 (C-4) and 173.9 (C-l); m /z  
137 (MH+, 12.1%), 120, 92, 69, 44 (100%) and 43 (Found: M m, 
137.0445. C4H11NO4 requires M , 137.0450).
Method 2
acid (2 ml) and dichlorom ethane (2 ml) was stirred  at room 
tem perature under nitrogen atmosphere for 2 h. The solvent was 
removed in vacuo to give an oily residue. This was partitioned 
between water (5 ml) and ethyl acetate (5 ml). The aqueous layer was 
separated and washed with ethyl acetate ( 3 x 5  ml). Removal of the 
solvent in vacuo gave a yellow solid, 264 mg (48% yield) with 
identical spectral data to those obtained for compound (102) made 
by Method 1 above.
OH NH3 CF3CO2
+
A solution of (106) (750 mg, 2.22 mmol) in trifluoroacetic
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Z- (110a) and £-DL-iV-t-Butoxvcarbonvlaspartic Acid p -Semialdehvde
t-Butvl Ester Oxime (110b).
13
Ni
OH
(Z) (E)
A solution of (101) (660 mg, 1.96 mmol) in dichloromethane 
(5ml) was added to a solution of hydroxylamine hydrochloride (136 
mg, 1 equiv.) in dichlorom ethane (3 ml) according to general 
procedure [3] to give a clear oil. Purification was achieved on a silica 
gel column eluting with 60% ether in hexane to afford a clear oil, 389 
mg (59% yield) RF 0.65 (50% EtOAc/hexane); vmax (CHCI3) 3590, 3430, 
3020, 2980, 1720, 1690 and 1500 cm“l;  1H NMR and 13c NMR 
analysis showed that both the geometric isomers of the oxime were 
present in the ratio (Z) 2 : (E) 1; 8H (200 MHz) (CDCI3) 1.45, 1.46, 1.47 
and 1.52 (4 x s, 6 -, 6 '-, 7-, 7'-, 8 -, 8 '-, 11-, ll '-1 2 -, 121-, 13- and 13'- 
H3), 2.70 and 2.82 (2 x t, 3- and 3'-H2), 4.36- 4.46 (m, 2 - and 2 f-H), 
5.42 and 5.60 (2 x br d, 2 x NH), 6.81 and 7.40 (2 x t, 4- and 4'-H) and 
9.05 (br s, 2 x N-OH); 8c (50 MHz) 27.8, 28.2 and 28.5 (C-6 , 6 ', 7, 71, 8 , 
8 ', 11, 11', 12, 12', 13 and 13f), 33.0 (C-3 and 3'), 51.5 and 51.8 (C-2 
and 2f), 80.0 and 82.5 (C-5, 5', 10 and 10'), 147.2 (C-4 and 4'), 170.9 
and 171.2 (C-l, 1', 9 and 9’); m /z  230, 187, 172, 159, 131, 87 and 57 
( 100%).
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Z- (111a) and E-DL-iV-t-Butoxvcarbonvlaspartic Acid B-Semialdehvde
f-Butvl Ester Methyloxime (111b).
113 I13'10'I-—;—12'H NH -CO r-p2 H NH-COz
i l  81 n MeQ, I  X  * 8'l '
N - Y  COfs] 7 “■ N ^ Y C O
MeO 6 3 r I
(Z) (E)
A solution of (101) (300 mg, 1.10 mmol) in dichloromethane 
(2 ml) was added to a solution of methoxylamine hydrochloride (1 0 1  
mg, 1.1 equiv.) in water (2 ml). The two-phase system was stirred at 
room tem perature overnight. The reaction mixture was extracted with 
dichloromethane ( 3 x 5  ml) and the combined organic extracts were 
dried (MgSCU). Removal of the solvent in vacuo gave a yellow oil, 279 
mg (84% yield), RF 0.85 and 0.67 (10% EtOAc/Et20); *H NMR and 13C 
NMR analysis showed that both the geometric isomers of the 
methyloxime had been formed in a 1:1 ratio; 5h (200 MHz) (CDCI3 )
1.45 (s, 6 -, 6 ’-, 7-, 7'-, 8 -, 8 '-, 11-, 11'-, 12-, 12'-, 13- and 13'-H3), 
2.68 (2 x m, 3 and 3'-H2), 3.81 and 3.88 (2 x s, 14- and 14'-H3), 4.36 
(m, 2 and 2'-H), 5.43 (br, 2 x NHC02), 6.71 and 7.33 (2 x t, 4- and 4'- 
H); 8C (50 MHz) 27.9 and 28.3 (C-6 , 6 ', 7, 7', 8 , 8 ', 11, 11', 12, 12', 13 
and 13'), 33.0 (C-3 and 3'), 51.5 (C-2 and 2'), 61.5 and 61.7 (C-14 and 
14'), 77.2 and 82.4 (C-5, 5', 10 and 10'), 146.2 and 146.5 (C-4 and 4’),
155.2 (C-9 and 9’) and 171.1 (C-l and 1'); m /z  302 (M+, 0.2%), 201, 
100, 85 and 57 (100%).
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Z- (1123.) and E-DL-N-t-Butoxvcarbonvlaspartic Acid p-Semialdehvde
t-Butvl Ester Semicarbazone (112b).
I13IQ* .13'
H  NH-CO^T-"12 O xtu /-/-v 10 ‘I I > I.. ¥  H NH-COj- j I2'
rV S /zY n -5-^ —7 H2NCHN I  JL 18
1 3 C 0 2  I 14' ^ K r V N y V Y n ^ i — 7'9 ^  ’  \ u 2 |6 " i f  'jffN/z- 'coj
H2NCHN r
14 ( Z )  ( E )
A solution of (101) (350 mg, 1.28 mmol) in dichloromethane 
(5 ml) was added to a solution of semicarbazide hydrochloride (143 
mg, 1 equiv.) and trie thy lam ine (0.18 ml, 1 equiv.) in 
dichloromethane (2 ml) according to general procedure [3]. Removal 
of the solvent in vacuo gave a white solid, 379 mg (90% yield), mp 
57-60 oC, r f 0.57 (10% MeOH/Et20); vmax (CHCI3) 3520, 3400, 1725, 
1690 and 1150 cm"1; iH NMR and 13C NMR analysis showed that both 
the geometric isomers of the semicarbazone had been formed in a 1:2 
ratio; 5H (200 MHz) (CDCI3 ) 1.44 (s, 6 -, 6 '-, 7-, 7'-, 8 -, 8 '-, 11-, 11'-,
12-, 12'-, 13- and 13'-H3), 2.72 (m, 3- and 3'-H2), 4.47 (m, 2 - and 2’- 
H), 5.43 and 5.74 (2 x b r d, 2 xNH), 5.74 (br, -CONH2), 6.53 (t, J5 .6  Hz,
4-H), 7.11 (t, J3 .8  Hz, 4'-H), 9.42 and 10.00 (2 x b r  s, 2 x-CONHN); 8c 
(50 MHz) 27.9 and 28.3 (C-6 , 6 ', 7, 7 \  8 , 8 1, 11, 11', 12, 12', 13 and 
13’), 35.3 (C-3 and 3'), 51.0 (C-2 and 2'), 79.9 and 82 3 (C-5, 5', 10 and 
10'), 139.7 (C-4 and 4'), 155.3 (C-9 and 9*), 158.3 (C-14 and 14’) and
171.3 (C-l and I 1); m /z  330 (M+, 0.3%), 229, 218 (100%), 201, 159, 
112 and 57 (Found: M+, 330.1876. Ci4H26N40 5  requires M, 330.1903)
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DL-N-f-Butoxvcarbonvlaspartic Acid p -Semialdehvde
t-Butvl Ester Thiosemicarbazone (113).
S
NH-CO
9 11
12
II 8
h 2nchnn c o 2 7
14 6
To a solution of thiosemicarbazide (78 mg, 0.86 mmol) in 
water (3 ml) was added a solution of the diprotected aldehyde ( 1 0 1 ) 
(236 mg, 0.86 mmol) in dichlorom ethane (5 ml). The two-phase 
system was stirred rapidly at room tem perature for 48 h. The 
mixture was extracted with dichlorom ethane (2 x 8 ml) and the 
combined organic solvents were dried (MgS0 4 ). Removal of solvent in 
vacuo gave a white solid. Purification was achieved on a silica gel 
column eluting with diethyl ether to give a white solid, 256 mg (8 6 % 
yield), mp 65-68 °C, RF 0.55 (Et20); vmax (KBr disc) 3435, 3170, 2980, 
1710, 1520 and 1155 cm’l; 5H (200 MHz) (CDCI3) 1.44 (18H, s, 6 -, 7-,
(1H, br d, -NHCO2), 6.38 (br s, -CSNH2), 7.30 (1H, t, J3 .6  Hz, 4-H) and 
10.13 (br s, -CONHN); 5C (50 MHz) 28.0 and 28.3 (C-6 , 7, 8 , 11, 12 and 
13), 35.5 (C-3), 50.7 (C-2), 80.2 and 82.7 (C-5 and 10), 142.4 (C-4),
155.3 (C-9), 171.3 (C-l) and 178.5 (C-14); m /z  346 (M+, 10.6%), 290, 
216, 189, 144 and 57 (100%) (Found: M +, 346.1681; C, 48.39; H, 7.56; 
N, 16.17. C i 4H26N40 4S requires M, 346.175; C, 48.54; H, 7.56; N,
8 -, 11-, 12- and 13-H3), 2.78 (2H, m, 3-H2), 4.52 (1H, m, 2-H), 5.30
16.17%).
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DL-N-t-Butoxvcarbonvlaspartic Acid p-Semialdehvde
t-Butvl Ester Ethvl Hvdrazinoacetate (114).
NH-CO- 1 0 '
14
ch3ch2o 2c
17 16 15
H A•NN
113
11
•12
CO1 2 5
A solution of (101) (200 mg, 0.73 mmol) in dichloromethane 
(5 ml) was added to a solution of ethyl hyd razinoaceta te  
hydrochloride (113 mg, 1 equiv.) and triethylam ine (1 equiv.) in 
dichloromethane (2 ml) according to general procedure [3]. Removal 
of the solvent in vacuo gave a yellow oil. Purification was achieved on 
neutral alumina column eluting with 60% ethyl acetate in hexane to 
give a pale solid, 178 mg (65% yield), Rf 0.83 (60% EtOAc/hexane); 
Vmax (CHCI3) 3410, 1730, 1710 and 1150 cm’l; SH (200 MHz) (CDCI3) 
1.25 (3H, t, J  7.1 Hz I 7 -H3 ), 1.42 (18H, s, 6-, 7-, 8-, 11-, 12- and 13- 
H3), 2.63 (2H, m, 3-H2), 3.82 (2H, s, 14-H2), 4.19 (2H, q, J7.1  Hz, 16- 
H2), 4.40 (1H, m, 2-H), 5.25 (1H, br, -NHC02) and 6.97 (1H, t, 4-H); 8c 
(50 MHz) 14.2 (C-17), 27.9 and 28.3 (C-6, 7, 8, 11, 12 and 13), 35.1 (C- 
3), 50.8 (C-14), 52.0 (C-2), 61.0 (C-16), 79.6 and 81.9 (C-5 and 10),
138.6 (C-4), 155.7 (C-9), 170.7 and 171.3 (C-l and 15); m /z  373 (M+, 
2.7%), 316, 272, 200, 155 (100%) and 127 (Found: M +, 373.2195. 
C17H31N3O6 requires M, 373.2203).
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Trifluoroacetate Salt of Z- (115a) and T-DL-Aspartic Acid p- 
Semialdehvde Oxime (115b).
u NH3 CF3C02‘
+
H NH3 c f3c o 2-
Nl c o2h c o 2h 1'
OH (E)(Z)
A mixture of (110a) and (110b) (208 mg, 0.59 mmol) was 
deprotected with trifluoroacetic acid according to general procedure 
[2] to give a pale syrup, 128 mg (65% yield); vmax (thin film) 3350, 
2980, 2520, 1730, 1670 and 1430 cm*l; 5H (200 MHz) (D20) 2.75 (br 
m, 3- and 3'-H2), 4.05 (br m, 2- and 2'-H), 6.80 and 7.34 (2 x t, 4- and 
4'-H); 5c (50 MHz) 30.4 and 34.3 (C-3 and 3'), 51.3 (C-2 and 2'), 147.8 
and 148.0 (C-4 and 4'), 172.3 and 174.1 (C-l and l f); m /z  132 (M+, 
0.9%), 116, 98, 87, 69 and 57 (100%) (Found: M+, 132.0541. C4 H8 N2 0 3  
requires M, 132.0534).
Trifluoroacetate Salt of Z- (116a) and f-DL-Aspartic Acid p- 
Semialdehvde Methvloxime (116b).
A mixture of (116a) and (116b) (150 mg, 0.50 mmol) was 
deprotected with trifluoroacetic acid according to general procedure
MeO (Z) (E)
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[2] to give a yellow solid, 62 mg (48% yield); vmax (KBr disc) 2980, 
2530, 1730, and 1430 cm-l; gH (200 MHz) (D2O) 2.68 (br m, 3- and 3'- 
H2), 3.65 (br s, 7- and 7'-H3), 3.81 (br m, 2- and 2'-H), 6.76 and 7.34 
(2 x br m, 4- and 4'-H); 5c (50 MHz) 37.6 (C-3 and 3?), 51.8 and 52.2 
(C-2 and 2') and 62.2 (C-7 and T).
Trifluoroacetate Salt of Z- (117a) and £-dl-Aspartic Acid fl-
A mixture of (112a) and (112b) (159 mg, 0.48 mmol) was 
deprotected with trifluoroacetic acid according to general procedure 
[2] to give a pale green solid, 90 mg (65% yield), mp 57-59 °C; vmax 
(KBr disc) 3455, 3000-2500 (broad), 2985, 1730, 1670, 1590, 1530 
and 1205 cm-l; 5h (200 MHz) (CDCI3 ) 2.76 (2H, b r m, 3- and 3'-H2), 
4.14 (1H, br t, 2- and 2'-H) and 7.20 (br m, 4- and 4'-H); 5c (50 MHz)
32.7 (C-3 and 3’), 51.1 (C-2 and 2'), 142.0 (C-4 and 4') and 169.5 (C-l 
and 1'); m /z  128, 114, 111, 69, 57 and 44.
Semialdehvde Semicarbazone (117b).
^N ^niN  (2 )
H?NCHN,
(E)
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Trifluoroacetate Salt o f  dl-Aspartic Acid ft-Semialdehvde
Thiosemicarbazone (118).
+
n h 3 c f 3c o 2-
s
II
H^NCHNN 4 Y  C 0?H
7 3 1 ‘
C om pound (113) (129mg, 037 mmol) was depro tected  with 
trifluoroacetic acid according to general p rocedure  [2] to give a pale 
green  solid, 89 mg (79% yield), mp 65-70 °C; vmax (KBr disc) 3425, 
3175, 3000-2500 (broad), 1730, 1675, 1610, 1530 and  1200 cm-l; §H
173.2 (C-l); m /z  144, 129, 114 and 57.
D ifluorom ethvldiphenvlphosphine Oxide (119).115
To a solution of diphenylphosphine oxide (4.50 g, 22.3 mmol) 
in THF (100 ml) at -50 °C was added  n-buty l lith ium  (15.3 ml, 1.1 
equiv.). After 15 min, ch lorodifluorom ethane (approx. 100 ml) was 
added  and  the mixture was stirred at -50 °C for 2 h followed by 10 h 
at room tem pera tu re  with a dry ice condenser in place. The reaction
(200 MHz) (D20) 2.87 (2H, br m, 3-H2), 4.12 (1H, t, J 5 .3  Hz, 2-H) and
7.27 (1H, br t, 4-H); 5C (50 MHz) 32.8 (C-3), 51.0 (C-2), 145.3 (C-4) and
13. .14 O H
6
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mixture was concentrated in vacuo and the residue was taken up in 
dichloromethane (50 ml) and washed with water (2 x 50 ml). The 
organic portion was concentrated in vacuo to give a brown solid. 
Purification was achieved on a silica gel flash column eluting with 33% 
ethyl acetate in toluene to give white crystals, 2.70 g (48% yield), mp 
92-94 oC (lit.H5, 93-94 o q , Rf 0.52 (33% EtOAc/toluene); v max (KBr 
disc) 3030, 2960, 1590, 1440, 1210 and 1040 cm -l; 5r (200 MHz) 
(CDC13) 6.35 (1H, dt, 2 jhf 50.0 Hz and 2 /PH 22.4 Hz, 1-H), 7.60 (6 H, m,
5-, 6 -, 7-, 11-, 12- and 13-H) and 7.89 (4H, dd, 3 / HH 6 .6  Hz and 3j  
PCCH H .8 Hz, 4-, 8 -, 10- and 14-H); 5C (50 MHz) 116.0 (C-l), 127.0 (C- 
3 and 9), 129.8 (C-4,8 ,10 and 14), 132.8 (C-5, 7, 11 and 13) and 134.3 
(C-6  and 12); 5F (188 MHz) -132.6 (dd, 2 j hf 48.9 Hz and 2 j pf 69.8 
Hz); m /z  252 (M+, 0.6%), 201 (100%) and 77 (Found: M+, 252.0506;
C, 61.95; H, 4.38. C13H11F2OP requires M, 252.0516; C, 61.90; H, 4.36%)
7.3 Experimental to Chapter 4 .
General Procedure f 11 - Alkvlation of Malonate Derivatives.120
A solution of the brom oalkene (49.6 mmol) in distilled 
ethanol (10 ml) was added dropwise to a solution of sodium (50.0 
mmol) and the malonate derivative (44.6 mmol) heated to reflux in 
distilled ethanol (40 ml). The mixture was heated at reflux for 1 h, 
cooled to room tem perature and the brown supernatant layer was 
decanted from the small am ount of sedim ent. The solvent was 
removed in vacuo to give a brown residue. This was taken up in 
dichloromethane and washed with water and brine, dried (MgSCU)
155
and the solvent was removed in vacuo. Purification was achieved by
recrystallisation or column chromatography when necessary.
General Procedure T21 - Hvdrolvsis and Decarboxylation of Alkvlated
Malonate Derivatives.
A mixture of the alkylated malonate derivative (6.4 mmol) in 
ethanol (15 ml) and 10% aqueous sodium hydroxide (15 ml) was 
heated at reflux overnight. The reaction mixture was cooled to room 
tem perature and solvent was removed in vacuo. The residue was 
taken up in water (15 ml), acidified with conc. hydrochloric acid 
(Congo red) and the mixture was heated at reflux for 3 h. The reaction 
was cooled and carefully  neutra lised  with aqueous sodium  
bicarbonate solution (pH 7). The solvent was removed in vacuo, the 
residue was dissolved in 25% aqueous sodium hydroxide and the 
solution was heated a t reflux overnight. After cooling to room 
tem perature, the reaction mixture was diluted with water and 
acidified with conc. hydrochloric acid. Removal of the solvent in vacuo 
gave a brown solid. Purification was achieved by taking the brown 
solid up in hot ethanol and filtering through celite. Removal of the 
solvent in vacuo gave the hydrochloride salt of the amino acid.
General Procedure T31 - Alkvlation of N-
(Diphenvlmethvlene)aminoacetonitrile (1451.126
To a solution of N-(diphenylmethylene)aminoacetonitrile 
(145) (9.1 mmol) in toluene (8 ml) was added 50% aqueous sodium 
hydroxide solution (5 ml). The resulting two-phase system was 
stirred vigorously. Upon addition of benzyltriethylammonium chloride 
(0.8 mmol) the reaction became deep red in colour. The bromoalkene 
(10.9 mmol) was added dropwise over 1 h at 0 °C with stirring. The 
reaction mixture was stirred at 0 °C for an additional 1 h then heated 
gently at 40 °C overnight. The reaction mixture was poured into a 
separatory funnel containing dichloromethane (15 ml) and water (20 
ml). The aqueous portion was extracted with dichloromethane (3 x 1 5  
ml) and the combined organic portions were washed with water (3 x 
20 ml) and brine (1 x 20 ml), dried (MgS0 4 ), filtered and concentrated 
in vacuo to give a dark red oil.
General Procedure 141 - Removal of Dibenzvlidene Protecting Group.
To a solution of the protected amine (7 mmol) in diethyl 
ether (15 ml) was added 2M aqueous hydrochloric acid solution (15 
ml). The two-phase system was stirred  vigorously for 4 h. The 
aqueous layer was washed with diethyl ether (20 ml) and the organic 
fractions were discarded. The aqueous layer was carefully basified 
with saturated sodium bicarbonate solution and was extracted with 
ethyl acetate (3 x 25 ml). The combined organic fractions were 
washed with brine (1 x 25 ml), d ried  (MgSCU), filtered and 
concentrated in vacuo to yield an orange oil.
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General Procedure T51 - Alkvlation of Schollkoof-Hartwig Reagents.128
To a stirred solution of the Schollkopf-Hartwig reagent (1 
equiv.) in dry THF (20 ml) at -70 °C under an atmosphere of nitrogen 
was added n-butyllithium (1.1 equiv.). The mixture was stirred for 10 
min at this tem perature and then treated dropwise with a solution of 
the bromoalkene (1 equiv.) in THF (8 ml). After 4 h at -70 °C the 
mixture was allowed to warm to room tem perature and was left 
stirring overnight. The solvent was removed in vacuo and the residue 
was taken up in ether (20 ml) and extracted with water (3 x 20 ml). 
The ethereal portion was dried (MgSCU), filtered and the solvent was 
removed in vacuo to yield an orange oil. Purification was achieved 
where necessary on a silica gel column eluting with 25% diethyl ether 
in hexane.
General Procedure T61 - Acid Hvdrolvsis of Alkvlated Schollkopf-
Hartwig Reagents.128
A suspension of the alkylated Schollkopf-Hartwig reagent (10 
mmol) in 1.0 M HC1 (50 ml) was stirred for 16 h at room temperature. 
The mixture was extracted once with diethyl ether, which was 
rejected. The aqueous layer was concentrated in vacuo and the 
residue was dissolved in a small amount of water, covered with ether 
and vigorously shaken with conc. ammonia solution until pH 8-10. 
The aqueous portion was extracted with ether (2 x 20 ml) and the 
combined organic portions were dried (MgS0 4 ). Ths solvent was 
removed in vacuo to yield a pale oil.
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Diethvl 3-Butenvlacetamidomalonate (136).
5 3 NH-COCH3
C02CH2CH3
c o 2c h 2c h 31 10  ^11 °
A solution of 4-brom obut-l-ene (6.00 g, 44.44 mmol) in 
distilled ethanol (10  ml) was added dropwise to a solution of sodium 
(1.23 g, 1.2 equiv.) and diethyl acetamidomalonate (9.65 g, 1 equiv.) 
heated to reflux in ethanol (50 ml) according to general procedure [1] 
to give an orange oil. Purification was achieved on a silica gel column 
eluting with 40% ethyl acetate in hexane to give a pale solid, 4.46 g 
(37% yield), mp 47-48 °C, R f  0.30 (50% EtOAc/hexane); v m a x  (CHCI3) 
3410, 2980, 1735, 1675 and 1640 cm’1; SH (200 MHz) (CDCI3) 1.26 
(6 H, t, J7 .12 Hz, 9- and II-H 3), 1.92 (2H, m, 3-H2), 2.04 (3H, s, 13-H3),
2.45 (2H, m, 4-H2), 4.24 (4H, q, J 7.12 Hz, 8 - and 10-H2), 4.98 (2H, m,
6 -H2), 5.73 (1H, m, 5-H) and 6.78 (1H, br s, N-H); 6c (50 MHz) 13.9 (C- 
9 and 11), 23.1 (C-13), 27.9 and 31.2 (C-3 and 4), 62.5 (C-8 and 10),
66.2 (C-2), 115.4 (C-6 ), 136.9 (C-5), 167.0 (C-12) and 168.1 (C-l and 
7); m /z  271 (M+, 4.3%), 226, 198, 156 (100%) and 82 (Found: M+, 
271.1417; C, 57.51; H, 7.77; N, 5.11. Ci3H2 iN0 5 requires M , 271.1420; 
C, 57.55; H, 7.80; N, 5.16%).
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Diethvl 4-Pentenvlacetamidomalonate (137).
NH-COCH3
8 9 10 
^ - c o2ch2ch3
3 c o 2c h 2c h 3
A solution of 5-brom opent-l-ene (6.00 g, 40.26 mmol) in 
distilled ethanol (10  ml) was added dropwise to a solution of sodium 
(1.04 g, 1.1 equiv.) and diethyl acetamidomalonate (8.75 g, 1 equiv.) 
heated to reflux in ethanol (50 ml) according to general procedure [1] 
to give a yellow oil. Purification was achieved on a silica gel column 
eluting with 50% ethyl acetate in hexane to give a white solid, 5.07 g 
(44% yield), mp 42-45 °C, Rf 0.40 (50% EtOAc/hexane); vmax (CHCI3) 
3410, 2980, 1735, 1675 and 1640 c u r l;  §H (200 MHz) (CDCI3 ) 1.26 
(8 H, t and m, J  7.12 Hz, 10-, 1 2 -H2 and 4 -H2), 2.04 (5H, m and s, 3 -H2 
and I 4 -H3), 2.32 (2H, m, 5-H2), 4.24 (4H, q, J  7.12 Hz, 9- and 11-H2), 
4.97 (2H, m, 7-H2), 5.72 (1H, m, 6-H) and 6.83 (1H, br s, N-H); 5c (50 
MHz) 14.0 (C-10 and 12), 23.1 (C-4), 31.7 and 33.3 (C-3 and 5), 62.5 
(C-9 and 11), 66.5 (C-2), 115.0 (C-7), 137.9 (C-6), 168.2 and 169.0 (C- 
1, 8 and 13); m /z  285 (M+, 7.6%), 212 (100%), 170 and 96 (Found: M 
+ , 285.1575; C, 58.89; H, 7.98; N, 4.90. C14H23NO5 requires M, 
285.1577; C, 58.95; H, 8.07; N, 4.91%).
Ethvl 3-Butenvlacetamidocvanoacetate (139).
10 11 
3 NH-COCH:
'  ~ 21~ ^C 0 2CH2CH3
1 8 9CN
7
A solution of 4-brom obut-l-ene (5.00 g, 37.03 mmol) in 
distilled ethanol (1 0  ml) was added dropwise to a solution of sodium 
(0.85 g, 1.3 equiv.) and ethyl acetamidocyanoacetate (4.85 g, 1.0 
equiv.) heated to reflux in ethanol (50 ml) according to general 
procedure [1] to give a brown residue. Recrystallisation from 
ethanol/water gave white needles, 2.31 g (36% yield), mp 98-101 °C, 
Rf 0.54 (EtOAc); vmax (CDC13) 3440, 3400, 2980, 1750, 1690 and 1640 
cm-l; 5h (200 MHz) (CDCI3 ) 1.36 (3H, t, 7  7.12 Hz, 9-H3), 2.07 (3H, s,
II-H 3), 2.24 (4H, m, 3- and 4-H2), 4.32 (2H, q, J7 .12  Hz, 8 -H2), 5.11 
(2H, m, 6 -H2), 5.74 (1H, m, 5-H) and 6.96 (1H, br s, N-H); 8C (50 MHz)
13.9 (C-9), 22.3 (C -ll), 28.0 (C-3), 35.0 (C-4), 56.9 (C-2), 63.7 (C-8 ),
116.4 (C-7), 116.9 (C-6 ), 135.1 (C-5), 166.2 and 170.2 (C-l and 10); 
m /z  224 (M+, 0.2%), 179, 109 (100%) and 82 (Found: M+, 224.1164; 
C, 58.79; H, 7.23; N, 12.47. C nH i6N20 3  requires M, 224.1161; C, 58.91; 
H, 7.19; N, 12.49%).
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Ethvl 4-Pentenvlacetamidocvanoacetate (140).
NH-COCH3
9 10
2c h 2c h 3
A solution of 5-brom opent-l-ene (5.73 g, 38.46 mmol) in 
distilled ethanol ( 1 0  ml) was added dropwise to a solution of sodium 
(0.96 g, 1.1 equiv.) and ethyl acetamidocyanoacetate (5.95 g, 34.96 
mmol) heated to reflux in ethanol (50 ml) according to general 
p rocedure  [1] to give a brown oil. R ecrystallisation from 
ethanol/w ater gave white needles, 1.59 g (20% yield), mp 43-45 °C, 
Rf 0.22 (Et20); vmax (CHCI3) 3440, 3400, 1750, 1690, 1645 cm 'l; SH 
(200 MHz) (CDCI3) 1.39 (3H, t,J7 .12  Hz, 10-H2), 1.5-2.2 (6 H, m, 3-, 4- 
and 5 -H2 ), 2.07 (3H, s, 12-H3), 4.33 (2H, q, /7 .1 2  Hz, 9-H2), 5.06 (2H, 
m, 7-H2), 5.75 (1H, m, 6 -H) and 6.72 (1H, br s, N-H); 8c (50 MHz) 14.0 
(C-10), 22.4 (C-12), 23.0 (C-4), 32.7 and 35.5 (C-3 and 5), 57.1 (C-2),
63.7 (C-9), 116.1 (C-7), 116.5 (C-8 ), 136.8 (C-6 ), 166.4 and 170.1 (C-l 
and 11); m / z  238 (M+, 0.7%), 195,165 and 123 (100%) (Found: M+, 
238.1318; C, 60.63; H, 7.52; N, 11.68. C12H18N2O3 requires M, 
238.1317; C, 60.50; H, 7.56; N, 11.76%).
CO
CN
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Ethvl N-(Diphenvlmethvlene)-2-amino-5-pentenoate (141).
Ph
C02CH2CH3
i
n-Butyllithium (2.5 M solution in hexanes) (13.17 ml, 32.9 
mmol) was added dropwise to a solution of diisopropylamine (5.0 ml,
1.1 equiv.) in dry tetrahydrofuran (150 ml) at -20 °C under a 
nitrogen atmosphere. The pale orange solution was then stirred at 0 
°C for 20 min. After cooling to -70 °C, a so lu tion  of N- 
(diphenylmethylene)-glycine ethyl ester (8.0 g, 29.9 mmol) in 
tetrahydrofuran (20 ml) was added dropwise over 10 min. The 
reaction became deep red in colour and was stirred at -70 °C for a 
further 20 min. before dropwise addition of 4-brom obut-l-ene (3.65 
ml, 35.9 mmol). The reaction was allowed to warm to room 
tem perature and was then heated gently at 50 °C for 16 h. Upon 
cooling the reaction mixture was poured into water ( 1 0 0  ml) and 
extracted with ethyl acetate (3 x 100 ml). The combined organic 
fractions were washed with water (1 x 1 0 0  ml), saturated  brine 
solution (1 x 100 ml), dried (MgSC>4 ), filtered and the solvent was 
removed in vacuo to give a dark red oil, 7.82 g (81% yield), Rf 0.65 
(50% EtOAc/hexane); vmax (thin film) 3025, 2980, 1735, 1660, 1600, 
1580 and 1490 cm“l; 5H (200 MHz) (CDC13) 1.26 (3H, t, J  7.14 Hz, 8 - 
H3), 2.02 (4H, m, 3- and 4-H2), 4.06 (2H, t, 2-H), 4.16 (2H, q, J7.1S  Hz, 
7-H2), 4.94 (2H, m, 6 -H2), 5.74 (1H, m, 5-H) and 7.15-7.83 (aromatic 
protons); 5C (50 MHz) 14.2 (C-8 ), 30.2 and 33.0 (C-3 and 4), 60.9 (C-7),
64.9 (C-2), 115.0 (C-6 ), 128.1, 128.6, 130.2 and 136.4 (aromatic 
carbons), 137.8 (C-5), 170.6 (C-9) and 172.3 (C-l); m / z  320 (M+-H,
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99%), 292, 248 and 193 (Found: M+-H, 320.1638. C2 1 H2 3 NO2 requires 
M-H, 320.1651).
Ethyl N-(Diphenylmethylene)-2-amino-6-hexenoate (142).
Ph
C02CH7CH3
1 8 9
n-Butyllithium (2.5 M solution in hexanes) (13.17 ml, 32.9 
mmol) was added dropwise to a solution of diisopropylamine (5.0 ml,
1.1 equiv.) in dry tetrahydrofuran (150 ml) at -20 °C under nitrogen 
atmosphere. The pale orange solution was then stirred at 0 °C for 20 
min. After cooling to -70 °C, a solution of N'-(diphenylmethylene)- 
glycine ethyl ester (8.0 g, 29.9 mmol) in tetrahydrofuran (20 ml) was 
added dropwise over 10 min. The reaction became deep red in colour 
and was stirred at -70 °C for a further 20 min. before dropwise 
addition of 5-bromopent-l-ene (3.9 ml, 32.9 mmol). The reaction was 
allowed to warm to room temperature and was then heated gently at 
50 °C for 16 h. Upon cooling the reaction mixture was poured into 
water (100 ml) and extracted with ethyl acetate (3 x 100 ml). The 
combined organic fractions were washed with water (1 x 100 ml), 
saturated brine solution (1 x 100 ml), dried (MgSCU), filtered and the 
solvent was removed in vacuo to give a dark red oil, 8.91 g (72% 
yield), Rf 0.64 (50% EtOAc/hexane); vmax (thin film) 3025, 2980, 
1735, 1660, 1600, 1580 and 1490 cm"i; 5H (200 MHz) (CDCI3 ) 1.27 
(3H, t, J 7 . l l  Hz, 9 -H3 ), 1.38 (2H, m, 4-H2), 1.91 (4H, m, 3- and 5-H2),
4.01 (1H, t, 2-H), 4.12 (2H, q, J7.12 Hz, 8-H2), 4.90 (2H, m, 7-H2), 5.76
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(1H, m, 6 -H) and 7.15-7.83 (aromatic protons); 8c (50 MHz) 14.2 (C-9),
25.3 (C-4), 33.1 and 33.4 (C-3 and 5), 60.8 (C-8 ), 65.4 (C-2), 114.6 (C-
7), 128.0, 128.6, 130.1 and 136.5 (aromatic carbons), 138.5 (C-6 ),
170.3 (C-10) and 172.4 (C-l); m /z  334 (M+, 41%), 262 (100%), 193 
and 165 (Found: M+-H, 334.1804. C22H25NO2 requires M-H, 334.1807)
Ethvl 2-Amino-5-pentenoate (143).
NH2 
CO2CH2CH3
A solution of (141) (7.5 g, 22.0 mmol) in diethyl ether (70 
ml) was stirred vigorously with 2M HC1 (70 ml) according to general 
procedure [4] to give an orange oil, 2.3 g (67% yield); vmax (CHCI3) 
3390, 3335, 3080, 2980, 1730 and 1640 cm’i; 5H (200 MHz) (CDCI3)
1.29 (3H, t, J  7.11 Hz, 8 -H3), 1.76 (4H, br m, 3-H2 andNH2), 2.15 (2H, 
m, 4-H2), 3.44 (1H, m, 2-H), 4.14 (2H, q, J 7 . l l  Hz, 7-H2), 5.05 (2H, m, 
6 -H2) and 5.81 (1H, m, 5-H); 5C (50 MHz) 14.3 (C-8 ), 29.9 and 34.1 (C- 
3 and 4), 53.9 (C-2), 60.9 (C-7), 115.4 (C-6 ), 137.6 (C-5) and 176.1 (C-
1); m / z  157 (M+, 1.2%), 112, 84 (100%) and 67.
Ethvl 2-Amino-6-hexenoate (144).
C02CH2CH:
1 8 9 '
A solution of (142) (8.26 g, 24.62 mmol) in diethyl ether 
(100 ml) was stirred vigorously with 2M HC1 (100 ml) according to 
general procedure [4] to give a dark orange oil, 2.64 g (63% yield); 
Vmax (CHC13) 3400, 3330, 3080, 2980, 1740 and 1640 cm 'l; 5H (200 
MHz) (CDCI3) 1.28 (3H, t, J7.12 Hz, 9-H3), 1.41-1.79 (6 H, m, 3- and 4- 
H2 and NH2), 2.10 (2H, m, 5-H2), 3.43 (1H, br, 2-H), 4.17 (2H, q, J7.12 
Hz, 8 -H2), 4.97 (2H, m, 7-H2) and 5.78 (1H, m, 6 -H); 8C (50 MHz) 14.3 
(C-9), 24.7 (C-4), 33.4 and 34.4 (C-3 and 5), 54.4 (C-2), 114.7 (C-6 ) 
and 138.3 (C-7); m /z  171 (M+, 1.1%), 126, 98 (100%) and 81.
iV-(Diphenylmethvlene)-2-amino-5-pentenvl Cvanide (1461,
To a vigorously s tirred  tw o-phase m ixture of N- 
(diphenylmethylene)aminoacetonitrile (2.0 g, 9.1 mmol), benzyl- 
triethylammonium chloride (0.18 g), 50% sodium hydroxide solution 
(10 ml) and toluene (10 ml) at 0 °C was added 4-brom obut-l-ene 
(1.11 ml, 10.9 mmol) according to general procedure [3] to give a dark 
red oil, 2.26 g (91% yield), Rf 0.60 (50% EtOAc/hexane); vmax (CHCI3)
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3080, 3010, 2980, 1660, 1610, 1580 and 1490 cm 'l; 5H (200 MHz) 
(CDCI3 ) 2 .0 1  (2 H, m, 3-H2), 2.16 (2 H, m, 4-H2), 4.23 (1H, t, 2 -H), 4.97 
(2H, m, 6 -H2), 5.69 (1H, m, 5-H) and 7.10-7.52 (aromatic protons); §c 
(50 MHz) 29.6 and 34.0 (C-3 and 4), 52.34 (C-2), 116.0 (C-6 ), 119.6 
(C-l), 127.4, 128.2, 128.9 and 135.2 (aromatic carbons), 136.3 (C-5) 
and 173.1 (C-7); m / z  273 (M+-H, 100%), 219, 180, 165, 116 and 77 
(Found: M+-H, 273.1365. C19H18N2 requires M-H, 273.1392).
N-(Diphenvlmethylene)-2-amino-6-heptenonitrile (147).
Ph
CN
1
To a vigorously stirred  tw o-phase m ixture of N- 
(diphenylmethylene)aminoacetonitrile (6.0 g, 27.2 mmol), benzyl- 
triethylammonium chloride (0.55 g), 50% sodium hydroxide solution 
(20 ml) and toluene (20 ml) at 0 °C was added 5-brom opent-l-ene 
(3.87 ml, 32.7 mmol) according to general procedure [3] to give a dark 
red oil, 7.56 g (96% yield), Rf 0.66 (50% EtOAc/hexane); vmax (CHCI3) 
3080, 3010, 2980, 1660, 1620, 1600, 1580 and 1490 cm 'l; 5H (200 
MHz) (CDCI3) 1.53 (2H, m, 4-H2), 2.01 (4H, m, 3- and 5-H2), 4.23 (1H, t, 
2-H), 5.03 (2H, m, 7-H2), 5.71 (1H, m, 6 -H), 7.10 and 7.79 (aromatic 
protons); 5C (50 MHz) 24.7 (C-4), 32.9 and 34.2 (C-3 and 5), 52.9 (C-2),
115.3 (C-7), 119.7 (C-l), 128.2, 129.3 129.7 and 138.4 (aromatic 
carbons) and 137.6 (C-6 ); m /z  287 (M+-H, 83%), 219, 208, 180, 165, 
116 (100%), and 77 (Found: M+-H, 287.1531. C20H23N2 requires M-H, 
287.1549).
167
N-(Diphenvlmethvlene)-2-amino-7-octenonitrile (148).
Ph
Ph
CN
To a vigorously stirred  tw o-phase m ixture of N- 
(diphenylmethylene)aminoacetonitrile (6.0 g, 27.2 mmol), benzyl- 
triethylammonium chloride (0.55 g), 50% sodium hydroxide solution 
(10 ml) and toluene (10 ml) at 0 °C was added 6 -brom ohex-l-ene 
(4.38 ml, 32.7 mmol) according to general procedure [3] to give a dark 
red oil, 8.15 g (99% yield), Rp 0.68 (50% EtAOc/hexane); vmax (CHCI3) 
3080, 3010, 2980, 1660, 1620, 1600. 1580 and 1490 cm’l; 8H (200 
MHz) (CDCI3) 1.39 (4H, m, 4- and 5-H2), 1.92 (4H, m, 3- and 6 -H2),
4.21 (1H, t, 2-H), 4.99 (2H, m, 8-H2), 5.77 (1H, m, 7-H) and 7.17-7.67 
(aromatic protons) ; 8c (50 MHz) 24.9 and 28.1 (C-4 and 5), 33.4 and
34.7 (C-3 and 6 ), 53.0 (C-2), 114.7 (C-8 ), 119.7 (C-l), 127.4, 128.2,
129.0 and 135.2 (aromatic carbons), 138.3 (C-7) and 172.7 (C-9) ; m /z  
301 (M+-H, 36%), 219, 208, 180, 165 116 (100%), and 77 (Found: M+- 
H, 301.1710. C2 i H22N2 requires M-H, 301.1704).
2-Amino-5-hexenonitrile (149).
CN
168
A solution of (146) (5.00 g, 18.22 mmol) in diethyl ether (25 
ml) was stirred vigorously with 2M HC1 (25 ml) according to general 
procedure [4] to give an orange oil, 1.38 g (69% yield); vmax (CHCI3 ) 
3390, 3340, 3080, 2980, 2230 and 1640 cm“l; 5H (200 MHz) (CDCI3 ) 
1.66 (2H, br, NH2), 1.85 (2H, m, 3-H2), 2.29 (2H, m, 4-H?), 3.69 (1H, br 
m, 2-H), 5.10 (2H, m, 6 -H?) and 5.76 (1H, m, 5-H); 5C (50 MHz) 29.6 
and 34.3 (C-3 and 4), 42.7 (C-2), 116.5 (C-6 ), 122.1 (C-l) and 136.2 
(C-5); m /z  110 (M+ 11%), 84 and 6 8 .
2-Amino-6-heptenonitrile (150).
NH
5 i
A solution of (147) (11.5 g, 39.9 mmol) in diethyl ether (40 
ml) was stirred vigorously with 2M HC1 (40 ml) according to general 
procedure [4] to give an orange oil, 3.32 g (67% yield); vmax (CHCI3 ) 
3390, 3340, 3080, 2980, 2230 and 1640 cm‘1; 5H ( 2 0 0  MHz) (CDCI3 ) 
1.57 (2H, m, 4-H?), 1.69 (2H, br s, NH2), 1.85 (4H, m, 3- and 5-H2), 
3.69 (1H, br m, 2-H), 5.12 (2H, m, 7-H?) and 5.78 (1H, m, 6 -H); 5C (50 
MHz) 24.5 (C-4), 29.6 and 34.3 (C-3 and 5), 42.7 (C-2), 116.5 (C-7),
122.1 (C-l) and 136.2 (C-6 ); m /z  124 (M+, 1.1%), 98, 82 (100%) and 
68 .
169
2-Amino-S-hexenoic Acid Hydrochloride (126).
NH3 Cl 
CCbHi
Method 1
A mixture of compound (149) (2.00 g, 18.16 mmol) and 10% 
sodium hydroxide solution ( 2 0  ml) was heated at reflux overnight. 
The reaction mixture was cooled, carefully acidified with conc. 
hydrochloric acid and washed with ethyl acetate (3 x 20 ml). The 
aqueous layer was freezed dried to give a pale solid, 4.06 g (135% 
yield-due to sodium chloride impurity); vmax (KBr disc) 3000-2500 
(broad), 1735, 1655, 1490 and 960 cm"1; 5H (200 MHz) (D20) 1.8-2.2 
(4H, m, 3- and 4-H2), 3.75 (1H, br t, 2-H), 5.08 (2H, m, 6 -H2), 5.82 (1H, 
m, 5-H); 5C (50 MHz) 29.9 and 30.9 (C-3 and 4), 55.5 (C-2), 117.4 (C- 
6 ), 138.3 (C-5) and 175.9 (C-l); m /z  130 (M+, 0.1%), 84 (100%) and 
36/38 (3:1) (Found: M+, 130.0844. C6Hi?N02 requires M, 130.0868).
Method 2
2-Amino-5-hexenoic acid hydrochloride (126) was prepared 
from compound (136) (1.73 g, 6.38 mmol) according to general 
procedure [2] as a pale solid, 1.01 g (95% yield). This compound had 
identical spectral data to those quoted for the material synthesised by 
Method 1 above.
170
2-Amino-6-heptenoic Acid Hydrochloride (127).
NH3 Cl
Method 1
A mixture of compound (150) (2.80 g, 22.55 mmol) and 10% 
sodium hydroxide solution (25 ml) was heated at reflux overnight. 
The reaction mixture was cooled, carefully acidified with conc. 
hydrochloric acid and washed with ethyl acetate (3 x 25 ml). The 
aqueous layer was freezed dried to give a pale solid, 5 . 5 9  g (138% 
yield-due to sodium chloride impurity); vmax (KBr disc) 3420, 3200- 
2500 (broad), 1730, 1640, 1510 and 950 cn r l;  5H (200 MHz) (D2 0) 
1.28 (2H, m, 4-H2), 1.7-2.0 (4H, m, 3- and 5-H2), 3.83 (1H, br t, 2-H), 
4.82 (2H, m, 7-H?) and 5.65 (1H, m, 6 -H); 5C (50 MHz) 24.1, 30.0 and
33.1 (C-3, 4 and 5), 53.8 (C-2), 116.1 (C-7), 139.1 (C-6 ) and 173.4 (C-
1); m /z  144 (M+, 0.3%), 98, 56 (100%) and 36/38 (3:1) (Found: Mb 
144.1027. C7 H1 4 NO? requires M, 144.1025).
Method 2
2-Amino-6-hexenoic acid hydrochloride (127) was prepared 
from compound (137) (2.03 g, 7.11 mmol) according to general 
procedure [2] as a pale solid, 1.10 g (8 6 % yield). This compound had 
identical spectral data to those quoted for the material synthesised by 
Method 1 above.
171
2-Amino-7-octenoic Acid Hvdrochloride (152).
CO?H
1
A mixture of compound (151) (2.10 g, 15.19 mmol) and 10% 
sodium hydroxide solution ( 2 0  ml) was heated at reflux overnight. 
The reaction mixture was cooled, carefully acidified with conc. 
hydrochloric acid and washed with ethyl acetate (3 x 20 ml). The 
aqueous layer was freezed dried to give a pale solid, 4.12 g (140% 
yield-due to sodium chloride impurity); vmax (KBr disc) 3420, 3200- 
2500 (broad), 1735, 1640 and 1500 cn r l;  5H (200 MHz) (D2 0) 1.38 
(4H, m, 4- and 5-H2), 1 .8-2.0 (4H, m, 3- and 6 -H2 ), 3.92 (1 H, br t, 2-H), 
4.97 (2H, m, 8 -H2 ) and 5.83 (1H, m, 7-H); 5C (50 MHz) 24.6, 28.5, 30.7 
and 33.5 (C-3, 4, 5 and 6 ), 54.6 (C-2), 115.6 (C-8 ), 140.6 (C-7) and
174.4 (C-l); m /z  158 (M+, 0.1%), 112 (100%) and 36/38 (3:1).
172
(3R. 6S)-3-But-3-enyl-3,6-dihydro-6-isopropvl-2.5-
dimethoxvpvrazine (158).
10
N OMe
r
13
MeO iN 12 14
15
A so lu tio n  of (2S)-(+)-2,5-dihydro-3,6-dimethoxy-2- 
isopropylpyrazine (1.5 ml, 8.37 mmol) in THF (20 ml) was treated 
sequentially with n-butyllithium (3.68 ml of a 2.5 M solution in 
hexane, 9.21 mmol) and a solution of 4-bromobut-l-ene (0.94 ml,
9.21 mmol) in THF ( 8  ml) according to general procedure [5]. The 
resultant orange oil was purified on a silica gel column eluting with 
25% ether in hexane to give a colourless oil, 1.55 g (78% yield), 84% de 
value by GC analysis. Rf 0.75 (EtOAc); vmax (thin film) 3080, 2960, 
2870, 1695, 1640, 1240 and 1015 cm*1; 5H (200 MHz) (CDC13) 0.68 
(3H, d, J  6 . 8  Hz, IO-H3 ), 1.06 (3H, d ,J6 .9  Hz, II-H 3 ), 1.76-2.07 (4H, m,
12- and 13-Fb), 2.26 (1H, m, 9-H), 3.67 and 3.70 (6 H, 2 x s, 7- and 8 - 
H3), 3.94 (1H, t, J3 .4  Hz, 3-H), 4.04 (1H, m, 6 -H), 4.97 (2H, m, 15-H2) 
and 5.81 (1H, m, 14-H); 5C (50 MHz) 16.6 and 19.1 (C-10 and 11), 28.9 
(C-12), 31.7 (C-9), 33.4 (C-13), 52.4 (C-7 and 8 ), 54.9 (C-3), 60.8 (C- 
6),114.5 (C-15), 138.4 (C-14), 163.6 and 163.7 (C-2 and 5); m /z  238 
(M+, 7.8%), 223, 195, 183, 153 and 141 (100%). (Found: M+, 238.1695. 
C1 3 H2 2 N2 O2 requires M, 238.1709).
173
(35*. 6R)-3-But-3-envl-3,6-dihvdro-6-isopropvl-2.5-
dimethoxvpvrazine (160).
A solution of (2 i? ) -(-) -2 ,5 -d ih yd ro -3 ,6 -d im ethoxy -2 - 
isopropylpyrazine (1.5 ml, 8.37 mmol) in THF (20 ml) was treated 
sequentially with n-butyllithium (3.68 ml of a 2.5 M solution in 
hexane, 9.21 mmol) and a solution of 4-bromobut-l-ene (0.85 ml, 
8.37 mmol) in THF ( 8  ml) according to general procedure [5]. The 
resultant orange oil was purified on a silica gel column eluting with 
25 % diethyl ether in hexane to give a clear oil, 1.58 g (79% yield), 
85% de by GC analysis. Rf 0.77 (EtOAc); vmax (thin film) 3075, 2960, 
1695, 1640, 1235 and 1015 cm’l; 5H (200 MHz) (CDC13) 0.67 (3H, d, J
6 . 8  Hz, IO-H3 ), 1.04 (3H, d ,J6 .9  Hz, II-H 3 ), 1.76-2.07 (4H, m, 12- and
13-H2), 2.26 (1H, m, 9-H), 3.67 and 3.70 (6 H, 2 x s, 7- and 8 -H3 ), 3.93 
(1H, t, J  3.4 Hz, 3-H), 4.03 (1H, m, 6 -H), 4.97 (2H, m, 15-H2) and 5.80 
(1H, m, 14-H); 5C (50 MHz) 16.6 and 19.1 (C-10 and 11), 28.9 (C-12),
31.7 (C-9), 33.4 (C-13), 52.4 (C-7 and 8 ), 54.9 (C-3), 60.8 (C-6 ), 114.5 
(C-15), 138.4 (C-14), 163.6 and 163.7 (C-2 and 5); m / z  238 (M+, 
6.5%), 223, 195 (100%), 183, 153 and 141. (Found: Af+, 238.1673. 
C1 3 H2 2 N2 O2 requires M, 238.1681).
174
(3R. 65)-3-But-3-enyl-3.6-dihvdro-6-isopropvl-2.5-dime thoxv-3-
methvlpvrazine (162).
A solution of (25, 55R)-(+)-2,5-dihydro-3,6-dimethoxy-2- 
isopropyl-5-methvlpyrazine (0.82 ml, 4.14 mmol) in THF (20 ml) was 
treated sequentially with n-butyllithium (2.84 ml of a 1.6 M solution 
in hexane, 4.55 mmol) and a solution of 4-bromobut-l-ene (0.42 ml, 
4.14 mmol) in THF (5 ml) according to general procedure [5] to give a 
pale oil, 0.99 g (95% yield). Rf 0.76 (50% EtOAc/hexane); vmax (thin 
film) 3080, 2970, 2840, 1690, 1640, 1240 and 1005 cmfl; 5H (200 
MHz) (CDCls) 0.68 (3H, d, J 6 . 8  Hz, 10-H3), 1.06 (3H, d, J6 .9  Hz, II-H 3 ),
1.32 (3H, s, I 6 -H3 ), 1.56-1.94 (4H, m, 12- and 13-H2), 2.25 (1H, m, 9- 
H), 3.66 (6 H, br s, 7- and 8 -H3 ), 3.92 (1H, d, 73.4 Hz, 6 -H), 4.91 (2H, m, 
15-H2) and 5.74 (1 H, m, 14-H); 5C (50 MHz) 16.9 and 19.4 (C-10 and
11), 28.7 (C-16), 29.1 (C-l2), 31.0 (C-9), 40.5 (C-13), 52.1 (C-7 and 8 ),
58.2 (C-3), 61.2 (C-6 ), 114.1 (C-15), 138.6 (C-14), 162.0 and 165.2 (C- 
2  and 5); m /z  252 (M+, 2.8%), 237, 209, 197, 195 and 155 (100%). 
(Found: M+, 252.1829. C1 4 H2 4 N2 O2 requires M, 252.1835).
175
(35. 6R)-3-But-3-envl-3.6-dihvdro-6-isopropvl-2.5-dimethoxv-3-
A solution of (2R, 55R)-(-)-2,5-dihydro-3,6-dimethoxy-2- 
isopropyl-5-methylpyrazine (2.5 ml, 12.61 mmol) in THF (40 ml) was 
treated sequentially with n-butyllithium (5.55 ml of a 2.5 M solution 
in hexane, 13.87 mmol) and a solution of 4-bromobut-l-ene (1.28 ml, 
12.61 mmol) in THF ( 8  ml) according to general procedure [5] to give 
a pale oil, 3.15 g (99% yield). Rf 0.71 (50% Et2 0 /hexane); vmax (thin 
film) 3080, 2970, 2840, 1690, 1640, 1240 and 1005 cn r l;  5H (200 
MHz) (CDC13) 0.68 (3H, d, J 6.8 Hz, IO-H3 ), 1.06 (3H, d, 7 6.9 Hz, II-H3 ),
1.32 (3H, s, I 6 -H3 ), 1.56-1.94 (4H, m, 12- and 13-H2), 2.25 (1H, m, 9- 
H), 3.66 (6 H, br s, 7- and 8 -H3 ), 3.92 (1H, d, 73.4 Hz, 6 -H), 4.91 (2H, m, 
15-H2) and 5.74 (1H, m, 14-H); 5C (50 MHz) 16.8 and 19.3 (C-10 and
11), 28.6 (C-16), 29.0 (C-12), 30.9 (C-9), 40.4 (C-13), 52.1 (C-7 and 8 ),
58.1 (C-3), 61.1 (C-6 ), 114.0 (C-15), 138.5 (C-14), 161.9 and 165.1 (C- 
2 and 5); m /z  252 (M+, 2.3%), 237, 209, 197, 195 and 155 (100%). 
(Found: M+, 252.1825. C1 4 H2 4 N2 O2 requires M, 252.1837).
methvlpvrazine (164).
16
176
Mixture o f Methvl (2id-2-Amino-5-hexenoate (159) an d  Methvl L-
Valinate.
iC02Me
J
4'
1' 6' 
M ethyl L-Valinate
CO?Me1 ' C.'
(159)
A suspension of (158) (720 mg, 3.02 mmol) in 1.0 M HC1 (20 
ml) was stirred for 16 h at room temperature according to general 
procedure [6 ] to yield a light yellow oil, 325 mg. lH and l^C NMR 
spectra indicated this to be a 1 : 1  mixture of the (R)-amino acid 
methyl ester (159) and methyl L-valinate. 5h (200 MHz) (CDCI3 ) 0.88 
and 0.95 (6 H, 2 xd, J 6 . 8  Hz and 6 . 8  Hz, 4'- and 5'-H3), 1.48 (4H, br s, 
2 x NH2), 1.56-2.21 (5H, m, 3- and 4-H2 and 3'-H), 3.27 (1H, d, 75.0 
Hz, 2'-H), 3.44 (1H, dd, J 7.8 Hz and 7.8 Hz, 2-H), 3.70 (6 H, s, 7-H3 and 
6 '-H3), 5.00 (2H, m, 6 -H2) and 5.77 (1H, m, 5-H); 5C (50 MHz) 17.2 and
19.3 (C-4' and 5'), 29.9 (C-3), 32.2 (C-3'), 34.1 (C-4), 51.7 and 51.9 (C- 
6 ' and C-7), 53.9 (C-2), 60.0 (C-21), 115.4 (C-6 ), 137.6 (C-5), 176.1 and
176.5 (C-l and C-l').
177
Mixture of Methvl (2S)-2-Amino-5-hexenoate (161) an d  Methvl n-
Valinate.
iCO?Me 4 ' NH-
+
’• 'it
H o N  3
(161)
C 0 2Me 
1 '  6 ’
M ethyl D-Valinate
A suspension of (160) (500 mg, 2.10 mmol) in 1.0 M HC1 (20 
ml) was stirred for 16 h at room temperature according to general 
procedure [6 ] to yield a light yellow oil, 205 mg. XH and 13C NMR 
spectra indicated this to be a 1:1 mixture of the (S)-amino acid methyl 
ester (161) and methyl D-valinate. 8h (200 MHz) (CDCI3 ) 0.89 and 0.94 
(6 H, 2 x d, J 6 . 8  Hz and 6 . 8  Hz, 4 ’- and 5 '-H3 ), 1.49 (4H, br s, 2 x NH2 ), 
1.55-2.20 (5H, m, 3- and 4-H2 and 3'-H), 3.27 (1H, d, J  5.0 Hz, 2'-H), 
3.45 (1H, dd, J  7.8 Hz and 7.8 Hz, 2-H), 3.72 (6 H, s, 7-H3 and 6 f-H3),
5.00 (2H, m, 6 -H2 ) and 5.76 (1H, m, 5-H); Sc (50 MHz) 17.2 and 19.3 
(C-4' and 5’), 29.9 (C-3), 32.2 (C-3'), 34.1 (C-4), 51.7 and 51.9 (C-6 ' 
and C-7), 53.9 (C-2 ), 60.1 (C-2'), 115.4 (C-6 ), 137.6 (C-5), 176.2 and
176.5 (C-l and C-l').
178
Mixture of Methvl (2R)-2-Amino-2-methvl-5-hexenoate (163) and
Methvl I-Valinate.
A suspension of (162) (816 mg, 3.23 mmol) in 1.0 M HC1 (30 
ml) was stirred for 16 h at room temperature according to general 
procedure [6 ] to yield a light yellow oil, 646 mg. iH and i3C NMR 
spectra indicated this to be a 1:1 mixture of the (R)-amino acid 
methyl ester (163) and methyl L-valinate. 8h (200 MHz) (CDCI3 ) 0.84 
and 0.90 (6 H, 2 x d, J  7.0 Hz and 6.9 Hz, 4 ’- and 5'-H3), 1.34 (3H, s, 8 - 
H3), 1.58 (4H, br s, 2 x NH2), 1.63-2.10 (5H, m, 3- and 4-H2 and 3'-H),
3.30 (1 H, d, J  5.0 Hz, 2'-H), 3.72 (6 H, br s, 7-H3 and 6 '-H3), 4.98 (2H, m,
6 -H?) and 5.77 (1H, m, 5-H); 5c (50 MHz) 17.2 and 19.3 (C-41 and 5'),
26.5 (C-8 ), 28.5 (C-3), 32.2 (C-31), 40.1 (C-4), 51.7 and 52.8 (C-7 and 
C-6 '), 57.6 (C-2 ), 59.9 (C-21), 114.9 (C-6 ), 137.9 (C-5), 176.1 and 178.0 
(C-l and C-l').
1'  6 '  
M ethyl L-Valinate(163)
Mixture of Methvl (2M-2-amino-2-methvl-5-hexenoate (165) and
Methvl D -V alinate.
A suspension of (164) (2.50 g, 9.91 mmol) in 1.0 M HC1 (60 
ml) was stirred for 16 h at room temperature according to general 
procedure [6 ] to yield a colourless oil, 2.10 g. XH and NMR spectra 
indicated this to be a 1:1 mixture of the (S)-amino acid methyl ester 
(165) and methyl D-valinate. 5h (200 MHz) (CDCI3 ) 0.90 and 0.97 (6 H, 
2 x d J  6 . 8  Hz and 6.9 Hz, 4 ’- and 5'-H3), 1.33 (3H, s, 8 -H3 ), 1.64 (4H, 
br s, 2 x NH2), 1.67-2.10 (5H, m, 3- and 4-H2 and 3'-H), 3.29 (1H, d, J
5.0 Hz, 2'-H), 3.72 (6 H, br s, 7-H3 and 6 '-H3), 4.98 (2H, m, 6 -H?) and 
5.77 (1H, m, 5-H); §c (50 MHz) 17.0 and 19.1 (C-4' and 51), 26.2 (C-8 ),
28.5 (C-3), 32.0 (C-3'), 39.3 (C-4), 51.5 and 52.0 (C-7 and C-6 '), 57.4 
(C-2 ), 59.7 (C-2'), 114.7 (C-6 ), 137.7 (C-5), 175.8 and 177.8 (C-l and 
C-l').
1’ 6' 
M ethyl D-Valinate(165)
180
t-Butvl DL-2-Amino-S-hexenoate Hydrochloride (166).
CO
2-Methylpropene (excess) was added to a stirred suspension 
of (126) (0.60 g, 3.62 mmol) in dichloromethane (40 ml) at -78 °C 
Cone, sulfuric acid (1.5 ml) was added dropwise over 10 min. The 
mixture was stirred at -78 °C for 15 min then allowed to warm to 
room temperature and stirred for 18 h with a dry ice condenser 
fitted. The resulting clear solution was carefully basified to pH 8  with 
sodium bicarbonate solution. The organic layer was separated, washed 
with brine solution ( 2  x 50 ml), dried (Na?S0 4 ), filtered and 
concentrated in vacuo to give a yellow oil. A white precipitate 
resulted on addition of a solution of dry HC1 gas in ether (20 ml). The 
white solid was filtered and dried under vacuum, 0.27 g (33% yield), 
mp 132-133 °C; Vmax (CHC13) 2980, 2880, 1745, 1600 and 1500 cm'l; 
5H (200 MHz) (D20) 1.34 (9H, s, 8 -, 9- and IO-H3 ), 1.85 (2H, m, 3-H?),
2.02 (2H, m, 4-H2), 3.84 (1H, t, 2-H), 4.95 (2H, m, 6 -H?) and 5.17 (1H, 
m, 5-H); 5c (50 MHz) 28.2 (C-8 , 9 and 10), 29.5 and 30.3 (C-3 and C-4),
54.0 (C-2), 8 6 . 8  (C-7), 117.5 (C-6 ), 137.6 (C-5) and 170.3 (C-l); m /z  
186 (M+, 0.6%), 129, 85 and 57 (100%) (Found: M+, 186.1480; C, 54.21; 
H, 9.00; N, 6.20. CioH2 0 NO? requires M, 186.1494; C, 54.16; H, 9.09; N, 
6.32%).
181
t-Butvl DL-N-t-Butoxvcarbonvl-2-amino-5-hexenoate (167).
To a stirred suspension of (166) (0.64 g, 2.90 mmol) in 
dichloromethane (10 ml) was added sodium bicarbonate (0.24 g, 1 
equiv.) in water (5 ml), sodium chloride (0.7 g) and di-t- 
butyldicarbonate (0.66 ml, 1 equiv.). The mixture was heated at 
reflux for 1.5 h then cooled to room temperature and the organic 
layer was separated. The aqueous layer was extracted with 
dichloromethane (2 x 40 ml) and the combined organic extracts 
weredried (MgSCU), filtered and concentrated in vacuo to give a 
yellow oil. Purification was achieved on a silica gel column eluting 
with 10% ethyl acetate/hexane to give a pale oil, 0.73 g (8 8 % yield), 
Rf 0.37 (10% EtOAc/hexane); v ^ x  (CHC13) 3440, 2980, 1750, 1710 and 
1500 cm-1; 5H (200 MHz) (CDCI3 ) 1.47 (18H, br s, 8 -, 9-, 10-, 13-, 14- 
and I 5 -H3 ), 2.1-2.2 (4H, m, 3- and 4-H2), 4.20 (1H, m, 2-H), 5.08 (3H, 
m, 6 -H2 and NH) and 5.70 (1H, m, 5-H); 5C (50 MHz) 27.6 and 28.1 (C- 
8 , 9, 10, 13, 14 and 15), 29.3 and 32.1 (C-3 and 4), 53.4 (C-2), 82.7 
and 84.9 (C-7 and 12), 115.2 (C-6 ), 137.1 (C-5), 155.1 (C-ll) and
171.7 (C-l); m /z  285 (M + ,0.1%), 2 1 2 , 184, 128 and 57 (100%).
182
5-Hvdroxv PL-N-t-Butoxvcarbonvlproline t-Butvl Ester (169).92
HO' s 'N ^ 'C O fT
I 112 ‘
C O X j-13
10 l 14
A solution of (167) (276 mg, 0.96 mmol) in dichloromethane 
(10 ml) was flushed with ozone at -78 °C according to general 
procedure [1], experimental to Chapter 3. Purification was achieved on 
a silica gel column eluting with diethyl ether to give a gluey white 
solid, 198 mg (72% yield), RF 0.45 (Et2 0); vmax (CHCI3 ) 3590, 2980, 
1735, 1695 and 1160 cm-1; The lH NMR and 13C NMR spectra indicate 
the presence of the diastereoisomers of compound (169); 5h (200 
MHz) (CDCI3 ) 1.48 (18H, 4 x s, 7-, 8 -, 9-, 12-, 13- and 14-H3), 1.84- 
2.42 (4H, br m, 3- and 4-H2), 2.95-3.59 (1 H, 4 x br d, OH), 4.17 (1H, br 
m, 2-H) and 5.61 (1H, br m, 5-H); 5C (50 MHz) 28.0 and 28.3 (C-7, 8 , 9, 
12, 13 and 14), 30.9 and 32.2 (C-3 and 4), 59.9 and 60.0 (C-2), 80.7 
(C-l 1), 82.3 and 82.5 (C-5), 85.2 (C-6 ), 146.8 (C-10) and 171.6 (C-l); 
m /z  270 (M-OH, 11.6%), 186, 170, 130, 6 8  and 57 (100%).
Potassium Salt of DL-N-t-Butoxvcarbonvl- 
2-amino-5-hexenoic Acid (171).
C O ’7  K+
1
To a solution of (126) (1.00 g, 6.04 mmol) in water (10 ml) 
was added dioxan (7 ml), potassium bicarbonate (1.27 g, 2.1 equiv) 
and di-r-butyl dicarbonate (1.39 ml, 1 equiv) with continuous stirring
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at room temperature for 18 h. The solvents were removed with 
ethanol in vacuo to give a white solid, 1.55 g (96 % yield); vmax (KBr 
disc) 3420, 3080, 2980, 1690 and 1590 cm“l; 5H (200 MHz) (D2 0) 1.32 
(9H, s, 9-, 10- and 11-H3), 1.62 (2H, m, 3-H2), 1.99 (2H, m, 4-H2), 3.75 
(1H, m, 2-H), 4.95 (2H, m, 6 -H2) and 5.79 (1H, m, 5-H); 5C (50 MHz)
28.7 (C-9, 10 and 1 1 ), 30.5 and 31.9 (C-3 and 4), 56.4 (C-2), 81.8 (C-
8 ), 116.3 (C-6 ), 139.1 (C-5), 163.5 (C-7) and 181.3 (C-l); m /z  228 (M 
H+, 0.7%), 184, 171, 83 and 57.
Potassium Salt of DL-N-t-Butoxvcarbonvl- 
2-amino-6-heptenoic Acid (172).
I10Nn-corrr"
/ N ^ A o 2 K+
 ^ s 3 1
To a solution of (127) (1.00 g, 5.57 mmol) in water (10 ml) 
was added dioxan ( 8  ml), potassium bicarbonate (1.17 g, 2.1 equiv) 
and di-t-butyl dicarbonate (1.28 ml, 1 equiv) with continuous stirring 
at room temperature for 18 h. The solvents were removed with 
ethanol in vacuo to give a white solid, 1.49 g (95% yield); vmax (KBr 
disc) 3430, 3080, 2980, 1680 and 1590 c n r 1; 5H (200 MHz) (D20) 1.30 
(9H, s, 10-, 11-, and 12-H3), 1.49 (4H, br m, 3- and 4-H2), 1.94 (2H, m,
5-H2), 3.72 (1H, m, 2-H), 4.90 (2H, m, 7-H2) and 5.76 ( 1 H, m, 6 -H); 5C 
(50 MHz) 25.4 (C-4), 28.6 (C-10, 11 and 12), 32.2 and 33.5 (C-3 and
5), 56.9 (C-2), 81.8 (C-9), 115.5 (C-7), 140.3 (C-6 ), 162.1 (C-8 ) and
181.4 (C-l); m /z  198 (M+-C02), 142, 124, 81 and 57 (100%) (Found 
M+-CO?, 198.1489. CiiH 2 qN02 requires M, 198.1489).
184
p-Methoxvbenzvl DL-N-1-Butoxvcarbonvl-
2-amino-5-hexenoate (173).
•NH-CO
OMe
13 12
To a solution of (171) (0.50 g, 1.87 mmol) in DMF (3 ml) was 
added 4-methoxybenzyl chloride (0.27 ml, 1.0 equiv.) with continuous 
stirring for 48 h. DMF was removed with xylene in vacuo and the 
resultant residue was partitioned between dichloromethane ( 8  ml) 
and aqueous sodium bicarbonate solution ( 8  ml). The organic portion 
was washed with water (3 x 10 ml), dried (MgSC>4 ) and the solvent 
w'as removed in vacuo to give a yellow oil. Purification was achieved 
on a silica gel column eluting with 50% diethyl ether/hexane to give a 
white solid, 0.41 g (63% yield), mp 33-35 °C, Rf 0.38 (50% 
EtzO/hexane); vmax (KBr disc) 3360, 3080, 2980, 2835, 1750, 1690, 
1610, 1580 and 1510 cm“l; SH (200 MHz) (CDCI3 ) 1.43 (9H, s, 17-, 18- 
and I 9 -H3 ), 1.75 (2H, br m, 3-H2), 2.04 (2H, br m, 4-H2), 3.80 (3H, s,
I 4 -H3 ), 4.34 (1H, m, 2-H), 4.99 (2H, m, 6 -H2), 5.14 (2H, br d, 7-H?), 
5.73 (1H, m, 5-H), 6 . 8 8  (2H, d, 10- and 12-H) and 7.28 (2H, d, 9- and 
13-H); 5C (50 MHz) 28.3 (C-17, 18 and 19), 29.4 and 31.9 (C-3 and 4),
53.1 (C-2), 55.2 (C-14), 6 6 . 6  (C-7), 79.8 (C-16), 113.9 (C-10 and 12),
115.6 (C-6 ), 127.5 (C-8 ), 130.2 (C-9 and 13), 136.9 (C-5), 155.3 (C-15),
159.7 (C-ll) and 172.7 (C-l); m /z  349 (M+, 0.1%), 293, 184, 121 
(100%) (Found: M+, 349.1879; C, 65.48; H, 7.79; N, 4.01. Ci9H2 7 N0 5  
requires M, 349.1889; C, 65.32; H, 7.74; N, 4.01%).
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p-Methoxvbenzvl DL-N- t-Butoxvcarbonvl-
2-amino-6-heptenoate (174).
OMe
15
14 13
To a solution of (172) (0.90 g, 3.20 mmol) in DMF ( 8  ml) was 
added 4-methoxybenzyl chloride (0.46 ml, 1.0 equiv.) with continuous 
stirring for 48 h. DMF was removed with xylene in vacuo and the 
resultant residue was partitioned between dichloromethane ( 1 0  ml) 
and aqueous sodium bicarbonate solution (10 ml). The organic portion 
was washed with water (3 x 10 ml), dried (MgSCM) and the solvent 
was removed in vacuo to give a yellow oil, 0.88 g (75% yield), Rf 0.30 
(50% Et2 0/hexane); vmax (CHC13) 3440, 3290, 2980, 1735, 1710, 1610 
and 1515 cm'l; 5H (200 MHz) (CDCI3 ) 1.43 (9H, s, 18-, 19- and 20-H3), 
1.75 (6 H, br m, 3-, 4- and 5-H2), 3.80 (3H, s, 15-H3), 4.30 (1H, m, 2-H),
5.00 (4H, m, 7-H2 and 8 -H?), 5.70 (1H, m, 6 -H), 6.87 (2H, d, 11- and 
13-H) and 7.27 (2H, d, 10- and 14-H); 5C (50 MHz) 24.4 (C-4), 28.3 (C- 
18, 19 and 20), 32.1 and 33.2 (C-3 and 5), 53.4 (C-2), 55.3 (C-15), 6 6 . 8  
(C-8 ), 79.8 (C-17), 113.9 (C-ll and 13), 115.0 (C-7), 127.6 (C-9), 130.2 
(C-10 and 14), 137.6 (C-6 ), 155.5 (C-16), 159.7 (C-12) and 172.8 (C-l); 
m /z  363 (M+, 0.9%), 307, 242, 198, 121 (100%) and 57 (Found M+, 
363.2039. C2 0 H2 9 NO5 requires M, 363.2045).
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p-Methoxvbenzvl DL-N. N-Bis( t-Butoxvcarbonvl)-
2-amino-5-hexenoate (175).
CO
N-CO-
OMe
1213
To a solution of (173) (1.40 g, 4.01 mmol) in dry acetonitrile 
(10 ml) was added 4-dimethylaminopyridine (49 mg, 0.40 mmol) 
followed by di-t-butyldicarbonate (1.01 ml, 4.41 mmol). The mixture 
was stirred at room temperature for 18 h. The brownish reaction 
mixture was concentrated in vacuo at room temperature and the oily 
residue was partitioned between diethyl ether ( 2 0  ml) and 1 M KHSO4  
solution (15 ml). The organic portion was washed with 1 M KHSO4  ( 2  x 
15 ml), 5% sodium bicarbonate solution (15 ml), saturated brine 
solution (15 ml), dried (MgSCU) and solvent was removed in vacuo to 
give an orange oil, 1.47 g (82% yield), Rf 0.60 (50% Et2 0 /hexane); vmax 
(CHCI3 ) 3010, 2980, 2840, 1735, 1670, 1640 and 1500 cm’l; 5H (200 
MHz) (CDCI3 ) 1.45 (18H, s, 17-, 18-, 19-, 22-, 23- and 24-H3), 2.10 (4H, 
br m, 3- and 4-H2), 3.80 (3H, s, 14-H3), 5.00 (5H, br m, 2-H, 6 -H2 and
7-H2), 5.78 (1H, m, 5-H), 6.89 (2H, 10- and 12-H) and 7.26 (2H, 9- and
13-H); 5C (50 MHz) 27.9 (C-17, 18, 19, 22, 23 and 24), 28.9 and 30.4 
(C-3 and 4), 55.2 (C-2), 57.7 (C-14), 6 6 . 6  (C-7), 83.0 (C-16 and 21),
113.8 (C-10 and 12), 115.5 (C-6 ), 127.8 (C-8 ), 129.9 (C-9 and 13),
137.4 (C-5), 152.2 (C-15 and 20), 159.5 (C-ll) and 170.8 (C-l); m /z  
449 (M+, 3.0%), 293, 121 (100%) and 57 (Found M+, 449.2452. 
C2 4 H3 5 NO7 requires M, 449.2413).
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p-Methoxvbenzvl DL-M N-Bis( t-Butoxvcarbonvl)-
2-amino-6-heptenoate (176).
21CO
N-CO
OMeCO7CH
To a solution of (174) (2.10 g, 7.11 mmol) in dry acetonitrile 
(15 ml) was added 4-dimethylaminopyridine (87 mg, 0.71 mmol) 
followed by di-t-butyldicarbonate (1.80 ml, 7.82 mmol). The mixture 
was stirred at room temperature for 18 h. The brownish reaction 
mixture was concentrated in vacuo at room temperature and the oily 
residue was partitioned between diethyl ether (20 ml) and 1M KHSO4  
solution (20 ml). The organic portion was washed with 1M KHSO4 
solution (2 x 15 ml), 5% sodium bicarbonate solution (15 ml), 
saturated brine solution (15 ml), dried (MgSCM) and solvent was 
removed in vacuo to give an orange oil, 3.09 g (94% yield), Rf 0.68 
(50% EtOAc/hexane); vmax (CHCI3 ) 3010, 2980, 2840, 1735, 1670, 
1640 and 1515 cm-1; 5H (200 MHz) (CDCI3 ) 1.44 (18H, s, 17-, 18-, 19-, 
23-, 24- and 25-H3), 1.46 (2H, m, 4-H2), 2.08 (4H, br m, 3- and 5-H2),
3.80 (3H, s, I 5 -H3 ), 5.00 (5H, br m, 2-H, 7-H2 and 8-H?), 5.76 (1H, m,
6-H), 6.87 (2H, 11- and 13-H) and 7.27 (2H, 10- and 14-H); 5C (50 
MHz) 25.5 (C-4), 27.9 (C-18, 19, 20, 23, 24 and 25), 28.9 and 33.2 (C-3 
and 5), 55.3 (C-15), 58.1 (C-2), 66.6 (C-8), 82.9 (C-17 and 22), 113.8 
(C-ll and 13), 114.9 (C-7), 127.9 (C-9), 129.9 (C-10 and 14), 138.3 (C-
6), 152.2 (C-16 and 21), 159.5 (C-12) and 170.9 (C-l); m / z  463
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(MUO.7%), 363, 121 (100%) and 57 (Found M+, 463.2581. C2 5H3 7NO7 
requires M, 463.2570).
DL-iV. N-Bisf t-butox\ carbonvl)-glutamic Acid y-Semialdehvde 
p-Methoxvbenzvl Ester (177).
CO
N-CO
H
12 11
A solution of compound (1 7 5 )  (1.28 g, 2.85 mmol) in 
dichloromethane (35 ml) was saturated with ozone according to 
general procedure [1], experimental to Chapter 3. Purification was 
achieved on a silica gel column eluting with ether to give a pale oil, 
970 mg (75% yield), Rp 0.55 (ether); vmax (CHCI3 ) 3020, 2840, 2730, 
1735, 1710 and 1515 cm 'l; 5H (200 MHz) (CDCI3 ) 1.45 (18H, s, 16-, 
17-, 18-, 21-, 22- and 23-H3), 2.16 (2H, m, 3-H2), 2.54 (2H, m, 4-H2),
3.80 (3H, s, 1 3 -H3 ), 4.88 (1H, m, 2-H), 5.10 (2H, br s, 6-H2), 6.87 (2H, 
9- and 11-H), 7.27 (2H, 8- and 12-H) and 9.76 (1H, br s, 5-H); 5C (50 
MHz) 22.2 (C-3), 27.9 (C-16, 17, 18, 21, 22 and 23), 40.5 (C-4), 55.3 
(C-13), 57.5 (C-2), 66.8 (C-6), 83.4 (C-15 and 20), 113.8 (C-9 and 11),
127.7 (C-7), 130.0 (C-8 and 12), 152.1 (C-14 and 19), 170.2 (C-l) and
201.0 (C-5); m /z  451 (Af+, 0.1%), 277, 186 and 121 (100%) (Found 
M+, 451.2212. C?3 H3 3 NOs requires M, 451.2206).
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dl-N. N-Bisf t-butoxycarbonvl)-a-aminoadipic Acid 5-Semialdehvde
p-Methoxvbenzvl Ester (178).
20 CO
24
N-COH
OMe
A solution of compound (1 7 6 )  (1.64 g, 3.54 mmol) in 
dichloromethane (40 ml) was saturated with ozone according to 
general procedure [1], experimental to Chapter 3. Purification was 
achieved on a silica gel column eluting with diethyl ether to give a 
yellow oil, 1.16 g (70% yield), Rf 0.71 (ether); vmax (CHCI3 ) 3010, 
2980, 2840, 1740, 1710 and 1510 cm 'l; 5H (200 MHz) (CDCI3 ) 1.45 
(18H, s, 17-, 18-, 19-, 22-, 23- and 24-H3), 1.60-2.52 (6 H, br m, 3-, 4- 
and 5-H2), 3.80 (3H, s, 14-H3), 4.86 (1 H, m, 2-H), 5.09 (2H, 7-H2), 6 . 8 6  
(2H, 10- and 12-H), 7.27 (2H, 9- and 13-H) and 9.75 (1H, br s, 6 -H); 5c 
(50 MHz) 14.1 (C-4), 18.8 (C-3), 27.9 (C-17, 18, 19, 22, 23 and 24),
43.3 (C-5), 55.3 (C-14), 57.9 (C-2), 66.7 (C-7), 83.2 (C-16 and 21),
113.8 (C-10 and 12), 127.7 (C-8 ), 130.1 (C-9 and 13), 152.2 (C-15 and 
20), 170.5 (C-l) and 201.8 (C-6 ); m /z  264, 137, 121, 82 and 57.
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Trifluoroacetate Salt of DL-Glutamic Acid vSemialdehvde Hydrate
(179).
OH
HO
n h 3 c f 3c o 2-
co2h
A solution of compound (177) (490 mg, 1.1 mmol) in 
trifluoroacetic acid (3 ml) and dichloromethane (3 ml) was stirred at 
room temperature under an atmosphere of nitrogen for 2 h. The 
solvent was removed in vacuo to give an oily residue which was 
partitioned between distilled water (10 ml) and ethyl acetate (10 ml). 
The aqueous layer was separated, washed with ethyl acetate ( 3 x 1 0  
ml) and freeze dried to give a cream coloured solid, 108 mg (40% 
yield), mp 57-58 °C; vmax (KBr disc) 3435 (broad), 3000-2500 (broad), 
1700, 1635 and 1200 cm-1; 5h (200 MHz) (D2 O) 1.5-2.5 (br m, 3- and 
4 -H3 ), 4.16 (br m, 2-H) and 5.40 (br m, 5-H); §c (50 MHz) 31.1 and
38.7 (C-3 and 4), 55.3 (C-2 ), 60.2 (C-5) and 173.1 (C-l); m /z  113, 8 6 , 
69 and 41.
Trifluoroacetate Salt of DL-a-Aminoadipic Acid S-Semialdehvde
Hvdrate (180).
A solution of compound (178) (334 mg, 0.72 mmol) in 
trifluoroacetic acid (3 ml) and dichloromethane (3 ml) was stirred at
OH n h 3 CF3C02'
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room tem perature under an atmosphere of nitrogen for 2 h. The 
solvent was removed in vacuo to give an oily residue which was 
partitioned between distilled water (5 ml) and ethyl acetate (5 ml). 
The aqueous layer was separated, washed with ethyl acetate ( 3 x 8  
ml) and freeze dried to give a yellow solid, 81 mg (43 % yield), mp °Q 
vm ax (KBr disc) 3435 (broad), 3000-2500 (broad), 1700, 1635 and 
1200 cm-l; 5H (200 MHz) (D20) 1.35-2.32 (br m, 3-, 4- and 5-H3) and 
3.80 (br m, 2-H); fc (50 MHz) ; m /z  164, 114, 55 and 44.
7.4 Experimental to Chapter 5.
Diethyl (R)-3,4-Dihvdro-2H-1.4-thiazine-3.5-dicarboxvlate (42).136
To a solution of L-cysteine ethyl ester (5.00 g, 26.9 mmol) 
and triethylamine (7.51 ml, 1.0 equiv) in dichlorom ethane (20 ml) 
under an atmosphere of nitrogen was added a solution of ethyl 
bromopyruvate (3.38 ml, 2.0 equiv) in dichloromethane (10 ml) with 
stirring. The mixture was stirred at room tem perature for 12 h, 
washed with water (3 x 30 ml) and the organic portion was dried 
(MgS0 4 ). The solvent was removed in vacuo to give an orange oil. 
Purification was achieved on a silica gel column eluting with 20% 
ethyl acetate in hexane to give a yellow oil, 6.30 g (95% yield), Rf 0.28 
(20% EtOAc/hexane); vmax (CHCI3 ) 3405, 3020, 2985, 1735, 1715 and 
1605 cm-l; §H (200 MHz) (CDCI3 ) 1.30 (6 H, 2 x t ,J 7 .1  Hz and J 7.2 Hz,
CH3CH20 2C 4 N  ^  c o 2c h 2c h 312 11 10 H H ?  8 9
s
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9- and 12-H3), 2.99 (1H, d d ,/1 2 .1  Hz and J  6.7 Hz, 2a-H), 3.25 (1H,
Hz, 8- and 11-H2 and 3-H), 4.79 (1H, br s, N-H) and 6.17 (1H, s, 6 -H); 
8C (50 MHz) 14.1 and 14.2 (C-9 and 12), 26.9 (C-2), 53.1 (C-3), 61.2 
and 61.8 (C-8  and 1 1 ), 101.1 (C-6 ), 128.2 (C-5), 162.3 (C-10) and
170.2 (C-7); m /z  245 (M+, 37%), 172 (100%), 127 and 98 (Found: M*-, 
245.0733. C10H15NO4S requires M, 245.0722).
3.4-Dihvdro 2H-1.4-Thiazine-3.5-diamide (193).
A solution of (42) (730 mg, 2.97 mmol) in methanolic 
ammonia (20 ml) was stirred at room tem perature for 48 h. The 
resulting orange precipitate was filtered off and recrystallised from 
methanol to give a white solid, 167 mg (30% yield); vmax (KBr disc) 
3395, 3340, 1690, 1655, 1600 and 1490 c n rl; 8H (200 MHz) (CDCI3) 
2.54 (1H, dd, J  12.3 Hz and J 3.3 Hz, 2-H), 3.37 (1H, d d d ,/1 2 .3  Hz, J
3.3 Hz and J  1.8 Hz, 2-H), 4.42 (1H, m, 3-H), 5.93 (2H, br s, NH2), 6.33 
(1H, d, J  1.8 Hz, 6 -H) and 6.52 (2H, br s, NH2); 8C (50 MHz) 24.3 (C-2),
52.0 (C-3), 103.1 (C-6 ), 126.5 (C-5), 162.4 and 163.0 (C-7 and 8 ); m /z  
172, 158, 142, 126 (100%), 98, 72 and 54.
dd, J  12.1 Hz and J  2.9 Hz, 2b-H), 4.26 (5H, 2 x q + m, J7 .1  Hz and J  7.2
CONH
Ha
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Diethvl 2#-1.4-Thiazine-3.5-dicarboxvlate (194).
CH3CH20 2C 5 'n " 3 c o 2c h 2c h 3
12 11 10 4 7 8 9
To a s o lu t io n  o f 2 ,3 -d ic h lo ro -5 ,6 -  
dicyanobenzoquinone (611 mg, 2.69 mmol) in dichloromethane (6 ml) 
was added  a solution of (42) (600 mg, 2.45 mmol) in 
dichloromethane (6 ml) at room temperature with continuous stirring 
for 1 h. The resultant reddish brown precipitate was filtered through 
Celite, washed with 5% aqueous sodium bicarbonate solution (3 x 10 
ml) and dried (MgSCU). The solvent was removed in vacuo to give an 
orange oil. Purification was achieved on a silica gel column eluting 
with 50% chloroform in ether to give a yellow oil, 385 mg (65% yield), 
RF 0.41 (50% CHCl3/ether); vmax (CHCI3) 3420, 2980, 1730, 1710 and 
1465 cm-1; 5H (200 MHz) (CDCI3) 1.34 (6 H, 2 x t, 9- and 12-H3), 3.32 
(2H, d, J  1.2 Hz, 2-H2), 4.30 (4H, 2 x q, 8- and 11-H2) and 7.60 (1H, t, J
1.2 Hz, 6 -H); 8C (50 MHz) 14.1 and 14.2 (C-9 and 12), 20.6 (C-2), 63.0 
and 63.3 (C-8 and 11), 128.3 (C-6 ), 137.2 and 137.9 (C-3 and 5), 167.5 
and 168.9 (C-7 and 10); m /z  243 (M+, 47.0%), 215, 169, 141,97, 45 
and 29 (100%).
194
Ethyl N-Benzvl-3-hvdroxvmethvl-2H-3.4-dihvdrothiazine-5-
carboxvlate (199).
CH3CH9O9C
10 9 8
To a solution of S-benzyl-L-cysteinol (2.00 g, 10.14 mmol) in 
dichloromethane (15 ml) under an atmosphere of nitrogen was added 
dropwise a solution of ethyl bromopyruvate (1.27 ml, 1.0 equiv) in 
dichloromethane (5 ml). The mixture was stirred at room temperature 
for 18 h, washed with water (3 x 15 ml) and the organic portion was 
dried (Na2 SC>4 ). Removal of solvent in vacuo gave a dark orange oil 
which was purified  on a silica gel colum n eluting with 
dichloromethane to give an orange oil, 1.51 g (73% yield), Rp 0.47 
(CHzCbR.vmax (CHCI3 ) 3630, 3030, 2985, 1740, 1705, 1570, 1495, 
1240 and 1075 cm"!; 5H (200 MHz) (CDCI3 ) 1.32 (3H, t, J  7.1 Hz, 10- 
H3), 2.67 (1H, m, 3-H), 3.40 (4H, m, 2- and 11-H2), 4.27 (2H, q, J7 .2  
Hz, 9-H2), 4.30 (2H, m, 7-H2), 6 . 8 8  (1H, s, 6 -H) and 7.38 (5H, m, 
aromatic protons); 5c (50 MHz) 14.2 (C-10), 21.7 (C-2), 53.3 (C-3), 58.5 
(C-ll), 60.9 (C-9), 61.0 (C-7), 116.8 (C-6 ), 127.6 (C-15), 128.5 (C-14 
and 16), 128.9 (C-13 and 17), 130.2 (C-5), 137.9 (C-12) and 164.2 (C- 
8 ); m /z  293 (M+, 9.5%), 262, 203, 172, 126 and 91.
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Diethvl 1.3-Thiazole-2.4-dicarboxvlate (43).
CH3CH20 2C
11 10 9
2 c o 2c h 2c h 3
A solution of ethyl thioxamate (1.54 g, 11.56 mmol) and 
ethyl bromopyruvate (4.35 ml, 3.0 equiv) in ethanol (10 ml) was 
heated at reflux for 2 h. The solvent was removed in vacuo and ether 
( 1 0  ml) was added to precipitate triethylam ine hydrobrom ide. 
Filtration and removal of of the solvent in vacuo gave a yellow oil. 
Purification was achieved on a neutral alumina column eluting with 
20% ethyl acetate in hexane to give a pale solid, 1.27 g (48% yield), 
mp 39-41 °C, Rf 0.50 (20% EtOAc/hexane); vmax (KBr disc) 3110, 
2985, 1720, 1485 and 1460 cnr*; 5H (200 MHz) (CDC13) 1.42 (6 H, 2 x 
t, J  7.1 Hz, 8 - and II-H 3), 4.49 (4H, 2 x q, J  7.1 Hz, 7- and 10-H2) and 
8.45 (1H, s, 5-H); 5c (50 MHz) 14.2 and 14.3 (C-8 and 11), 61.9 and
63.0 (C-7 and 10), 132.3 (C-5), 149.0 (C-4), 159.3 (C-2), 159.6 and
160.8 (C-6  and 9); m /z  229 (M+, 6.3%), 184 (100%), 157 and 83 
(Found: NP, 229.0399; C, 47.36; H, 4.73; N, 6.01. C9H11NO4S requires M, 
229.0409; C, 47.16; H, 4.80; N, 6.11%).
A solution of (43) (865 mg, 3.77 mmol) in methanolic ammonia 
(20 ml) was stirred at room tem perature for 48 h. The resultant
1.3-Thiazole-2.4-diamide (200T
2 CONH
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precipitate was filtered, washed with cold water and dried in vacuo 
to give a white solid, 550 mg (85% yield); vmax (KBr disc) 3400 
(broad), 3270, 3200, 1680, 1590 and 1485 cm“l; 8H (200 MHz) 7.76 
(2H, br s, NH2), 8.21 (2H, br s, NH2), 8.46 (1H, s, 5-H); 5C (50 MHz)
129.0 (C-5), 150.4 (C-4), 160.5 (C-2), 161.8 and 163.0 (C-6  and 7); 
m /z  171 (M+,100%), 154, 128, 112, 84 and 70.
1.3-Thiazole-2.4-dinitrile (201).
A solution of compound (200) (470 mg, 2.75 mmol) in 
1 ,1,2,2-tetrachloroethane was heated  to 110 °C. Phosphorus 
oxychloride (2.56 ml, 10 equiv.) was added dropwise over 10 min and 
the mixture was heated at reflux for 1.5 h. The solution was decanted 
from remaining solid and the solvent was removed in vacuo to give a 
yellow residue. Chloroform (10 ml) was added and the solution was 
washed with 10% sodium carbonate solution (3 x 10 ml), water (2 x 
10  ml), dried (MgSCU) and the solvent was removed in vacuo to give a 
yellow oil. Recrystallisation from ethanol gave white needles, 162 mg 
(44% yield), mp 82-83 °C, Rf 0.46 (50% EtOAc/hexane); vmax (KBr disc) 
3100, 2240, 1610, 1465 and 1420 c n r l;  8H (200 MHz) (CDCI3) 8.35 
(1H, s, 5-H); 5C (50 MHz) 111.0 and 112.0 (C-6  and 7), 129.3 (C-4), 
134.6 (C-5) and 138.5 (C-2); m /z  135 (M+, 55%), 83 (100%) and 58 
(Found M+, 134.9874. C5HN3S requires M, 134.9891).
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7.5 Experimental to Chapter 6 .
4-Hvdroxvpiperidine-ds-2,6-dicarboxvlic Acid (203) and 
Piperidine-ds-2,6-dicarboxvlic Acid (204).143
OH
A S 3. ^ 5'
h o 2c ^ n ^ c o 2 h o 2c^ n ^ c o 2
' h 2 8 7' H2 8
(203) (204)
An aqueous solution of chelidamic acid (5.0 g, 27.3 mmol) 
was hydrogenated in the presence of 5% rhodium-alumina catalyst 
(0.20 g, 4% by weight) for 8  h at 80 °C and 10 Bar. The reaction 
mixture was filtered and concentrated in vacuo to give a brown solid, 
5.37 g (approximately quantitative yield); vmax (KBr disc) 3465, 3170, 
2980, 2510, 1710, 1635, 1355 and 1075 cn ri;  5H (200 MHz) (D2 0) 
1.18-2.10 (10H, br m, 3-, 3'-, 4'-, 5- and 5'-H2) and 3.39-3.58 (5H, br 
m, 2, 2'-, 4-, 6 - and 6 '-H); 5C (50 MHz) 22.9 (C-4'), 26.0 (C-3* and 5'),
34.2 (C-3 and 5), 56.7 and 58.5 (C-2, 2', 6  and 6 '), 66.3 (C-4), 172.6 
and 173.4 (C-7, 7’, 8  and 8 ').
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Dimethvl 4-Hydroxypiperidine-c/s-2.6-dicarboxvlate (205) 
and Dimethvl Piperidine-cis-2.6-dicarboxvlate (206).143
OH
(205) (206)
A mixture of (203) and (204) (LOO g, approx. 5.5 mmol) in 
methanol (15 ml) and conc. sulfuric acid (1.0 ml) was heated at reflux 
for 18 h. The reaction mixture was cooled and water (15 ml) was 
added. The aqueous solution was basified with sodium carbonate (pH 
8 ), extracted with chloroform (3 x 20 ml), dried (MgSOq) and solvent 
was removed in vacuo to give a cream solid which showed two spots 
on TLC. Separation was achieved on a neutral alumina column eluting 
with ethyl acetate to give (205), 285 mg (25% yield), mp 134-136 °C 
(lit. , 14 3 134-135 o q , Rf 0.17 (EtOAc) and (206), 253 mg, (24% yield), 
mp 92-94 oc (lit. , 143 88-92 o q ,  Rf 0.67 (EtOAc).
Spectral data for compound (205): vmax (KBr disc) 3160, 
2965, 1735, 1305 and 1070 cm'1; 5H (200 MHz) (CDC13) 1.36 and 2.33 
(4H, 2 x m, 3- and 5-H2), 1.93 (2H, br s, NH and OH), 3.40 (2H, m, 2- 
and 6 -H), 3.74 (1H, m, 4-H) and 3.76 (6 H, s, 8 - and IO-H3 ); 8C (50 
MHz) 37.6 (C-3 and 5), 52.3 (C- 8  and 10), 56.3 (C-2 and 6 ), 68.0 (C-4) 
and 172.2 (C-7 and 9); m /z  217 (M +, 0.4%), 158, 140 and 80 (100%) 
(Found: M+, 217.0947; C, 49.81; H, 6.96; N, 6.33. C9 H1 5 NO5 requires M, 
217.0950; C, 49.77; H, 6.91; N, 6.45%).
Spectral data for compound (206): vmax (KBr disc) 3435, 
3340, 2980, 2870, 1735, 1445 and 1220 c n r 1; 5H (200 MHz) (CDCI3 ) 
1.43 and 2.00 (6 H, 2 x br m, 3-, 4- and 5-H2), 2.42 (1H, br s, NH), 3.40
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(2H, m, 2- and 6 -H) and 3.74 (6 H, s, 8 - and IO-H3 ); 8 c (50 MHz) 24.1 
(C-4), 28.6 (C-3 and 5), 52.1 (C- 8  and 10), 58.4 (C-2 and 6 ) and 172.9 
(C-7 and 9); m/z201 (M+, 0.8%), 142 (100%) and 82 (Found: M+, 
201.0997; C, 53.60; H, 7.49; N, 6.82. C9 H1 5 NO4  requires 201.1001; C, 
53.73; H, 7.46; N, 6.96%).
Dimethvl 4-Pioeridone-cis-2.6-dicarboxvlate (207) and 2.3- 
unsaturated analogue (208).
0  ' O
' r  i 'CH30?C^2'' N'^>C02CH3 CH30?C 2s  N'^CCHCHj
8 7 H  9 10 8 ’ 7* H  9 ‘ 10’
(207) (208)
To a mixture of compound (205) (500 mg, 2.30 mmol) and 
pyridinium dichromate (1.30 g, 1.5 equiv.) in dry dichloromethane 
( 1 0  ml) under a nitrogen atmosphere was added freshly activated, 
powdered 3A sieves (2 g) and glacial acetic acid (0.25 ml). The 
reaction mixture was stirred at room temperature for 2 h. Analysis by 
TLC indicated that no starting material remained. The reaction 
mixture was stirred with Celite (500 mg/mmol) for 20 min, filtered 
and solvent was removed in vacuo to give a dark brown solid. 
Puification was achieved on a silica gel column eluting with 2% 
methanol in dichloromethane to give 110 mg of a pale solid. Although 
this showed one spot on TLC (2 % MeOH/CFbCb), GC analysis gave two 
distinct peaks, in approximately 1:1 ratio. Further analysis by GCMS 
indicated a mixture of the ketone (207) and the over-oxidised enone
(208) to be present; vmax (KBr disc) 3450, 3300, 3245, 3010, 2960,
2 0 0
1735, 1710, 1625 and 1590 cm-l; 5H (200 MHz) (CDC13) 1.68 (1H, br s, 
-NH), 2.64 (6 H, m, 3-, 5- and 5'-H2), 3.68 (2H, d, 2- and 6 -H), 3.80 (6 H, 
s, 8 - and IO-H3 ), 3.82 (3H, s, 10'-H3), 3.91 (3H, s, 8 '-H3), 4.39 (1H, dd, 
6 '-H), 5.78 (1H, s, 3'-H) and 6.08 (1H, br s, -NH’); §c (50 MHz) 38.0 (C- 
5'), 44.2 (C-3 and 5), 52.7 (C- 8  and 10), 53.1 and 53.5 (C-8 ' and 10'), 
54.5 (C-6 1), 56.9 (C- 2  and 6 ), 102.3 (C-3’), 147.2 (C-2'), 163.3 (C-7’), 
170.2 (C-91), 171.0 (C-7 and 9), 193.5 (C-4') and 202.7 (C-4); m /z  
First peak: 215 (M+), 156 (100%), 114 and 96. Second peak: 213 (M+), 
154 (100%) and 94.
4-Hvdroxv-iV-benzvloxvcarbonvl-piperidine-eis-2,6-dicarboxvlic Acid
(209) and iV-Benzvloxvcarbonvl-piperidine-cis-2,6-dicarboxvlic Acid
I21QL
OH
h o2c n co2h
7 5 C=0 8 
O’
10 L  , ,  12
(209)
H02C 2 N 6 C02H
7' *,C=0 
0
( 210 )
To a solution of the hydrogenation mixture, (203) and
(204), (2.0 g, approx. 11.0 mmol), and benzyl triethylammonium 
chloride (450 mg, 2.0 mmol) in 2M aqueous sodium hydroxide (10 ml) 
at 0 °C was added dropwise with stirring a solution of benzyl 
chloroformate (1.58 ml, 11.05 mmol) in diethyl ether (10 ml). The 
two-phase mixture was allowed to warm to room temperature and
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was heated at 50 °C overnight with vigorous stirring. The aqueous 
layer was acidified with 1M hydrochloric acid and extracted with 
ethyl acetate (3 x 10 ml). The combined organic extracts were dried 
(MgSCU), filtered and concentrated in vacuo to give a white, 
amorphous solid, 1.14 g, (approx. 35% yield); vmax (KBr disc) 3485, 
3035, 2955, 2540, 1695, 1630 and 1090 cm-!. Analysis by 1H NMR 
and 13C NMR showed this to be a 1:1 mixture of compounds (209) 
and (210). SH ( 2 0 0  MHz) (CDC13 /D6 -DMS0) 1.39-2.40 (1 0 H, m, 3-, 3’-, 
4'-, 5- and 5'-H2), 4.08 (1H, m, 4-H), 4.73 (4H, br d, 2-, 2’-, 6 - and 6 '- 
H), 5.16 (4H, br s, 10- and lO'-H), 7.32 (10H, s, 11-, 11’-, 12-, 12’-, 13- 
, 13’-, 14-, 14’-, 15-, 15’-, 16- and 16’-H) and 10.75 (4H, br s, 4 x 
-C02 H); 5c (50 MHz) 16.5 (C-41), 25.9 (C-3f and 5’), 32.5 (C-3 and 5),
51.3 and 54.1 (C-2, 2', 6  and 6 ’), 59.9 (C-4), 67.5 (C-10 and 10’), 127.3,
127.8 and 128.2 (C-12, 12’, 13, 13’, 14, 14’, 15, 15’, 16 and 16’), 135.6 
(C-ll and 11’), 155.5 (C-9 and 9’), 177.3 and 177.6 (C-7, 7', 8  and 8 ').
Dimethvl 4-Hvdroxv-N-benzvloxvcarbonvl-piperidine-cis-
2.6-dicarboxvlate (211) and Dimethvl N'-Benzvloxvcarbonvl- 
piperidine-cis-2 ,6 -dicarboxvlate (2 1 2 ).
A mixture of (209 ) and (210 ), (1.0 g, approx. 3.1 mmol), in 
methanol (20 ml) and conc. H2 SO4  (0.5 ml) was heated at reflux 
overnight. The reaction mixture was cooled, water was added, and the 
solution was carefully neutralised with sodium  carbonate (pH 8-9) 
and extracted with chloroform (3 x 15 ml). The com bined organic 
extracts were dried (MgSC>4 ) and concentrated in vacuo  to give a clear 
oil which showed two spots on TLC Separation was achieved on a 
silica gel column eluting with ethyl acetate to give (2 1 1 ) , 520 mg 
(49% yield), Rf 0.44 (EtOAc) and (2 1 2 ), 410 mg (39% yield), Rf 0.66  
(EtOAc).
Spectral data for com pound (2 1 1 ) :  vmax (CHCI3 solution) 
3470, 3020, 2900, 2850, 1745, 1700 and 1090 cm-1; 8h (200 MHz) 
(CDCI3 ) 1.84 and 2.42 (4H, 2 x m, 3- and 5 -H2 ), 3.59 ( 1 H, d, J 3 .6  Hz, 
-OH. Signal absent after D2 O exchange), 3.70 (6 H, s, 8 - and IO-H3 ),
4.08 (1H, br m, 4-H), 4.95 (2H, dd, J  1.7 and 7.0 Hz, 2- and 6 -H), 5.20  
(2H, br s, I 2 -H2 ) and 7.36 (5H, s, 14-, 15-, 16-, 17- and 18-H); 5c (50 
MHz) 31.9 (C-3 and 5), 50.5 (C-2 and 6 ), 52.3 (C- 8  and 10), 61.7 (C-4),
68.0 (C-12), 127.9 (C-14 and 18), 128.1 (C-16), 128.4 (C-15 and 17),
136.4 (C-13), 155.8 (C ll)  and 173.4 (C-7 and 9); m /z  351 (M* 1.3%), 
292, 260, 248, 230, 216 and 91 (100%) (Found: M+, 3 5 1 .1 3 1 6 . 
C17H2 1 NO7 requires M, 351.1318).
Spectral data for com pound (2 1 2 ) :  vmax (CHCI3 solution) 
3015, 2955, 1740 and 1700 cm-l; Sh (200 MHz) (CDCI3 ) 1.69 and 2.20 
(6 H, 2 x m, 3-, 4- and 5-H2), 3.67 (6 H, br s, 8 - and IO-H3 ), 4.89 (2H, br 
m, 2- and 6 -H), 5.20 (2H, br d, 12-H2) and 7.35 (5H, br s, 14-, 15-, 16- 
, 17- and 18-H); 5C (50 MHz) 16.5 (C-4), 25.6 (C-3 and 5), 52.0 (C- 8  
and 10), 52.4 (C-2 and 6 ), 67.8 (C-12), 127.9 (C-14 and 18), 128.1 (C-
16), 128.5 (C-15 and 17), 136.3 (C-13), 156.1 (C -ll)  and 171.6 (C-7
203
and 9); m /z  335 (Af+, 0.3%), 276, 232, 200, 140 and 91 (100%) 
(Found: M+, 335.1387. C1 7 H2 1 NO6  requires M, 335.1405).
To a solution of N-iodosuccinimide (0.91 g, 4.06 mmol) and 
tetra-N-butylammonium iodide (300 mg, 0.81 mmol) in distilled 
dichloromethane (6 ml) was added compound (211) (285 mg, 0.81 
mmol) in dichloromethane (4 ml). The dark solution was stirred at 
room temperature, under a nitrogen atmosphere for 12 h. The 
reaction mixture was diluted with saturated sodium thiosulfate 
solution (10 ml) and washed with water (3 x 8 ml). The organic 
portion was dried (MgSOq), filtered and the solvent was removed in 
vacuo to give a dark yellow oil. Purification was achieved on a silica 
gel column eluting with 50% ethyl acetate in hexane to give a pale 
solid, 170 mg (32% yield), mp 74-76 °C, Rf 0.30 (50% EtOAc/hexane); 
Vmax (KBr disc) 3425, 3010, 2985, 1745, 1715 and 1700 cm'1; 5H (200 
MHz) (CDCI3 ) 2.84 (4H, m, 3- and 5-H2), 3.65 and 3.76 (6 H, 2 x s, 8 -
Dimethvl N-Benzvloxvcarbonvl-4-piperidone- 
cis-2 .6 -dicarboxvlate (213).
O
17
and IO-H3 ), 5.01 (1 H, br t, 2-H), 5.24 (3H, br d and t, 12-H2 and 6 -H)
204
and 7.36 (5H, s, 14-, 15-, 16-, 17- and 18-H); 5c (50 MHz) 39.7 and
40.0 (C-3 and 5), 52.7 and 52.8 (C- 8  and 10), 53.3 and 53.6 (C-2 and 
6 ), 6 8 . 6  (C-12), 128.1 (C-14 and 18), 128.4 (C-16), 128.6 (C-15 and
17), 135.5 (C-13), 155.1 (C-ll), 171.0 (C-7 and 9) and 202.7 (C-4); 
m /z  349 (M+, 6.4%), 290, 246, 214 and 91 (100%) (Found: MC 
349.1178. C1 7 H1 9 NO7 requires M, 349.1194).
l,4-Pentadien-3-one-l,5-dicarboxvlic acid (215).148
2-Furanacrylic acid (5.00 g, 36.0 mmol) in 30% aqueous 
hydrogen peroxide solution (50 ml) and conc. hydrochloric acid (5 ml) 
was stirred at room temperature for 5 d. The resultant orange 
precipitate was filtered, washed with methanol and dried to give a 
pale orange solid, 2.21 g (36% yield), mp 230-235 °C (lit. , 14 8  243-245 
°C); vmax (KBr disc) 3450, 3035, 2650, 1700, 1665, 1640, 1410 and 
1000 cm-1; m /z  170 (M+, 100%), 153 and 125 (Found: M4-, 170.0206; 
C, 49.24; H, 3.45. C7 H6 0 5 requires M, 170.0215; C, 49.42; H, 3.55).
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Dimethvl l,4-Pentadien-3-one-l,5-dicarboxvlate (216).
0
A
h 3c o 2c
/ l  s \ ‘C02CH3
A solution of (2 1 5 ) (250 mg, 1.47 mmol) in methanol (3 ml) 
and conc. sulfuric acid (0.2 ml) was heated at reflux for 30 min. The 
solution was concentrated in vacuo  to give a brown residue. 
Crystallisation from ethyl acetate gave an orange solid, 220 mg (76%
1325 and 1000 cm'l; SH (200 MHz) (CDCI3 ) 3.84 (6 H, s, 7- and 9-H3), 
6.82 and 7.34 (4H, AB system, J 15«9 Hz, 1-, 2-, 4- and 5-H); 5c (50 
MHz) 52.5 (C-7 and 9), 132.7 and 137.6 (C-l, 2, 4 and 5), 165.5 (C- 6  
and 8 ) and 195.1 (C-3); m /z  198 (M+, 46%), 167 (100%) and 139 
(Found: M+, 198.0523. C9 H1 0 O5 requires M, 198.0528).
Mixture of the cis- (218) and trans- isomers of Diammonium 
Piperidin-4-one-2.6 -dicarboxvlate (217).
0
A solution of (2 1 5 ) (1.00 g, 5.88 mmol) in conc. ammonia 
solution (15 ml) was heated at reflux for 3 h. Concentration in vacuo
yield), mp 169-171 °C; vmax (KBr disc) 3060, 2950, 1725, 1675, 1615,
Sh/ o 2( A ' ' iA 6A o ; nh4
H
206
followed by drying over phosphorus pentoxide gave a dark brown 
solid, 940 mg (72% yield), mp >300 °C (lit. , 1 4 3  >300 °C); vmax (KBr 
disc) 3450, 2970, 1620, 1590 and 1250 c n r l ;  5H (200 MHz) (D?0) 
2.28-2.33 (4H, m, 3- and 5-H?) and 4.20 (2H, m, 2- and 6 -H); 5c (50 
MHz) 55.5 (C-3 and 5), 90.2 (C-2 and 6 ), 173.5 and 174.3 (C-7 and 8 ) 
and 201.3 (C-4); m /z  185 (-2 x H2 0, 11%), 143 and 79 (100%) (Found: 
185.0735. C7 H1 0 N3 O3 requires 185.0756).
2,2,6,6-Tetramethvl-4-piperidone Oxime Hydrochloride (221).
To a solution of 2,2,6,6-tetramethyl-4-piperidone (1.48 g, 
6.18 mmol) in dichloromethane (5 ml) was added a solution of 
hydroxylamine hydrochloride (594 mg, 1.0 equiv.) in water (5 ml). 
The two-phase mixture was stirred rapidly at room temperature for 3 
h. The resultant precipitate was filtered and triturated with ethereal 
HC1 to give a pale solid, 854 mg (67% yield), mp 290-293 °C 
(decomp.); vmax (KBr disc) 3280, 2955, 2820, 2600, 2480 and 1590 
c m - l ;  sH (200 MHz) (D2 0) 1.28 (12H, s, 7-, 8 -, 9- and IO-H3 ), 2.30 and 
2.58 (4H, 2 x s, 3- and 5-H2); 5c (50 MHz) 27.3 and 27.6 (C-7, 8 , 9 and 
10), 34.7 and 41.1 (C-3 and 5), 59.4 and 59.6 (C-2 and 6 ) and 154.0 
(C-4); m /z  170 (M+, 41.7%), 155 (100%), 110 and 36/38 (3:1) (Found: 
M+, 170.1423. C9 HigN2 0  requires M, 170.1419).
NOH
Cl
207
2.2.6.6-Tetramethvl-4-piperidone Methoxime (222).
NOCH
To a solution of 2,2,6,6-tetramethyl-4-piperidone (1.19 g, 
6.85 mmol) in dichloromethane (5 ml) was added a solution of 
methoxylamine hydrochloride (572 mg, 1.0 equiv.) in water (5 ml). 
The two-phase mixture was stirred rapidly at room temperature for 
48 h. The mixture was extracted with dichloromethane (2 x 10 ml), 
the combined organic extracts were dried (MgSCU) and the solvent 
was removed in vacuo to give a pale yellow solid, 1 1 2  mg ( 1 1 % 
yield), mp 255-257 °C (decomp.); vmax (KBr disc) 3440, 2960, 2815, 
1580, 1400 and 1050 c n r1; 5H (200 MHz) (CDCI3 ) 1.61 and 1.63 (12H, 
2 x s, 7-, 8 -, 9- and IO-H3 ), 2.50 and 2.78 (4H, 2 x s, 3- and 5-H2) and 
3.87 (3H, s, II-H 3 ); 5c (50 MHz) 27.6 and 27.8 (C-7, 8 , 9 and 10), 36.1 
and 41.5 (C-3 and 5), 58.9 and 59.1 (C-2 and 6 ), 61.6 (C-ll) and 151.1 
(C-4); m /z  184 (M+, 37%), 169, 153, 122 and 98 (100%) (Found: MC 
184.1568. C1 0 H2 0 N2 O requires M, 184.1576).
7.6 Test Data for Chapters 3. 4. 5 and 6 .
The standard assay for DHDP synthase was set up by 
Borthwick, 1 0 8  details of which are given in Section 3.4, Chapter 3 of 
this thesis. The following tables show the percentage inhibition of 
DHDP synthase when tested with various concentrations of inhibitors.
Test Data for Chapter 3.
Compound 
no. or name
Experimental 
page no.
Inhibitor concentration 
1 mM 0.5 miM 0.25 mM 0.1 mM
( 1 1 1 ) 148 15% 0 % - -
(1 1 2 ) 149 3% - - -
(113) 150 1 0 0 % - 33% 0 %
(114) 151 59% 17% - 0 %
(116) 152 14% 0 % - -
(117) 153 2 2 % 0 % - -
(118) 154 1 0 0 % - - 46%
Test Data for Chapter 4 .
Compound 
no. or name
Experimental 
page no.
Inhibitor concentration 
5 mM 4 mM 3 mM 1 mM
(126) 170 24% - - 0 %
(127) 171 8 % - - 0 %
(152) 172 0 % - - -
(143) 165 - - 53% 1 1 %
(144) 166 - 40% - 15%
(149) 168 - - 50% 0 %
(150) 169 - 51% - 25%
(180) 191 - - - 27%
209
Test Data for Chapter 5.
Compound 
no. or name
Experimental 
page no.
Inhibitor concentration 
1 mM 0.5 mM 0.25 mM 0.1 mM
(42) 192 85% 23% - 13%
(43) 196 1 0 0 % 1 0 0 % 1 0 0 % 15%
(2 0 1 ) 197 - - 47% 18%
Test Data for Chanter 6 .
Compound 
no. or name
Experimental 
page no.
Inhibitor concentration 
5 mM 1 mM 0.5 mM 0.1 mM
(205) 199 29% 0 % - -
(206) 199 6 % - - -
(207)/(208) 2 0 0 64% 1 1 %
(2 1 1 ) 2 0 2 0 % - - -
(2 1 2 ) 2 0 2 0 % - - -
(213) 204 1 2 % - - -
(217/218) 206 1 0 0 % 65% - 28%
(219) - - 89% 46% -
(2 2 0 ) - - 90% 2 2 % -
(2 2 1 ) 207 - - 8 % -
(2 2 2 ) 208 - - 23% -
2 1 0
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